QUARTERLY REPORT

Q1 FY2023 — Quarterly report

Q1 FY2023PDF · 81 pages1.1 MB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended August 28, 2022
OR
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission File Number: 1-37830
LAMB WESTON HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware 	61-1797411
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
599 S. Rivershore Lane
Eagle, Idaho 	83616
(Address of principal executive offices) 	(Zip Code)
(208) 938-1047
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s) 	Name of each exchange on which registered
Common Stock, $1.00 par value 	LW 	New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during
the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of September 28, 2022, the Registrant had 143,831,204 shares of common stock, par value $1.00 per share, outstanding.

-- 1 of 81 --

Table of Contents
2
Table of Contents
Part I. FINANCIAL INFORMATION
Item 1 Financial Statements (Unaudited)
Consolidated Statements of Earnings 	3
Consolidated Statements of Comprehensive Income 	4
Consolidated Balance Sheets 	5
Consolidated Statements of Stockholders’ Equity 	6
Consolidated Statements of Cash Flows 	7
Condensed Notes to Consolidated Financial Statements (Unaudited) 	8
Item 2 Management's Discussion and Analysis of Financial Condition and Results of Operations 	20
Item 3 Quantitative and Qualitative Disclosures About Market Risk 	28
Item 4 Controls and Procedures 	29
Part II. OTHER INFORMATION 	30
Item 1 Legal Proceedings 	30
Item 1A Risk Factors 	30
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 	30
Item 3 Defaults Upon Senior Securities 	30
Item 4 Mine Safety Disclosures 	30
Item 5 Other Information 	30
Item 6 Exhibits 	31
Signature 	32

-- 2 of 81 --

Table of Contents
3
PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS (Unaudited)
Lamb Weston Holdings, Inc.
Consolidated Statements of Earnings
(unaudited, in millions, except per share amounts)
Thirteen Weeks Ended
August 28, 	August 29,
2022 	2021
Net sales 	$ 1,125.6 $ 	984.2
Cost of sales 	852.3 	832.9
Gross profit 	273.3 	151.3
Selling, general and administrative expenses 	116.3 	91.1
Income from operations 	157.0 	60.2
Interest expense, net 	26.0 	27.9
Income before income taxes and equity method earnings 	131.0 	32.3
Income tax expense 	73.7 	8.7
Equity method investment earnings 	174.6 	6.2
Net income 	$ 	231.9 $ 	29.8
Earnings per share:
Basic 	$ 	1.61 $ 	0.20
Diluted 	$ 	1.60 $ 	0.20
Weighted average common shares outstanding:
Basic 	144.0 	146.3
Diluted 	144.6 	146.9
See Condensed Notes to Consolidated Financial Statements.

-- 3 of 81 --

Table of Contents
4
Lamb Weston Holdings, Inc.
Consolidated Statements of Comprehensive Income
(unaudited, dollars in millions)
Thirteen Weeks Ended 	Thirteen Weeks Ended
August 28, 2022 	August 29, 2021
Tax 	Tax
Pre-Tax 	(Expense) 	After-Tax 	Pre-Tax 	(Expense) 	After-Tax
Amount 	Benefit 	Amount 	Amount 	Benefit 	Amount
Net income 	$ 305.6 $ (73.7) $ 231.9 $ 	38.5 $ 	(8.7) $ 	29.8
Other comprehensive income (loss):
Reclassification of post-retirement benefits
out of accumulated other comprehensive
income 	— 	— 	— 	0.1 	— 	0.1
Unrealized currency translation gains
(losses) 	(31.7) 	1.0 	(30.7) 	(23.8) 	1.5 	(22.3)
Other 	0.2 	— 	0.2 	— 	— 	—
Comprehensive income 	$ 274.1 $ (72.7) $ 201.4 $ 	14.8 $ 	(7.2) $ 	7.6
See Condensed Notes to Consolidated Financial Statements.

-- 4 of 81 --

Table of Contents
5
Lamb Weston Holdings, Inc.
Consolidated Balance Sheets
(unaudited, dollars in millions, except share data)
August 28, 	May 29,
2022 	2022
ASSETS
Current assets:
Cash and cash equivalents 	$ 	485.3 $ 	525.0
Receivables, less allowance for doubtful accounts of $1.8 and $1.1 	449.5 	447.3
Inventories 	635.5 	574.4
Prepaid expenses and other current assets 	59.9 	112.9
Total current assets 	1,630.2 	1,659.6
Property, plant and equipment, net 	1,690.9 	1,579.2
Operating lease assets 	112.3 	119.0
Equity method investments 	372.5 	257.4
Goodwill 	352.2 	318.0
Intangible assets, net 	32.8 	33.7
Other assets 	218.8 	172.9
Total assets 	$ 	4,409.7 $ 	4,139.8
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Short-term borrowings 	$ 	9.1 $ 	—
Current portion of long-term debt and financing obligations 	32.2 	32.2
Accounts payable 	462.7 	402.6
Accrued liabilities 	276.3 	264.3
Total current liabilities 	780.3 	699.1
Long-term liabilities:
Long-term debt and financing obligations, excluding current portion 	2,700.1 	2,695.8
Deferred income taxes 	218.7 	172.5
Other noncurrent liabilities 	200.6 	211.9
Total long-term liabilities 	3,119.4 	3,080.2
Commitments and contingencies
Stockholders' equity:
Common stock of $1.00 par value, 600,000,000 shares authorized; 148,286,975 and
148,045,584 shares issued 	148.3 	148.0
Additional distributed capital 	(796.9) 	(813.3)
Retained earnings 	1,501.8 	1,305.5
Accumulated other comprehensive loss 	(46.1) 	(15.6)
Treasury stock, at cost, 4,456,388 and 3,974,156 common shares 	(297.1) 	(264.1)
Total stockholders' equity 	510.0 	360.5
Total liabilities and stockholders’ equity 	$ 	4,409.7 $ 	4,139.8
See Condensed Notes to Consolidated Financial Statements.

-- 5 of 81 --

Table of Contents
6
Lamb Weston Holdings, Inc.
Consolidated Statements of Stockholders’ Equity
(unaudited, dollars in millions, except share data)
Thirteen Weeks Ended August 28, 2022 and August 29, 2021
Additional 	Accumulated
Common Stock, Common Treasury 	Paid-in 	Other 	Total
net of Treasury 	Stock 	Stock 	(Distributed) 	Retained Comprehensive Stockholders’
Shares 	Amount Amount 	Capital 	Earnings 	Income (Loss) 	Equity
Balance at May 29, 2022 	144,071,428 $ 148.0 $ (264.1) $ 	(813.3) $ 1,305.5 $ 	(15.6) $ 	360.5
Dividends declared, $0.245 per share 	— 	— 	— 	— 	(35.2) 	— 	(35.2)
Common stock issued 	241,391 	0.3 	— 	0.2 	— 	— 	0.5
Stock-settled, stock-based compensation
expense 	— 	— 	— 	7.6 	— 	— 	7.6
Repurchase of common stock and common
stock withheld to cover taxes 	(482,232) 	— 	(33.0) 	— 	— 	— 	(33.0)
Other 	— 	— 	— 	8.6 	(0.4) 	— 	8.2
Comprehensive income 	— 	— 	— 	— 	231.9 	(30.5) 	201.4
Balance at August 28, 2022 	143,830,587 $ 148.3 $ (297.1) $ 	(796.9) $ 1,501.8 $ 	(46.1) $ 	510.0
Balance at May 30, 2021 	146,191,864 $ 147.6 $ (104.3) $ 	(836.8) $ 1,244.6 $ 	29.5 $ 	480.6
Dividends declared, $0.235 per share 	— 	— 	— 	— 	(34.4) 	— 	(34.4)
Common stock issued 	376,001 	0.4 	— 	1.5 	— 	— 	1.9
Stock-settled, stock-based compensation
expense 	— 	— 	— 	5.2 	— 	— 	5.2
Repurchase of common stock and common
stock withheld to cover taxes 	(506,849) 	— 	(33.4) 	— 	— 	— 	(33.4)
Other 	— 	— 	— 	(0.1) 	— 	— 	(0.1)
Comprehensive income 	— 	— 	— 	— 	29.8 	(22.2) 	7.6
Balance at August 29, 2021 	146,061,016 $ 148.0 $ (137.7) $ 	(830.2) $ 1,240.0 $ 	7.3 $ 	427.4
See Condensed Notes to Consolidated Financial Statements.

-- 6 of 81 --

Table of Contents
7
Lamb Weston Holdings, Inc.
Consolidated Statements of Cash Flows
(unaudited, dollars in millions)
Thirteen Weeks Ended
August 28, 	August 29,
2022 	2021
Cash flows from operating activities
Net income 	$ 	231.9 $ 	29.8
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of intangibles and debt issuance costs 	49.8 	47.3
Stock-settled, stock-based compensation expense 	7.6 	5.2
Equity method investment (earnings) loss in excess of distributions 	(174.6) 	3.5
Deferred income taxes 	34.5 	1.7
Other 	(2.8) 	1.5
Changes in operating assets and liabilities, net of acquisition:
Receivables 	9.9 	(35.1)
Inventories 	(51.5) 	43.4
Income taxes payable/receivable, net 	42.3 	9.7
Prepaid expenses and other current assets 	45.5 	33.0
Accounts payable 	24.3 	10.0
Accrued liabilities 	(24.8) 	11.8
Net cash provided by operating activities 	$ 	192.1 $ 	161.8
Cash flows from investing activities
Additions to property, plant and equipment 	(101.2) 	(78.9)
Acquisition of interest in joint venture, net 	(42.3) 	—
Additions to other long-term assets 	(20.0) 	—
Other 	(3.4) 	0.1
Net cash used for investing activities 	$ 	(166.9) $ 	(78.8)
Cash flows from financing activities
Proceeds from issuance of debt 	13.8 	—
Repayments of debt and financing obligations 	(8.0) 	(7.9)
Dividends paid 	(35.3) 	(34.4)
Repurchase of common stock and common stock withheld to cover taxes 	(34.4) 	(33.4)
Other 	0.4 	(0.1)
Net cash used for financing activities 	$ 	(63.5) $ 	(75.8)
Effect of exchange rate changes on cash and cash equivalents 	(1.4) 	(1.0)
Net (decrease) increase in cash and cash equivalents 	(39.7) 	6.2
Cash and cash equivalents, beginning of period 	525.0 	783.5
Cash and cash equivalents, end of period 	$ 	485.3 $ 	789.7
See Condensed Notes to Consolidated Financial Statements.

-- 7 of 81 --

Table of Contents
8
Lamb Weston Holdings, Inc.
Condensed Notes to Consolidated Financial Statements
(Unaudited)
1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Lamb Weston Holdings, Inc. (“we,” “us,” “our,” the “Company,” or “Lamb Weston”), along with our joint
ventures, is a leading global producer, distributor, and marketer of value-added frozen potato products and is headquartered
in Eagle, Idaho. We have four reportable segments: Global, Foodservice, Retail, and Other. See Note 13, Segments, for
additional information on our reportable segments.
Basis of Presentation
The accompanying unaudited Consolidated Financial Statements present the financial results of Lamb Weston for
the thirteen weeks ended August 28, 2022 and August 29, 2021, and have been prepared in accordance with generally
accepted accounting principles (“GAAP”) in the United States of America (“U.S”).
These consolidated financial statements are unaudited, and include all adjustments that we consider necessary for
a fair presentation of such financial statements and consist only of normal recurring adjustments. The preparation of
financial statements involves the use of estimates and accruals. The actual results that we experience may differ materially
from those estimates. Results for interim periods should not be considered indicative of results for our full fiscal year,
which ends the last Sunday in May.
These financial statements and condensed notes should be read together with the consolidated financial statements
and notes in our Annual Report on Form 10-K for the fiscal year ended May 29, 2022 (the “Form 10-K”), where we
include additional information on our critical accounting estimates, policies, and the methods and assumptions used in our
estimates. We filed the Form 10-K with the Securities and Exchange Commission on July 27, 2022.
There were no accounting pronouncements recently issued that had or are expected to have a material impact on
our consolidated financial statements.

-- 8 of 81 --

Table of Contents
9
2. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per common share for the periods
presented:
Thirteen Weeks Ended
August 28, 	August 29,
(in millions, except per share amounts) 	2022 	2021
Numerator:
Net income 	$ 	231.9 $ 	29.8
Denominator:
Basic weighted average common shares outstanding 	144.0 	146.3
Add: Dilutive effect of employee incentive plans (a) 	0.6 	0.6
Diluted weighted average common shares outstanding 	144.6 	146.9
Earnings per share:
Basic 	$ 	1.61 $ 	0.20
Diluted 	$ 	1.60 $ 	0.20
(a) Potential dilutive shares of common stock under employee incentive plans are determined by applying the treasury stock method to
the assumed exercise of outstanding stock options and the assumed vesting of outstanding restricted stock units and performance
awards. As of August 28, 2022, 0.6 million shares of stock-based awards were excluded from the computation of diluted earnings
per share because they would be antidilutive. As of August 29, 2021, an insignificant number of stock-based awards were excluded
from the computation of diluted earnings per share because they would be antidilutive.
3. INCOME TAXES
Income tax expense was $73.7 million and $8.7 million for the thirteen weeks ended August 28, 2022 and August
29, 2021, respectively. The effective income tax rate (calculated as the ratio of income tax expense to pre-tax income,
inclusive of equity method investment earnings) was 24.1% and 22.6% for the thirteen weeks ended August 28, 2022 and
August 29, 2021, respectively, in our Consolidated Statements of Earnings. The effective tax rate varies from the U.S.
statutory tax rate of 21% principally due to the impact of U.S. state taxes, foreign taxes, permanent differences, and discrete
items. Excluding the impact of both the gain associated with the acquisition of an additional 40% interest in our Argentina
joint venture, Lamb Weston Alimentos Modernos S.A. (“LWAMSA”), and the mark-to-market adjustments associated with
changes in natural gas and electricity derivatives at our Lamb-Weston/Meijer v.o.f (“LWM”) joint venture, which are
discussed at Note 6, Joint Venture Investments, and Note 13, Segments, respectively, our effective tax rate was 25.0%.
Income Taxes Paid
Income tax refunds, net of taxes paid, were $3.2 million and $2.9 million during the thirteen weeks ended August
28, 2022 and August 29, 2021, respectively.

-- 9 of 81 --

Table of Contents
10
4. INVENTORIES
Inventories are valued at the lower of cost (determined using the first-in, first-out method) or net realizable value
and include all costs directly associated with manufacturing products: materials, labor, and manufacturing overhead. The
components of inventories were as follows:
August 28, 	May 29,
(in millions) 	2022 	2022
Raw materials and packaging 	$ 	89.3 $ 	96.1
Finished goods 	493.7 	426.5
Supplies and other 	52.5 	51.8
Inventories 	$ 	635.5 $ 	574.4
5. PROPERTY, PLANT AND EQUIPMENT
The components of property, plant and equipment were as follows:
August 28, 	May 29,
(in millions) 	2022 	2022
Land and land improvements 	$ 	118.2 $ 	114.1
Buildings, machinery, and equipment 	2,982.7 	2,919.0
Furniture, fixtures, office equipment, and other 	98.2 	92.1
Construction in progress 	236.5 	156.1
Property, plant and equipment, at cost 	3,435.6 	3,281.3
Less accumulated depreciation 	(1,744.7) 	(1,702.1)
Property, plant and equipment, net 	$ 1,690.9 $ 1,579.2
Depreciation expense was $47.3 million and $44.5 million for the thirteen weeks ended August 28, 2022 and
August 29, 2021, respectively. At August 28, 2022 and May 29, 2022, purchases of property, plant and equipment included
in accounts payable were $64.4 million and $38.3 million, respectively.
Interest capitalized within construction in progress for the thirteen weeks ended August 28, 2022 and August 29,
2021, was $2.0 million and $1.2 million, respectively.
6. JOINT VENTURE INVESTMENTS
Consolidated Joint Ventures
In July 2022, we acquired an additional 40% interest in LWAMSA, which increased our total ownership from 50%
to 90%. We recorded LWAMSA’s assets and liabilities at fair value, which included remeasuring our previously held equity
interest at fair value, and we recognized a $15.1 million gain in “Equity method investment earnings” in our Consolidated
Statement of Earnings. The fair value was determined utilizing industry EBITDA multiples and control premium
comparable information, which are unobservable inputs, or Level 3 in the fair value hierarchy. We recorded the preliminary
fair values as of the date of acquisition.
In connection with the purchase of the additional interest in LWAMSA, we ceased equity method accounting and
began consolidating LWAMSA’s financial statements. The net sales, income from operations, and total assets acquired were
not material to our consolidated net sales, income from operations, and total assets. LWAMSA’s operating results are
included in our Global segment.

-- 10 of 81 --

Table of Contents
11
On September 6, 2022, we announced an expansion of french fry processing capacity in Argentina with the
planned construction of a new manufacturing facility in Mar del Plata. The new processing facility is expected to produce
more than 200 million pounds of frozen french fries and other potato products per year. Construction of the new line is
expected to be completed in fiscal 2025. The total investment is expected to be approximately $240 million. This
investment will add to the capacity produced at LWAMSA’s existing production facility in Buenos Aires.
Noncontrolling Interest
As of August 28, 2022, total LWAMSA interest not directly attributable to Lamb Weston, or NCI, was $8.2
million and was recorded in “Additional distributed capital” on our Consolidated Balance Sheet. For the thirteen weeks
ended August 28, 2022, the net loss attributable to NCI was not significant and was recorded in “Selling, general and
administrative expenses” in our Consolidated Statement of Earnings.
Unconsolidated Joint Ventures
Our equity method investments were as follows:
August 28, 	May 29,
(in millions) 	2022 	2022
LWM (a) 	$ 	347.8 	$ 	211.2
Lamb-Weston/RDO Frozen ("Lamb Weston RDO") (b) 	24.1 	19.4
LWAMSA (c) 	— 	26.1
Other 	0.6 	0.7
$ 	372.5 	$ 	257.4
(a) We own 50% of LWM, a joint venture with Meijer Frozen Foods B.V., headquartered in the Netherlands that manufactures and sells
frozen potato products principally in Europe and the Middle East. The investment balance includes $146.3 million of unrealized
gains related to mark-to-market adjustments associated with changes in natural gas and electricity derivatives as commodity
markets in Europe have experienced significant volatility during the thirteen weeks ended August 28, 2022. In September 2022,
LWM completed the previously announced withdrawal from its joint venture in Russia.
(b) We own 50% of Lamb Weston RDO, a joint venture with RDO Frozen Co., that operates a potato processing facility in the U.S.
(c) In July 2022, we acquired an additional 40% interest in LWAMSA, increasing our total ownership to 90% and began consolidating
the joint venture.
We have an agreement to share the costs of our global enterprise resource planning (“ERP”) system and related
software and services with LWM. Under the terms of the agreement, LWM will pay us for the majority of its portion of the
ERP costs in five equal annual payments, plus interest, beginning in the period the system is deployed at LWM. At August
28, 2022 and May 29, 2022, LWM’s portion of the ERP costs totaled $29.5 million and $23.4 million, respectively. We had
$25.3 million and $20.5 million of receivables recorded in “Other assets” on our Consolidated Balance Sheets at August
28, 2022 and May 29, 2022, respectively. We expect the total receivable from LWM to increase as development and
implementation of the next phase of our ERP system continues throughout fiscal 2023.

-- 11 of 81 --

Table of Contents
12
7. GOODWILL AND OTHER IDENTIFIABLE INTANGIBLE ASSETS
The following table presents changes in goodwill balances, by segment, during the thirteen weeks ended August
28, 2022:
(in millions) 	Global Foodservice Retail 	Other 	Total
Balance at May 29, 2022 	$ 259.8 $ 42.8 $ 10.9 $ 4.5 $ 318.0
Acquisition of interest in joint venture (a) 	42.1 	— 	— 	— 	42.1
Foreign currency translation adjustment 	(7.9) 	— 	— 	— 	(7.9)
Balance at August 28, 2022 	$ 294.0 $ 42.8 $ 10.9 $ 4.5 $ 352.2
(a) In July 2022, we acquired an additional 40% interest in LWAMSA, which increased our total ownership from 50% to 90%, and we
recorded $42.1 million of goodwill, that is not deductible for tax purposes, in our Global segment. See Note 6, Joint Venture
Investments, for more information.
Other identifiable intangible assets were as follows:
August 28, 2022 	May 29, 2022
Weighted 	Weighted
Average 	Gross 	Average 	Gross
Useful Life Carrying Accumulated Intangible Useful Life Carrying Accumulated Intangible
(dollars in millions) 	(in years) Amount Amortization Assets, Net (in years) Amount Amortization Assets, Net
Non-amortizing intangible assets (a) 	n/a 	$ 18.0 $ 	— $ 18.0 	n/a 	$ 18.0 $ 	— $ 18.0
Amortizing intangible assets (b) 	10 	41.1 	(26.3) 	14.8 	10 	41.4 	(25.7) 	15.7
$ 59.1 $ (26.3) $ 32.8 	$ 59.4 $ (25.7) $ 33.7
(a) Non-amortizing intangible assets represent brands and trademarks.
(b) Amortizing intangible assets are principally composed of licensing agreements, brands, and customer relationships. Developed
technology, which is excluded from this balance, is recorded as “Other assets” on our Consolidated Balance Sheets. Amortization
expense, including developed technology amortization expense, was $1.4 million and $1.5 million for the thirteen weeks ended
August 28, 2022 and August 29, 2021, respectively. Foreign intangible assets are affected by foreign currency translation.
8. ACCRUED LIABILITIES
The components of accrued liabilities were as follows:
August 28, 	May 29,
(in millions) 	2022 	2022
Compensation and benefits 	$ 	84.6 $ 	81.0
Accrued trade promotions 	43.4 	41.2
Income taxes payable 	36.1 	1.7
Dividends payable to shareholders 	35.2 	35.3
Current portion of operating lease obligations 	22.8 	22.4
Accrued interest 	14.9 	42.1
Franchise, property, and sales and use taxes 	14.1 	10.4
Other 	25.2 	30.2
Accrued liabilities 	$ 	276.3 $ 	264.3

-- 12 of 81 --

Table of Contents
13
9. DEBT AND FINANCING OBLIGATIONS
The components of our debt, including financing obligations, were as follows:
August 28, 	May 29,
(in millions) 	2022 	2022
Short-term borrowings:
Other credit facilities 	$ 	9.1 $ 	—
Long-term debt:
Term A-1 loan facility, due June 2024 	255.0 	258.7
Term A-2 loan facility, due April 2025 	292.5 	296.6
RMB loan facility, due February 2027 (a) 	31.0 	19.7
4.875% senior notes, due May 2028 	500.0 	500.0
4.125% senior notes, due January 2030 	970.0 	970.0
4.375% senior notes, due January 2032 	700.0 	700.0
2,748.5 	2,745.0
Financing obligations:
Lease financing obligations due on various dates through 2040 (b) 	7.0 	7.0
Total debt and financing obligations 	2,764.6 	2,752.0
Debt issuance costs (c) 	(23.2) 	(24.0)
Short-term borrowings 	(9.1) 	—
Current portion of long-term debt and financing obligations 	(32.2) 	(32.2)
Long-term debt and financing obligations, excluding current portion 	$ 	2,700.1 $ 	2,695.8
(a) The effective average interest rate on this facility was 4.60% as of August 28, 2022.
(b) The interest rates on our lease financing obligations ranged from 2.08% to 3.32% as of August 28, 2022 and May 29, 2022.
(c) Excludes debt issuance costs of $3.1 million and $3.3 million as of August 28, 2022 and May 29, 2022, respectively, related to our
revolving credit facility, which are recorded in “Other assets” on our Consolidated Balance Sheets.
At August 28, 2022, we had no borrowings outstanding under our revolving credit facility and $994.6 million of
availability under the facility, which is net of outstanding letters of credit of $5.4 million. For the thirteen weeks ended
August 28, 2022, we had no borrowings under the facility.
For the thirteen weeks ended August 28, 2022 and August 29, 2021, we paid $56.8 million and $2.7 million of
interest on debt, respectively.
For more information on our debt and financing obligations, interest rates, and debt covenants, see Note 7, Debt
and Financing Obligations, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and
Supplementary Data” of the Form 10-K.

-- 13 of 81 --

Table of Contents
14
10. STOCK-BASED COMPENSATION
The Compensation and Human Capital Committee (“the Committee”) of our Board of Directors administers our
stock compensation plan. The Committee, in its discretion, authorizes grants of restricted stock units (“RSUs”),
performance awards payable upon the attainment of specified performance goals (“Performance Shares”), stock options,
dividend equivalents, and other stock-based awards. As of August 28, 2022, 6.2 million shares were available for future
grant under the plan.
RSUs
We grant RSUs to eligible employees and non-employee directors. The employee RSUs generally vest over a
three-year period while the non-employee director RSUs generally vest after one year. We estimate the fair value of the
RSUs based upon the market price of our common stock on the date of grant. Compensation expense is recognized over the
period the employee or non-employee director provides service in exchange for the award.
Performance Shares
Performance Shares are granted to certain executives and other key employees with vesting contingent upon
meeting various Company-wide performance goals. Awards actually earned range from 0% to 200% of the targeted number
of Performance Shares for each of the performance periods. Awards, if earned, would be paid in shares of our common
stock. Subject to limited exceptions set forth in our stock plan, any shares earned will generally vest over a three-
year service period. The value of these Performance Shares is adjusted based upon the market price of our common stock
and the anticipated attainment of Company-wide performance goals at the end of each reporting period and amortized as
compensation expense over the service period.
We have also granted Performance Shares with vesting contingent upon relative total shareholder return goals,
and, under special circumstances, stock price growth goals. Awards actually earned range from 0% to 200%, in the case of
awards contingent on total shareholder return goals, or 0% to 300%, in the case of awards contingent on stock price growth
goals, of the targeted number of Performance Shares. These Performance Shares are equity-settled awards that vest over a
three-year service period, and the number of units that actually vest is determined based on the achievement of the
performance criteria set forth in the respective award agreement. The awards are measured based on estimated fair value as
of the date of grant using a Monte Carlo simulation, and are amortized over the service period.
The weighted average Monte Carlo assumptions for Performance Shares granted during the thirteen weeks ended
August 28, 2022 were:
Assumptions
Dividend yield (%) 	0.00 - 1.42
Expected volatility of stock (%) 	42.99
Risk-free interest rate (%) 	2.89
Expected life (years) 	2.82
Weighted average grant date fair value per unit 	$ 91.43 - $118.97
Stock Options
Under special circumstances, we have granted options to employees for the purchase of stock at exercise prices
equal to the fair market value of the underlying stock on the grant date. Options generally become exercisable in three
annual installments beginning on the first anniversary of the grant date and have a maximum term of seven years.

-- 14 of 81 --

Table of Contents
15
The weighted average Black-Sholes assumptions for stock options granted during the thirteen weeks ended
August 28, 2022 were:
Assumptions
Weighted average fair value 	$ 25.90
Dividend yield (%) 	1.22
Expected volatility of stock (%) 	34.06
Risk-free interest rate (%) 	2.82
Expected life of stock option (years) 	5.75
Weighted average exercise price per share 	$ 79.66
Stock Based Compensation Grants
During the thirteen weeks ended August 28, 2022, we granted 0.3 million, 0.3 million, and 0.6 million RSUs,
Performance Shares, and stock options, respectively, at an average grant date fair value of $79.47, $92.85, and $25.90,
respectively.
Compensation Expense
Our stock-based compensation expense is recorded in “Selling, general and administrative expenses.”
Compensation expense for stock-based awards recognized in the Consolidated Statements of Earnings, net of forfeitures,
was as follows:
Thirteen Weeks Ended
August 28, 	August 29,
(in millions) 	2022 	2021
Stock-settled RSUs 	$ 	4.7 $ 	3.6
Performance Shares 	2.4 	1.6
Stock options 	0.5 	—
Total compensation expense 	$ 	7.6 $ 	5.2
Income tax benefit (a) 	(1.3) 	(0.9)
Total compensation expense, net of tax benefit 	$ 	6.3 $ 	4.3
(a) Income tax benefit represents the marginal tax rate, excluding non-deductible compensation.
Based on estimates at August 28, 2022, total unrecognized compensation expense related to stock-based awards
was as follows:
Remaining
Weighted
Unrecognized 	Average
Compensation 	Recognition
(in millions, except data in years) 	Expense 	Period (in years)
Stock-settled RSUs 	$ 	44.6 	1.9
Performance Shares 	33.9 	2.5
Stock options 	13.8 	2.0
Total unrecognized compensation expense 	$ 	92.3

-- 15 of 81 --

Table of Contents
16
11. FAIR VALUE MEASUREMENTS
The fair values of cash equivalents, receivables, accounts payable, and short-term debt approximate their carrying
amounts due to their short duration.
The following table presents our financial assets and liabilities measured at fair value on a recurring basis based
upon the level within the fair value hierarchy in which the fair value measurements fall:
As of August 28, 2022
Fair Value
of Assets
(in millions) 	Level 1 	Level 2 	Level 3 	(Liabilities)
Derivative assets (a) 	— 	3.5 	— 	3.5
Derivative liabilities (a) 	— 	(0.5) 	— 	(0.5)
Deferred compensation liabilities (b) 	— 	(22.2) 	— 	(22.2)
Fair value, net 	$ 	— $ (19.2) $ 	— $ (19.2)
As of May 29, 2022
Fair Value
of Assets
(in millions) 	Level 1 	Level 2 	Level 3 	(Liabilities)
Derivative assets (a) 	— 	7.0 	— 	7.0
Deferred compensation liabilities (b) 	— 	(21.6) 	— 	(21.6)
Fair value, net 	$ 	— $ (14.6) $ 	— $ (14.6)
(a) Derivative assets and liabilities included in Level 2 primarily represent commodity swap and option contracts. The fair values of our
Level 2 derivative assets and liabilities were determined using valuation models that use market observable inputs including both
forward and spot prices for commodities. Derivative assets are presented within “Prepaid expenses and other current assets” and
derivative liabilities are presented within “Accrued liabilities” on our Consolidated Balance Sheets.
(b) The fair values of our Level 2 deferred compensation liabilities were valued using third-party valuations, which are based on the net
asset values of mutual funds in our retirement plans. While the underlying assets are actively traded on an exchange, the funds are
not. Deferred compensation liabilities are primarily presented within “Other noncurrent liabilities” on our Consolidated Balance
Sheets.
At August 28, 2022, we had $2,170.0 million of fixed-rate and $587.6 million of variable-rate debt outstanding.
Based on current market rates, the fair value of our fixed-rate debt was estimated to be $2,006.2 million. Any differences
between the book value and fair value are due to the difference between the period-end market interest rate and the stated
rate of our fixed-rate debt. The fair value of our variable-rate term debt approximates the carrying amount as our cost of
borrowing is variable and approximates current market prices.
12. STOCKHOLDERS’ EQUITY
Share Repurchase Program
Our Board of Directors authorized a program, with no expiration date, to repurchase up to $500.0 million of our
common stock. During the thirteen weeks ended August 28, 2022, we repurchased 404,476 shares for $28.4 million, or a
weighted average price of $70.11 per share. As of August 28, 2022, $240.6 million remained authorized for repurchase
under the program.

-- 16 of 81 --

Table of Contents
17
Dividends
During the thirteen weeks ended August 28, 2022, we paid $35.3 million of dividends to common stockholders.
On September 2, 2022, we paid $35.2 million of dividends to stockholders of record as of the close of business on August
5, 2022. On September 28, 2022, our Board of Directors declared a dividend of $0.245 per share of common stock. The
dividend will be paid on December 2, 2022, to stockholders of record as of the close of business on November 4, 2022.
Accumulated Other Comprehensive Income (“AOCI”)
Changes in AOCI, net of taxes, as of August 28, 2022 were as follows:
Foreign 	Accumulated
Currency 	Pension and 	Other
Translation 	Post-Retirement 	Comprehensive
(in millions) 	Gains (Losses) 	Benefits 	Other 	Income (Loss)
Balance as of May 29, 2022 	$ 	(12.9) $ 	(3.3) $ 	0.6 $ 	(15.6)
Other comprehensive income before reclassifications,
net of tax 	(30.7) 	— 	0.2 	(30.5)
Amounts reclassified out of AOCI, net of tax 	— 	— 	— 	—
Net current-period other comprehensive income (loss) 	(30.7) 	— 	0.2 	(30.5)
Balance as of August 28, 2022 	$ 	(43.6) $ 	(3.3) $ 	0.8 $ 	(46.1)

-- 17 of 81 --

Table of Contents
18
13. SEGMENTS
We have four operating segments, each of which is a reportable segment: Global, Foodservice, Retail, and Other.
Our chief operating decision maker receives periodic management reports under this structure that generally focus on the
nature and scope of our customers’ businesses, which enables operating decisions, performance assessment, and resource
allocation decisions at the segment level. The reportable segments are each managed by a general manager and supported
by a cross functional team assigned to support the segment.
Thirteen Weeks Ended
August 28, 	August 29,
(in millions) 	2022 	2021
Net sales
Global 	$ 	559.7 $ 	501.2
Foodservice 	366.3 	321.4
Retail 	169.6 	132.5
Other 	30.0 	29.1
Total net sales 	$ 1,125.6 $ 	984.2
Product contribution margin (a)
Global 	$ 	83.7 $ 	42.6
Foodservice 	138.2 	96.4
Retail 	48.7 	14.8
Other (b) 	(1.8) 	(6.6)
268.8 	147.2
Add: Advertising and promotion expenses (a) 	4.5 	4.1
Gross profit 	273.3 	151.3
Selling, general and administrative expenses 	116.3 	91.1
Income from operations 	157.0 	60.2
Interest expense, net 	26.0 	27.9
Income tax expense 	73.7 	8.7
Equity method investment earnings (c) 	174.6 	6.2
Net income 	$ 	231.9 $ 	29.8
(a) Product contribution margin represents net sales less cost of sales and advertising and promotion expenses. Product contribution
margin includes advertising and promotion expenses because those expenses are directly associated with segment performance.
(b) The Other segment primarily includes our vegetable and dairy businesses and unrealized mark-to-market adjustments and realized
settlements associated with commodity hedging contracts.
(c) Equity method investment earnings for the thirteen weeks ended August 28, 2022 and August 29, 2021 include a $146.3 million and
$5.0 million unrealized gain, respectively, related to mark-to-market adjustments associated with changes in natural gas and
electricity derivatives as commodity markets in Europe have experienced significant volatility.
In July 2022, we acquired an additional 40% interest in LWAMSA, increasing our total ownership from 50% to 90%. See Note 6,
Joint Venture Investments, for more information.

-- 18 of 81 --

Table of Contents
19
14. COMMITMENTS, CONTINGENCIES, GUARANTEES AND LEGAL PROCEEDINGS
We have financial commitments and obligations that arise in the ordinary course of our business. These include
long-term debt, lease obligations, purchase commitments for goods and services, and legal proceedings. There have been
no material changes to the guarantees and indemnifications disclosed in Note 14, Commitments, Contingencies,
Guarantees, and Legal Proceedings, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial
Statements and Supplementary Data” of the Form 10-K.
We are a party to legal actions arising in the ordinary course of our business. These claims, legal proceedings and
litigation principally arise from alleged casualty, product liability, employment, and other disputes. In determining loss
contingencies, we consider the likelihood of loss as well as the ability to reasonably estimate the amount of such loss or
liability. An estimated loss is recognized when it is considered probable that a liability has been incurred and when the
amount of loss can be reasonably estimated. While any claim, proceeding or litigation has an element of uncertainty, we
believe the outcome of any of these matters that are pending or threatened will not have a material adverse effect on our
financial condition, results of operations, or cash flows.

-- 19 of 81 --

Table of Contents
20
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The following discussion and analysis of our financial condition and results of operations, which we refer to as
“MD&A,” should be read in conjunction with our condensed consolidated financial statements and related notes included
in "Financial Information" of this Quarterly Report on Form 10-Q (this "Form 10-Q") and in “Financial Statements and
Supplementary Data” of the Company's Annual Report on Form 10-K for the fiscal year ended May 29, 2022 (the “Form
10-K”), which we filed with the United States (“U.S.”) Securities and Exchange Commission (“SEC”) on July 27, 2022.
Forward-Looking Statements
This report, including the MD&A, contains forward-looking statements within the meaning of the federal
securities laws. Words such as “will,” “continue,” “may,” “expect,” “would,” “believe,” “increase,” “implement,”
“mitigate,” “manage,” “grow,” “improve,” “outlook,” and variations of such words and similar expressions are intended to
identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements
regarding our plans, execution, capital investments, operational costs, pricing actions, cash flows, liquidity, dividends,
enterprise resource planning (“ERP”) system implementation and business and financial outlook and prospects, as well as
supply chain constraints, inflation, our industry, and the global economy. These forward-looking statements are based on
management’s current expectations and are subject to uncertainties and changes in circumstances. Readers of this report
should understand that these statements are not guarantees of performance or results. Many factors could affect our actual
financial results and cause them to vary materially from the expectations contained in the forward-looking statements,
including those set forth in this report. These risks and uncertainties include, among other things: the availability and prices
of raw materials; labor shortages and other operational challenges; disruptions in the global economy caused by the war in
Ukraine and the possible related heightening of our other known risks; impacts on our business due to health pandemics or
other contagious outbreaks, such as the COVID-19 pandemic, including impacts on demand for our products, increased
costs, disruption of supply, other constraints in the availability of key commodities and other necessary services or
restrictions imposed by public health authorities or governments; levels of pension, labor and people-related expenses; our
ability to successfully execute our long-term value creation strategies; our ability to execute on large capital projects,
including construction of new production lines or facilities; the competitive environment and related conditions in the
markets in which we and our joint ventures operate; political and economic conditions of the countries in which we and our
joint ventures conduct business and other factors related to our international operations; disruption of our access to export
mechanisms; risks associated with possible acquisitions, including our ability to complete acquisitions or integrate acquired
businesses; our debt levels; changes in our relationships with our growers or significant customers; the success of our joint
ventures; actions of governments and regulatory factors affecting our businesses or joint ventures; the ultimate outcome of
litigation or any product recalls; our ability to pay regular quarterly cash dividends and the amounts and timing of any
future dividends; and other risks described in our reports filed from time to time with the SEC. We caution readers not to
place undue reliance on any forward-looking statements included in this report, which speak only as of the date of this
report. We undertake no responsibility for updating these statements, except as required by law.
Overview
Lamb Weston Holdings, Inc. (“we,” “us,” “our,” “the Company,” or “Lamb Weston”), along with our joint
ventures, is a leading global producer, distributor, and marketer of value-added frozen potato products. We, along with our
joint ventures, are the number one supplier of value-added frozen potato products in North America and a leading supplier
of value-added frozen potato products internationally, with a strong and growing presence in high-growth emerging
markets. We, along with our joint ventures, offer a broad product portfolio to a diverse channel and customer base in over
100 countries. French fries represent the majority of our value-added frozen potato product portfolio.
This MD&A is provided as a supplement to the consolidated financial statements and related condensed notes
included elsewhere herein to help provide an understanding of our financial condition, changes in financial condition and
results of our operations. Our MD&A is based on financial data derived from the financial statements prepared in
accordance with U.S. generally accepted accounting principles (“GAAP”) and certain other financial data (including
product contribution margin, on a consolidated basis, Adjusted EBITDA, Adjusted EBITDA including unconsolidated joint
ventures, Adjusted Net Income, and Adjusted Diluted EPS) that is prepared using non-GAAP financial measures.

-- 20 of 81 --

Table of Contents
21
Refer to “Non-GAAP Financial Measures” below for the definitions of product contribution margin, Adjusted EBITDA,
Adjusted EBITDA including unconsolidated joint ventures, Adjusted Net Income, and Adjusted Diluted EPS, and a
reconciliation of these non-GAAP financial measures to gross profit, net income, or diluted earnings per share, as
applicable.
Executive Summary
The following highlights our financial results in the first quarter of fiscal 2023, compared with the prior year
quarter. For more information, refer to the “Results of Operations” section below.
● Net sales increased 14% to $1,125.6 million
● Income from operations increased 161% to $157.0 million
● Net income increased 678% to $231.9 million, and diluted earnings per share increased 700% to $1.60, including
items impacting comparability of $161.4 million ($123.7 million after-tax, or $0.85 per share)
● Adjusted Net Income increased 315% to $108.2 million, and Adjusted Diluted EPS increased 317% to $0.75
● Adjusted EBITDA including unconsolidated joint ventures increased 92% to $227.8 million
● We returned $63.7 million of cash to stockholders, including $35.3 million in dividends and $28.4 million of
share repurchases
We drove strong sales, earnings growth, and gross margin expansion in the quarter by executing pricing actions
across each of our business segments and generating productivity savings to counter significant input, manufacturing, and
supply chain cost inflation. The increase in net sales was partially offset by a decline in sales volume, primarily reflecting
softer restaurant traffic and demand trends in the U.S., especially at casual dining and full-service restaurants, as consumers
adjusted to the severe inflationary environment. Overall traffic at large quick service restaurants (“QSR”) in the U.S.
remained solid. Our sales volume also reflects our inability to fully serve customer demand in our foodservice and retail
channels due to widespread industry supply chain constraints, including labor and commodities shortages, that affected
production run-rates and throughput in our factories.
The increase in our net income was driven by higher income from operations as well as sharply higher equity
method investment earnings, which include our share of earnings from our unconsolidated joint ventures. In the first
quarter of fiscal 2023, the increase in equity method investment earnings included a $146.3 million unrealized gain ($108.6
million after-tax, or $0.75 per share) on derivatives for natural gas and electricity contracts in Europe, reflecting the
volatility of those energy markets in that region. Equity method investment earnings also included a $15.1 million gain
(before and after-tax, or $0.10 per share) recognized in connection with our acquisition of an additional 40% interest in
Lamb Weston Alimentos Modernos S.A. (“LWAMSA”). The gain related to the remeasuring of our previously held 50%
ownership interest to fair value. The net sales, income from operations, and total assets acquired were not material to our
consolidated net sales, income from operations, and total assets. We have identified both of these gains as items impacting
comparability and have excluded their impact when providing Adjusted Net Income, Adjusted Diluted EPS, and Adjusted
EBITDA including unconsolidated joint ventures.
In September 2022, Lamb-Weston/Meijer v.o.f. ("LWM"), our joint venture in Europe, completed the previously
announced withdrawal from its joint venture in Russia.
Outlook
In the remainder of fiscal 2023, we expect price/mix to increase versus the prior year largely due to carryover
benefits of pricing actions taken in the prior year as well as earlier in fiscal 2023 to counter manufacturing and distribution
cost inflation. We expect demand and sales volumes growth will continue to be volatile as consumers respond to the current
inflationary environment, and that our volume will be affected by production capacity and logistics constraints due to
disruptions in the global supply chain network. We expect the rate of recovery of demand in our key international markets
will be mixed, and that our international shipments will continue to be tempered by limited shipping container availability
and disruptions to ocean freight networks, as well as efforts to divert the production volumes to higher-margin sales
channels in the U.S.

-- 21 of 81 --

Table of Contents
22
During the first half of fiscal 2023, we expect our gross margins will be pressured as compared to normalized
seasonal rates as we continue to manage through significant inflation as well as higher raw potato costs on a per pound
basis due to the impact of extreme summer heat that negatively affected the yield and quality of potato crops in the Pacific
Northwest in the fall of 2021. We also expect our gross margins in the first half of fiscal 2023 will be pressured by ongoing
industrywide operational challenges, including labor and commodities shortages, resulting from volatility in the broader
supply chain.
During the second half of fiscal 2023, we expect our gross margins to approach normalized annual levels based on
our continued successful implementation of our pricing actions to offset input and transportation costs inflation, as well as
our preliminary assessment that the overall quality of the 2022 potato crop will be in line with historical averages, although
significant heat waves late in the season affected yields in our growing regions in the Pacific Northwest. We expect LWM’s
earnings will be affected by a below-average potato crop in Europe resulting from high temperatures and drought
conditions, as well as likely production disruptions resulting from energy constraints.
While the near-term global demand trends may be volatile as consumers navigate this inflationary environment,
our recent announcement to expand capacity in Argentina, along with our ongoing investments in Idaho and China,
demonstrate our confidence in the long-term health and growth outlook of the frozen potato category.
Results of Operations
We have four reportable segments: Global, Foodservice, Retail, and Other. We report net sales and product
contribution margin by segment and on a consolidated basis. Product contribution margin, when presented on a
consolidated basis, is a non-GAAP financial measure. Net sales and product contribution margin are the primary measures
reported to our chief operating decision maker for purposes of allocating resources to our segments and assessing their
performance. Product contribution margin represents net sales less cost of sales and A&P expenses. Product contribution
margin includes A&P expenses because those expenses are directly associated with the performance of the Company’s
segments. For additional information on our reportable segments and product contribution margin, see “Non-GAAP
Financial Measures” below and Note 13, Segments, of the Condensed Notes to Consolidated Financial Statements in “Part
I, Item 1. Financial Statements” of this report.
Thirteen Weeks Ended August 28, 2022 compared to Thirteen Weeks Ended August 29, 2021
Net Sales, Gross Profit, and Product Contribution Margin
Thirteen Weeks Ended
August 28, 	August 29, 	%
(dollars in millions) 	2022 	2021 	Inc/(Dec)
Segment net sales
Global 	$ 	559.7 	$ 	501.2 	12%
Foodservice 	366.3 	321.4 	14%
Retail 	169.6 	132.5 	28%
Other 	30.0 	29.1 	3%
$ 	1,125.6 	$ 	984.2 	14%
Segment product contribution margin
Global 	$ 	83.7 	$ 	42.6 	96%
Foodservice 	138.2 	96.4 	43%
Retail 	48.7 	14.8 	229%
Other 	(1.8) 	(6.6) 	(73%)
268.8 	147.2 	83%
Add: Advertising and promotion expenses 	4.5 	4.1 	10%
Gross profit 	$ 	273.3 	$ 	151.3 	81%

-- 22 of 81 --

Table of Contents
23
Net Sales
Compared to the prior year quarter, Lamb Weston’s net sales for the first quarter of fiscal 2023 increased $141.4
million, or 14%, to $1,125.6 million. Price/mix increased 19%, reflecting the benefit of pricing actions across each of our
core business segments to offset input, manufacturing, and transportation cost inflation. Volume declined 5%, primarily
reflecting softer casual dining and full-service restaurant traffic in the U.S. as well as the timing of shipments to large chain
restaurant customers. Shipments into foodservice and retail channels in the U.S. continued to be affected by an inability to
fully serve customer demand due to widespread industry supply chain constraints, including labor and commodities
shortages, that impacted production run-rates and throughput in our production facilities.
Global segment net sales increased $58.5 million, or 12%, to $559.7 million. Price/mix increased 14% while
volume decreased 2%. The benefit of domestic and international product and freight pricing actions to offset inflation, as
well as favorable mix, drove the increase in price/mix. The timing of shipments to large QSR chain customers in the U.S.,
including the effect of lapping a notable limited time product offering in the prior year quarter, largely drove the decline in
volume. Export shipments declined modestly, primarily due to production volumes being diverted to higher-margin sales
channels in the U.S.
Foodservice segment net sales increased $44.9 million, or 14%, to $366.3 million. Price/mix increased 26% and
volume decreased 12%. The carryover benefits of product and freight pricing actions taken in the prior year as well as early
in fiscal 2023 to offset inflation drove the increase in price/mix. Demand in the segment’s restaurant and non-commercial
channels (such as lodging and hospitality, healthcare, schools and universities, sports and entertainment, and workplace
environments) softened along with restaurant traffic as consumers adjusted to the severe inflationary environment. The
slowdown in restaurant traffic and consumer demand was more pronounced in casual dining and other full-service
restaurants than in QSRs. Shipments were also affected by an inability to fully serve customer demand due to widespread
industry supply chain constraints, including labor and commodities shortages, that impacted production run-rates and
throughput in our production facilities, as well as incremental losses of certain low-margin non-commercial business.
Retail segment net sales increased $37.1 million, or 28%, to $169.6 million. Price/mix increased 32% while
volume decreased 4%. The carryover benefits of pricing actions across the branded and private label portfolios taken in the
prior year as well as earlier in fiscal 2023 to offset inflation drove the increase in price/mix. Lower shipments of private
label products, resulting from incremental losses of certain low-margin business, drove the sales volume decline.
Shipments of branded products increased, although growth was tempered by an inability to fully serve customer demand
due to constrained production run-rates and throughput in our production facilities.
Net sales in our Other segment increased $0.9 million, or 3%, to $30.0 million. Price/mix increased 11% while
volume decreased 8%. The increase in price/mix was driven by higher prices in our vegetable business, while the decrease
in volume reflected the negative effect of the extreme summer heat on the yield and quality of the vegetable crops.
Gross Profit and Product Contribution Margin
Gross profit increased $122.0 million, or 81%, to $273.3 million, as the benefits from higher price/mix and
productivity initiatives more than offset the impact of higher manufacturing and distribution costs on a per-pound basis, as
well as lower sales volumes. The higher costs per pound primarily reflected double-digit cost inflation from key inputs,
including: edible oils, ingredients such as grains and starches used in product coatings, labor costs, and transportation costs.
The increase in costs per pound also reflected higher costs associated with the impact of extreme summer heat that
negatively affected the yield and quality of potato crops in the Pacific Northwest in fall 2021, as well as the effects of labor
and commodities shortages on production run-rates. The increase in gross profit also included a $2.8 million increase in
unrealized mark-to-market adjustments associated with commodity hedging contracts, which includes a $4.0 million loss in
the first quarter, compared with a $6.8 million loss related to these items in the prior year quarter.
Lamb Weston’s overall product contribution margin, defined as gross profit less A&P expenses, increased $121.6
million, or 83%, to $268.8 million. The increase was largely due to higher gross profit (as described above).

-- 23 of 81 --

Table of Contents
24
Global segment product contribution margin increased $41.1 million, or 96%, to $83.7 million. Favorable
price/mix, primarily reflecting the benefit of pricing actions, drove the increase, more than offsetting higher manufacturing
and distribution costs per pound. Global segment cost of sales was $475.1 million, up 4% compared to the first quarter of
fiscal 2022, primarily due to higher manufacturing and distribution costs, partially offset by lower sales volumes.
Foodservice segment product contribution margin increased $41.8 million, or 43%, to $138.2 million. Favorable
price drove the increase, and was partially offset by higher manufacturing and distribution costs per pound, and the impact
of lower sales volumes. Foodservice segment cost of sales was $226.9 million, up 1% compared to the first quarter of fiscal
2022, primarily due to higher manufacturing and distribution costs, partially offset by lower sales volumes.
Retail segment product contribution margin increased $33.9 million, or 229%, to $48.7 million. The benefits of
pricing actions and favorable mix drove the increase, partially offset by higher manufacturing and distribution costs per
pound. Retail segment cost of sales was $118.6 million, a 3% increase compared to the first quarter of fiscal 2022,
primarily due to higher manufacturing and distribution costs, partially offset by lower sales volumes.
Other segment product contribution margin increased $4.8 million to a loss of $1.8 million in the first quarter of
fiscal 2023, as compared to a loss of $6.6 million in the first quarter of fiscal 2022. These amounts include a $8.8 million
loss related to unrealized mark-to-market adjustments and realized settlements associated with commodity hedging
contracts reported in the Other segment in fiscal 2023, and a $8.2 million loss related to the contracts in fiscal 2022.
Excluding these mark-to-market adjustments and realized settlements, Other segment product contribution margin
increased $5.4 million, largely due to favorable price in our vegetable business.
Selling, General and Administrative Expenses
SG&A increased $25.2 million to $116.3 million in the first quarter of fiscal 2023, as compared to $91.1 million
in the first quarter of fiscal 2022, primarily due to higher compensation and benefits expense, and higher expenses related
to improving our information and technology services infrastructure.
Interest Expense, Net
Compared with the prior year quarter, interest expense, net decreased $1.9 million to $26.0 million, primarily
reflecting higher capitalized interest and higher interest income. For more information see “Liquidity and Capital
Resources” in this MD&A.
Income Tax Expense
Income tax expense for the first quarter of fiscal 2023 and 2022 was $73.7 million and $8.7 million, respectively.
The effective income tax rate (calculated as the ratio of income tax expense to pre-tax income, inclusive of equity method
investment earnings) was 24.1% and 22.6% for the first quarter of fiscal 2023 and 2022, respectively. The effective tax rate
varies from the U.S. statutory tax rate of 21%, principally due to the impact of U.S. state taxes, foreign taxes, permanent
differences, and discrete items. Excluding items impacting comparability, our effective tax rate for the first quarter of fiscal
2023 was 25.0%.
Equity Method Investment Earnings
We conduct business through unconsolidated joint ventures in Europe and the U.S. and include our share of the
earnings based on our economic ownership interest in them. Our share of earnings from our equity method investments was
$174.6 million and $6.2 million for the first quarter of fiscal 2023 and 2022, respectively. Equity method investment
earnings included a $144.6 million unrealized gain related to mark-to-market adjustments associated with currency and
commodity hedging contracts in the first quarter of fiscal 2023, of which $146.3 million ($108.6 million after-tax, or $0.75
per share) related to changes in natural gas and electricity derivatives as commodity markets in Europe have experienced
significant volatility. Equity method investment earnings in the prior year quarter included a $4.3 million unrealized gain
for mark-to-market adjustments, of which $5.0 million related to changes in natural gas and electricity derivatives. Equity
method investment earnings in the first quarter of fiscal 2023 also included a $15.1 million gain (before and after-tax, or

-- 24 of 81 --

Table of Contents
25
$0.10 per share) recognized in connection with the Company’s acquisition of an additional 40% interest in LWAMSA. The
gain related to remeasuring our previously held 50% ownership interest to fair value.
Excluding the items impacting comparability noted above and the other mark-to-market adjustments, earnings
from equity method investments increased $13.0 million compared to the prior year quarter, reflecting favorable price/mix,
partially offset by higher manufacturing and distribution costs in both Europe and the U.S.
Liquidity and Capital Resources
Sources and Uses of Cash
We ended the first quarter of fiscal 2023 with $485.3 million of cash and cash equivalents and $994.6 million of
availability under our revolving credit facility, net of letters of credit. At the end of the first quarter of fiscal 2023, no
borrowings were outstanding under the revolving credit facility.
We believe we have sufficient liquidity to meet projected capital expenditures, service existing debt and meet
working capital requirements for at least the next 12 months with current cash balances and cash from operations, and in
the longer term, supplemented as necessary by available borrowings under our currently undrawn revolving credit facility.
Cash Flows
Below is a summary table of our cash flows, followed by a discussion of the sources and uses of cash through
operating, investing, and financing activities:
Thirteen Weeks Ended
August 28, 	August 29,
(in millions) 	2022 	2021
Net cash flows provided by (used for):
Operating activities 	$ 	192.1 $ 	161.8
Investing activities 	(166.9) 	(78.8)
Financing activities 	(63.5) 	(75.8)
(38.3) 	7.2
Effect of exchange rate changes on cash and cash equivalents 	(1.4) 	(1.0)
Net (decrease) increase in cash and cash equivalents 	$ 	(39.7) $ 	6.2
Operating Activities
In the first quarter of fiscal 2023, cash provided by operating activities increased $30.3 million to $192.1 million,
compared with $161.8 million in the same period a year ago. The increase related to a $57.4 million increase in income
from operations, adjusted for non-cash income and expenses, offset by $27.1 million of cash used for unfavorable changes
in working capital. See “Results of Operations” in this MD&A for more information related to the increase in income from
operations. Unfavorable changes in working capital primarily related to higher-cost finished goods inventories, due
primarily to increased potato and input cost inflation, and a decrease in accrued liabilities due to a shift in the timing of
interest payments for our senior notes due 2030 and 2032, which were issued in fiscal 2022. These unfavorable changes
were partially offset by a decrease in receivables due to timing of collections, and an increase in income taxes payable due
to higher taxable income in the first quarter of fiscal 2023, compared with the prior year quarter.
Investing Activities
Investing activities used $166.9 million of cash in the first quarter of fiscal 2023, compared with $78.8 million in
the same period in the prior year. The increase primarily relates to our investments in our chopped and formed capacity
expansion, our french fry processing line in American Falls, Idaho, and our greenfield french fry processing facility in
Ulanqab, Inner Mongolia, China. We expect to use approximately $475 million to $525 million for capital expenditures,
excluding acquisitions, in fiscal 2023. We also used $42.3 million to acquire an additional ownership interest in our joint

-- 25 of 81 --

Table of Contents
26
venture in Argentina and used $20.0 million to acquire assets associated with the improvement of our information and
technology services infrastructure.
Financing Activities
During the first quarter of fiscal 2023, cash used for financing activities decreased $12.3 million to $63.5 million,
compared with $75.8 million used during the same period a year ago. During the first quarter of fiscal 2023, financing
activities primarily related to additional borrowings under the RMB-denominated loan facility for net proceeds of $13.8
million, offset by $8.0 million of debt and financing obligation repayments, and the payment of $35.3 million of cash
dividends to common stockholders. In addition, we used $28.4 million of cash to repurchase 404,476 shares of our
common stock at an average price of $70.11 and withheld 77,756 shares from employees to cover income and payroll taxes
on equity awards that vested during the period.
During the first quarter of fiscal 2022, financing activities primarily related to the payment of $34.4 million of
cash dividends to common stockholders, and $7.9 million of debt and financing obligations repayments. We also used
$26.0 million of cash to repurchase 395,361 shares of our common stock at an average price of $65.86 and withheld
111,488 shares from employees to cover income and payroll taxes on equity awards that vested during the period.
For more information about our debt, interest rates, maturity dates, and covenants, see Note 9, Debt and Financing
Obligations, of the Condensed Notes to Consolidated Financial Statements in “Part I, Item 1. Financial Statements” of this
report and Note 7, Debt and Financing Obligations of the Notes to Consolidated Financial Statements in “Part II, Item 8.
Financial Statements and Supplementary Data” of the Form 10-K. At August 28, 2022, we were in compliance with the
financial covenant ratios and other covenants contained in our credit agreements.
Obligations and Commitments
There have been no material changes to the contractual obligations disclosed in “Management's Discussion and
Analysis of Financial Condition and Results of Operations" in the Form 10-K.
Non-GAAP Financial Measures
To supplement the financial information included in this report, we have presented product contribution margin on
a consolidated basis, Adjusted EBITDA, Adjusted EBITDA including unconsolidated joint ventures, Adjusted Net Income,
and Adjusted Diluted EPS, each of which is considered a non-GAAP financial measure.
Product contribution margin is one of the primary measures reported to our chief operating decision maker for
purposes of allocating resources to our segments and assessing their performance. Product contribution margin represents
net sales less cost of sales and A&P expenses. Product contribution margin includes A&P expenses because those expenses
are directly associated with the performance of our segments. Our management also uses Adjusted EBITDA and Adjusted
EBITDA including unconsolidated joint ventures to evaluate our performance excluding the impact of certain non-cash
charges and other special items in order to have comparable financial results to analyze changes in our underlying business
between reporting periods. We include these non-GAAP financial measures because management believes they provide
useful information to investors in that they provide for greater transparency with respect to supplemental information used
by management in its financial and operational decision making. We believe that the presentation of these non-GAAP
financial measures, when used in conjunction with GAAP financial measures, is a useful financial analysis tool that can
assist investors in assessing our operating performance and underlying prospects. These non-GAAP financial measures
should be viewed in addition to, and not as alternatives for, financial measures prepared in accordance with GAAP. These
measures are not a substitute for their comparable GAAP financial measures, such as gross profit, net income (loss), or
diluted earnings per share, and there are limitations to using non-GAAP financial measures. These non-GAAP financial
measures may differ from similarly titled non-GAAP financial measures presented by other companies, and other
companies may not define these non-GAAP financial measures the same way.

-- 26 of 81 --

Table of Contents
27
See “Results of Operations – Thirteen Weeks Ended August 28, 2022 compared to Thirteen Weeks Ended August
29, 2021 – Net Sales, Gross Profit, and Product Contribution Margin” above for a reconciliation of product contribution
margin on a consolidated basis to gross profit.
The following table reconciles net income to Adjusted EBITDA and Adjusted EBITDA including unconsolidated
joint ventures:
Thirteen Weeks Ended
August 28, 	August 29,
(in millions) 	2022 	2021
Net income 	$ 	231.9 	$ 	29.8
Equity method investment earnings 	(174.6) 	(6.2)
Interest expense, net 	26.0 	27.9
Income tax expense 	73.7 	8.7
Income from operations 	157.0 	60.2
Depreciation and amortization 	48.7 	46.0
Adjusted EBITDA 	205.7 	106.2
Unconsolidated Joint Ventures
Equity method investment earnings 	174.6 	6.2
Interest expense, income tax expense, and depreciation and
amortization included in equity method investment earnings 	8.9 	11.0
Items impacting comparability
Impact of LWM natural gas and electricity derivatives (a) 	(146.3) 	(5.0)
Gain on acquisition of interest in joint venture (b) 	(15.1) 	—
Add: Adjusted EBITDA from unconsolidated joint ventures 	22.1 	12.2
Adjusted EBITDA including unconsolidated joint ventures 	$ 	227.8 	$ 	118.4
(a) Equity method investment earnings for the thirteen weeks ended August 28, 2022 and August 29, 2021 included a $146.3 million
($108.6 million after-tax, or $0.75 per share) and $5.0 million ($3.7 million after-tax, or $0.02 per share) unrealized gain,
respectively, related to mark-to-market adjustments associated with changes in natural gas and electricity derivatives as commodity
markets in Europe have experienced significant volatility.
(b) Equity method investment earnings for the thirteen weeks ended August 28, 2022 included a $15.1 million gain (before and after-
tax, or $0.10 per share) recognized in connection with our acquisition of an additional 40% interest in our Argentina joint venture,
increasing our ownership from 50% to 90%. The gain related to the remeasuring of our previously held 50% ownership interest to
fair value.
The following table reconciles net income to Adjusted Net Income, and diluted EPS to Adjusted Diluted EPS:
For the Thirteen Weeks Ended
August 28, 	August 29, 	August 28, 	August 29,
2022 	2021 	2022 (a) 	2021 (a)
(in millions, except per share amounts) 	Net Income 	Diluted EPS
As reported 	$ 	231.9 $ 	29.8 $ 	1.60 $ 	0.20
Items impacting comparability:
Impact of LWM natural gas and electricity derivatives (b) 	(108.6) 	(3.7) 	(0.75) 	(0.02)
Gain on acquisition of interest in joint venture (c) 	(15.1) 	— 	(0.10) 	—
Total items impacting comparability 	(123.7) 	(3.7) 	(0.85) 	(0.02)
Adjusted 	$ 	108.2 $ 	26.1 $ 	0.75 $ 	0.18
(a) Diluted weighted average common shares were 144.6 million and 146.9 million for the thirteen weeks ended August 28, 2022 and
August 29, 2021, respectively.
(b) See footnote (a) to the reconciliation of net income to Adjusted EBITDA and Adjusted EBITDA including unconsolidated joint
ventures above for a discussion of the item impacting comparability.

-- 27 of 81 --

Table of Contents
28
(c) There was no tax impact associated with the gain of an additional 40% interest in our Argentina joint venture. See footnote (b) to
the reconciliation of net income to Adjusted EBITDA and Adjusted EBITDA including unconsolidated joint ventures above for a
discussion of the item impacting comparability.
Off-Balance Sheet Arrangements
There have been no material changes to the off-balance sheet arrangements disclosed in “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” included in the Form 10-K.
Critical Accounting Policies and Estimates
A discussion of our critical accounting policies and estimates can be found in "Management's Discussion and
Analysis of Financial Condition and Results of Operations" included in the Form 10-K. There were no material changes to
these critical accounting policies and estimates during the first quarter of fiscal 2023.
New and Recently Adopted Accounting Pronouncements
For a list of our new and recently adopted accounting pronouncements, see Note 1, Nature of Operations and
Summary of Significant Accounting Policies, of the Condensed Notes to Consolidated Financial Statements in “Part I, Item
1. Financial Statements” of this report.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Our operations are exposed to market risks from adverse changes in commodity prices affecting the cost of raw
materials and energy, foreign currency exchange rates, and interest rates. In the normal course of business, we may
periodically enter into derivatives to minimize these risks, but not for trading purposes. The disruptions in the global
economy caused by the war in Ukraine have resulted in volatility and uncertainty in the markets in which we operate. At
the time of this filing, we are unable to predict or determine the impacts that these events may continue to have on our
exposure to market risk from commodity prices, foreign currency exchange rates, and interest rates, among other factors.
Based on our open commodity contract hedge positions as of August 28, 2022 and August 29, 2021, a
hypothetical 10 percent decline in market prices applied to the fair value of the instruments would result in a charge to
“Cost of sales” of approximately $5.1 million ($4.0 million after-tax) and $5.7 million ($4.4 million after-tax), respectively.
Additionally, based on our LWM joint venture’s open commodity contract hedge positions as of August 28, 2022 and
August 29, 2021, a hypothetical 10 percent decline in market prices applied to the fair value of the instruments would result
in a charge to “Equity method investment earnings” of approximately $26.3 million ($19.5 million after-tax) and $1.7
million ($1.3 million after-tax), respectively. It should be noted that any change in the fair value of these contracts, real or
hypothetical, would be substantially offset by an inverse change in the value of the underlying hedged item.
We transact business in multiple currencies and are subject to currency exchange rate risk through investments and
businesses owned and operated in foreign countries. At August 28, 2022, we had no financial instruments to hedge foreign
currency risk.
At August 28, 2022, we had $2,170.0 million of fixed-rate and $587.6 million of variable-rate debt outstanding. At
August 29, 2021, we had $2,166.0 million of fixed-rate and $578.8 million of variable-rate debt outstanding. We have
interest rate risk associated with our variable-rate debt. A one percent increase in interest rates related to variable-rate debt
would have resulted in an increase in interest expense and a corresponding decrease in income before taxes of
approximately $6.0 million annually ($4.6 million after-tax) and $5.9 million annually ($4.5 million after-tax) at August
28, 2022 and August 29, 2021, respectively.
For more information about our market risks, see Note 9, Debt and Financing Obligations, of the Condensed
Notes to Consolidated Financial Statements in “Part I, Item 1. Financial Statements” of this report.

-- 28 of 81 --

Table of Contents
29
ITEM 4. CONTROLS AND PROCEDURES
Inherent Limitations on Effectiveness of Controls
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our
disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all
fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance
that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource
constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent
limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error
or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system
of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that
any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of
the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of
changes in conditions or deterioration in the degree of compliance with policies or procedures.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an
evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule
13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of August 28, 2022. Based on
that evaluation, our Chief Executive Officer and Chief Financial Officer, concluded that, as of the end of the period covered
by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information
required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized, and
reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to management,
including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding
required disclosures.
Changes in Internal Control over Financial Reporting
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated any
change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred
during the quarter covered by this report and determined that there was no change in our internal control over financial
reporting during the quarter ended August 28, 2022 that has materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.

-- 29 of 81 --

Table of Contents
30
Part II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
See Note 14, Commitments, Contingencies, Guarantees and Legal Proceedings, of the Condensed Notes to
Consolidated Financial Statements in “Part I, Item 1. Financial Statements” of this report for information regarding our
legal proceedings.
ITEM 1A. RISK FACTORS
We are subject to various risks and uncertainties in the course of our business. The discussion of these risks and
uncertainties may be found under “Part I, Item 1A. Risk Factors” in the Form 10-K. There have been no material changes
to the risk factors discussed in the Form 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Total shares of Lamb Weston common stock purchased by the Company during the thirteen weeks ended August
28, 2022 were as follows:
Approximate Dollar
Total Number of 	Value of Maximum
Total Number 	Average 	Shares (or Units) 	Number of Shares that
of Shares (or 	Price Paid 	Purchased as Part of 	May Yet be Purchased
Units) 	Per Share 	Publicly Announced 	Under Plans or Programs
Period 	Purchased (a) 	(or Unit) 	Plans or Programs (b) 	(in millions) (b)
May 30, 2022 through June 26, 2022 	195,225 $ 66.59 	194,753 $ 	255.9
June 27, 2022 through July 24, 2022 	206,283 $ 73.28 	181,791 $ 	242.6
July 25, 2022 through August 28, 2022 	80,724 $ 78.15 	27,932 $ 	240.6
Total 	482,232
(a) Represents repurchased shares of our common stock under our publicly announced share repurchase program, which were
repurchased at a weighted average price of $70.11, and shares withheld from employees to cover income and payroll taxes on equity
awards that vested during the period.
(b) On December 20, 2018, we announced that our Board of Directors had authorized a $250.0 million share repurchase program, with
no expiration date. On December 17, 2021, we announced that our Board of Directors had authorized the repurchase of an
additional $250.0 million of our common stock under this program. Repurchases may be made at our discretion from time to time
on the open market, subject to applicable laws, including pursuant to a repurchase plan administered in accordance with Rule 10b5-
1 under the Securities Exchange Act of 1934, or through privately negotiated transactions.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.

-- 30 of 81 --

Table of Contents
31
ITEM 6. EXHIBITS
Exhibit Number Exhibit Description
10.1 	Form of Lamb Weston Holdings, Inc. Restricted Stock Unit Agreement (Stock-settled) (post-July 20,
2022)
10.2 	Form of Lamb Weston Holdings, Inc. Performance Share Agreement (post-July 20, 2022)
10.3 	Form of Lamb Weston Holdings, Inc. Nonqualified Stock Option Agreement for Employees (post-
July 20, 2022)
10.4 	Form of Lamb Weston Holdings, Inc. Leveraged Performance Share Agreement
31.1 	Section 302 Certificate of Chief Executive Officer
31.2 	Section 302 Certificate of Chief Financial Officer
32.1 	Section 906 Certificate of Chief Executive Officer
32.2 	Section 906 Certificate of Chief Financial Officer
101.INS 	XBRL Instance Document - the instance document does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document.
101.SCH 	XBRL Taxonomy Extension Schema Document.
101.CAL 	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF 	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB 	XBRL Taxonomy Extension Label Linkbase Document
101.PRE 	XBRL Taxonomy Extension Presentation Linkbase Document
104 	Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension
information contained in Exhibits 101.*)

-- 31 of 81 --

Table of Contents
32
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.
LAMB WESTON HOLDINGS, INC.
By: /s/ BERNADETTE M. MADARIETA
BERNADETTE M. MADARIETA
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
Dated this 5th day of October, 2022.

-- 32 of 81 --

Exhibit 10.1
1
Form of Lamb Weston Holdings, Inc.
Restricted Stock Unit Agreement (Stock-settled) (post-July 20, 2022)
NOTICE OF GRANT
RESTRICTED STOCK UNITS (STOCK-SETTLED)
LAMB WESTON HOLDINGS, INC. 2016 STOCK PLAN
(AS AMENDED AND RESTATED AS OF JULY 20, 2017)
Lamb Weston Holdings, Inc., a Delaware corporation (the “Company”), has awarded to the Participant, as
identified below, the number of Restricted Stock Units (the “RSUs”, and each such unit, an “RSU”) set forth
below. The RSUs are subject to all of the terms and conditions as set forth in this Notice of Grant (the
“Notice”) as well as in the Company’s 2016 Stock Plan (as amended and restated as of July 20, 2017) (the
“Plan”) and the Restricted Stock Unit Agreement (Stock-Settled) (the “Agreement”), both of which are
attached hereto and incorporated in their entirety. Capitalized terms not explicitly defined in this Notice but
defined in the Plan or the Agreement will have the same definitions as in the Plan or the Agreement. In the
event of any conflict between the terms of the Award and the Plan, the terms of the Plan will control.
Participant: 	/$ParticipantName$/
Employee ID: 	/$OptioneeID$/
Number of RSUs: 	/$AwardsGranted$/
Date of Grant: 	/$GrantDate$/ (the “Date of Grant”)
Vesting Dates: 	33%, 33%, and 34%, respectively, of the RSUs shall vest on each of the first
three anniversaries of the Date of Grant (each, a “Vesting Date”), with any
fractional shares being rounded down to the nearest whole share and
vesting with the next vesting installment (if applicable) and subject to the
terms and conditions set forth in the Agreement
Dividend Equivalents: Dividend equivalents with respect to the RSUs will be accumulated for the
benefit of the Participant if and when regular cash dividends are declared
and paid on the Stock in accordance with Section 7 of the Agreement, and
will be paid in shares of Stock to the Participant upon any settlement of the
RSUs.
By the Company’s signature below and by the Participant’s clicking the “Accept” button online, the Company
and the Participant agree that the RSUs are governed by this Notice and by the provisions of the Plan and the
Agreement, both of which are attached to and made a part of this document. The Participant acknowledges
receipt of copies of the Plan and the Agreement, represents that the Participant has read and is familiar with
their provisions, and hereby accepts the RSUs subject to all of their terms and conditions.
The Company has caused this Notice and the Agreement to be effective as of the Date of Grant.
LAMB WESTON HOLDINGS, INC.
By:
Date: __________________________

-- 33 of 81 --

2
RESTRICTED STOCK UNIT AGREEMENT (STOCK-SETTLED)
LAMB WESTON HOLDINGS, INC. 2016 STOCK PLAN
(AS AMENDED AND RESTATED AS OF JULY 20, 2017)
Lamb Weston Holdings, Inc., a Delaware corporation (the “Company”), has awarded the
Participant, as named in the Notice of Grant (the “Notice”), to which this Restricted Stock Unit Agreement
(Stock-Settled) (this “Agreement”) is attached, a Restricted Stock Unit Award (the “RSUs”) that is subject
to the Company’s 2016 Stock Plan (as amended and restated as of July 20, 2017) (the “Plan”), the
Notice, and this Agreement, for the number of RSUs indicated in the Notice. In the event of any conflict
between the terms in this Agreement and the Plan, the terms of the Plan will control.
1. 	Definitions. Capitalized terms used herein without definition have the meanings set forth in the
Plan. The following terms shall have the respective meanings set forth below:
(a) 	“Change of Control” shall mean the occurrence of any of the following events:
(i) Individuals who, as of the effective date of the Plan, constitute the Board (the “Incumbent
Board”) cease for any reason to constitute at least a majority of the
Board; provided, however, that any person becoming a member of the Board subsequent
to the effective date of the Plan whose election, or nomination for the election by the
Company’s stockholders, was approved by a vote of at least a majority of the Board
members then comprising the Incumbent Board shall be, for purposes of this clause (i),
considered as though such person were a member of the Incumbent Board as of the
effective date of the Plan;
(ii) Consummation of a reorganization, merger or consolidation, in each case, with respect to
which persons who were the stockholders of the Company immediately prior to such
reorganization, merger or consolidation do not, immediately thereafter, own more than
50% of the Voting Power of the reorganized, merged or consolidated entity;
(iii) Any person becomes the beneficial owner, directly or indirectly, of securities of the
Company (not including in the securities beneficially owned by such person, any securities
acquired directly from the Company or its affiliates) representing 30% or more of the
Voting Power of the Company’s then outstanding securities;
(iv) A liquidation or dissolution of the Company; or
(v) The sale of all or substantially all of the assets of the Company.
(b) 	“Continuous Employment” shall mean the absence of any interruption or termination of employment
with the Company and its Subsidiaries and the performance of substantial services. Continuous Employment
shall not be considered interrupted or terminated in the case of sick leave, short-term disability (as defined in
the Company’s sole discretion), military leave or any other leave of absence approved by the Company
unless and until there is a Separation from Service (as defined in Section 1(f) below).
(c) 	“Divestiture” shall mean a permanent disposition to a person other than the Company of a plant or
other facility or property at which the Participant performs a majority of the Participant’s services, whether
such disposition is effected by means of a sale of assets, a sale of Subsidiary stock or otherwise.
(d) 	“Early Retirement” shall mean a Separation from Service with the Company and its Subsidiaries
when the Participant (i) is at least age 55, and (ii) has at least ten years of credited service with the
Company and its Subsidiaries.
(e) 	“Normal Retirement” shall mean a Separation from Service with the Company and its Subsidiaries
on or after attaining age 65.
(f) 	“Separation from Service,” “termination of employment” and similar terms shall mean the date
that the Participant incurs a “separation from service” within the meaning of Section 409A of the Code.
As used in connection with the definition of “Separation from Service,” the term “Company” includes
Lamb Weston Holdings, Inc. and any other entity that with Lamb Weston Holdings, Inc. constitutes a
controlled group of corporations (as defined in Section 414(b) of the Code), or a group of trades or
businesses (whether or not incorporated) under common control (as defined in Section 414(c) of the
Code), substituting 25% for the 80% ownership level for purposes of both Sections 414(b) and Section
414(c) of

-- 34 of 81 --

3
the Code.
(g) 	“Specified Employee” is as defined under Section 409A of the Code and Treasury Regulation
Section 1.409A-1(i).
(h) 	“Successors” shall mean the beneficiaries, executors, administrators, heirs, successors and assigns
of a person.
2. 	Vesting of RSUs.
(a) 	Normal Vesting. Subject to the Plan and this Agreement, if the Participant has been in
Continuous Employment through each of the Vesting Dates as set forth in the Notice, then the RSUs subject
to such Vesting Date will become nonforfeitable (“Vest” or similar terms).
(b) 	Termination of Employment. If, prior to the last Vesting Date set forth in the Notice, the
Participant’s employment with the Company and its Subsidiaries shall terminate:
(i) by reason of death, then all unvested RSUs evidenced by this Agreement shall, to the
extent such RSUs have not previously been forfeited, become 100% Vested;
(ii) by reason of Normal Retirement occurring on or after the date that is 12 months after the
Date of Grant, then all unvested RSUs evidenced by this Agreement shall, to the extent
such RSUs have not previously been forfeited, become 100% Vested;
(iii) by reason of Early Retirement or involuntary termination due to disability, position elimination,
reduction in force (each as defined in the Company's sole discretion), or Divestiture, in each
case, on or after the date that is 12 months after the Date of Grant, the Participant will Vest
in a pro rata portion of the RSUs determined by (A) multiplying the number of RSUs
evidenced by this Agreement by a fraction, the numerator of which is the total number of
calendar days during which the Participant was employed by the Company or a Subsidiary
during the period beginning on the Date of Grant and ending on the Separation from Service
and the denominator of which is the total number of calendar days beginning on the Date of
Grant and ending on the last Vesting Date, rounded to the nearest whole number of RSUs
and (B) subtracting any RSUs that have previously Vested or been forfeited from the
number of RSUs determined in the immediately preceding clause (A); and
(iv) for Cause prior to any Vesting Date, then all RSUs, whether Vested or unvested prior to
such Vesting Date, shall be immediately forfeited without further consideration to the
Participant.
(c) 	Accelerated Vesting in Connection with a Change of Control.
(i) If a Change of Control occurs prior to the last Vesting Date, and the Participant has been
in Continuous Employment between the Date of Grant and the date of such Change of
Control, then all unvested RSUs evidenced by this Agreement shall become 100%
Vested, except (A) to the extent such RSUs have previously been forfeited, or (B) to the
extent that a Replacement Award is provided to the Participant to replace, continue or
adjust the outstanding RSUs (the “Replaced Award”). If the Participant’s employment
with the Company or a Subsidiary (or any of its or their successors after the Change of
Control) (as applicable, the “Successor Company”) is terminated prior to the last Vesting
Date (x) by the Participant for Good Reason or by the Successor Company other than for
Cause, in each case within a period of two years after the Change of Control or (y) due to
Early Retirement or Normal Retirement at any time following a Change of Control that
qualifies as a permissible date of distribution under Section 409A(a)(2)(A) of the Code,
then, in each case, to the extent that the Replacement Award has not previously been
Vested or forfeited, the Replacement Award will become 100% Vested (and become
entitled to settlement as specified in Section 3(b)(ii)).
(ii) For purposes of this Agreement, a “Replacement Award” means an award (A) of the
same type (i.e., time-based restricted stock units) as the Replaced Award, (B) that has a
value at least equal to the value of the Replaced Award, (C) that relates to publicly traded
equity securities of the Successor Company in the Change of Control (or another entity
that is affiliated with the Successor Company following the Change of Control), (D)

-- 35 of 81 --

4
the tax consequences of which for such Participant under the Code, if the Participant is
subject to U.S. federal income tax under the Code, are not less favorable to the
Participant than the tax consequences of the Replaced Award, and (E) the other terms
and conditions of which are not less favorable to the Participant than the terms and
conditions of the Replaced Award (including the provisions that would apply in the event
of a subsequent change of control). A Replacement Award may be granted only to the
extent it does not result in the Replaced Award or Replacement Award failing to comply
with or ceasing to be exempt from Section 409A of the Code. Without limiting the
generality of the foregoing, the Replacement Award may take the form of a continuation
of the Replaced Award if the requirements of the preceding two sentences are satisfied.
The determination of whether the conditions of this Section 2(c)(ii) are satisfied will be
made in good faith by the Committee, as constituted immediately before the Change of
Control, in its sole discretion.
(iii) For purposes of this Agreement, “Cause” means: (A) the willful and continued failure by
the Participant to substantially perform the Participant’s duties with the Successor
Company (other than any such failure resulting from termination by the Participant for
Good Reason) after a demand for substantial performance is delivered to the Participant
that specifically identifies the manner in which the Successor Company believes that the
Participant has not substantially performed the Participant’s duties, and the Participant
has failed to resume substantial performance of the Participant’s duties on a continuous
basis within five days of receiving such demand; (B) the willful engaging by the
Participant in conduct which is demonstrably and materially injurious to the Successor
Company, monetarily or otherwise; or (C) the Participant’s conviction of, or plea of nolo
contendere to, (I) a felony or (II) a misdemeanor which impairs the Participant’s ability
substantially to perform the Participant’s duties with the Successor Company. For the
purposes of this definition, no act, or failure to act, on the Participant’s part shall be
deemed “willful” unless done, or omitted to be done, by the Participant not in good faith
and without reasonable belief that the Participant’s action or omission was in the best
interest of the Successor Company.
(iv) For purposes of this Agreement, “Good Reason” means: (A) any material failure of the
Successor Company to comply with and satisfy any of the terms of any employment or
change in control (or similar) agreement between the Successor Company and the
Participant pursuant to which the Participant provides services to the Successor
Company; (B) any significant involuntary reduction of the authority, duties or
responsibilities held by the Participant immediately prior to the Change of Control (and,
for the avoidance of doubt, involuntary removal of the Participant from an officer position
that the Participant holds immediately prior to the Change of Control will not, by itself,
constitute a significant involuntary reduction of the authority, duties or responsibilities
held by the Participant immediately prior to the Change of Control); (C) any material
involuntary reduction in the aggregate target cash remuneration opportunity of the
Participant as in effect immediately prior to the Change of Control; or (D) requiring the
Participant to become based at any office or location more than 50 miles from the office
or location at which the Participant was based immediately prior to such Change of
Control, except for travel reasonably required in the performance of the Participant’s
responsibilities; provided, however, that no termination shall be deemed to be for Good
Reason unless (x) the Participant provides the Successor Company with written notice
setting forth the specific facts or circumstances constituting Good Reason within ninety
days after the initial existence of the occurrence of such facts or circumstances, (y) the
Successor Company fails to cure such facts or circumstances within thirty days of its
receipt of such written notice, and (z) the Participant actually terminates employment
within thirty (30) days following the end of the Successor Company’s thirty-day cure
period, if such event or circumstance has not been cured.
(v) If a Replacement Award is provided, notwithstanding anything in this Agreement to the
contrary, any outstanding RSUs which at the time of the Change of Control are not
subject to a "substantial risk of forfeiture" (within the meaning of Section 409A of the
Code) will be deemed to be Vested at the time of such Change of Control (and such

-- 36 of 81 --

5
Vested RSUs shall be settled in accordance with Section 3(b)(iii) below).
(d) 	Forfeiture of RSUs. Subject to Section 2(b)(iv), any RSUs that have not Vested pursuant to
Section 2(a), Section 2(b), or Section 2(c) as of any Vesting Date will be forfeited automatically and
without further notice on such date (or earlier if, and on such date that, the Participant ceases to be in
Continuous Employment prior to such Vesting Date for any reason other than as described in Section 2(b)
or Section 2(c)).
3. 	Settlement of RSUs.
(a) 	Normal. Subject to Section 3(b), the Company will issue to the Participant one share of Stock on
each Vesting Date for each RSU that is a Vested RSU on such Vesting Date to the extent the RSU has not
previously been Vested, forfeited or settled.
(b) 	Other Settlement Events. Notwithstanding Section 3(a), to the extent the RSUs are Vested
RSUs on the dates set forth below and to the extent the Vested RSUs have not previously been Vested,
forfeited or settled, the Company will settle such Vested RSUs as follows:
(i) Death. If there are such Vested RSUs on the Participant's death, within thirty days of the
Participant's death, one share of Stock will be issued for each such Vested RSU.
(ii) Separation from Service. If there are such Vested RSUs upon the Participant's
Separation from Service by reason of involuntary termination due to disability, position
elimination, reduction in force or Divestiture pursuant to Section 2(b)(iii) or for any of the
reasons set forth in Section 2(c)(i) hereof, within thirty days of the Participant's
Separation from Service, one share of Stock will be issued for each such Vested RSU. If
there are such Vested RSUs upon the Participant’s Separation from Service by reason of
the Participant’s Normal Retirement or Early Retirement in any circumstance other than
as set forth in Section 2(c)(i), the settlement of such Vested RSUs will not be
accelerated and one share of Stock will be issued for each such Vested RSU on the
applicable Vesting Date, and with respect to Early Retirement, the amount settled on
such Vesting Date shall be a pro-rated amount of the originally scheduled installment
using the pro-ration factor determined under Section 2(b)(iii) hereof. Notwithstanding
anything in this Agreement to the contrary, if any Vested RSUs under the immediately
preceding sentence are outstanding as of a Change of Control, then such Vested RSUs
shall be settled in accordance with Section 3(b)(iii) below.
(iii) Change of Control. If there are such Vested RSUs upon a Change of Control, one
share of Stock will be issued for each such Vested RSU as of the date of the Change of
Control; provided, however, that if such Change of Control would not qualify as a
permissible date of distribution under Section 409A(a)(2)(A) of the Code, and the
regulations thereunder, and where Section 409A of the Code applies to such distribution,
the Participant is entitled to receive the corresponding payment on the date that would
have otherwise applied pursuant to Section 3 as though such Change of Control had not
occurred.
(c) 	Payment of Taxes Upon Settlement. As a condition of the issuance of shares of Stock upon
settlement of RSUs hereunder, the Participant agrees to remit to the Company at the time of settlement any
taxes or other amounts required to be withheld by the Company under Federal, State or local law as a result
of the settlement of the RSUs. As a condition of the issuance of shares of Stock upon settlement of RSUs
hereunder, the Participant agrees that the Company will deduct from the total shares to be issued
as a result of the Vesting of the RSUs a sufficient number of shares to satisfy the required statutory
withholding amount, which may exceed the minimum statutory tax withholding amount permissible only if
it would not cause adverse accounting or tax consequences for the Company or a Subsidiary.
(d) 	Specified Employee. Notwithstanding anything (including any provision of the Agreement or the
Plan) to the contrary, if a Participant is a Specified Employee and if the RSUs are subject to Section 409A
of the Code, payment to the Participant on account of a Separation from Service shall, to the extent
required to comply with Treasury Regulation Section 1.409A-3(i)(2), be made to the Participant on the
earlier of (i) the Participant’s death or (ii) the first business day (or within 30 days after such first business
day) that is more than six months after the date of Separation from Service. Notwithstanding anything
contained herein to the contrary, the Participant shall not be considered to have terminated employment

-- 37 of 81 --

6
with the Company or any Subsidiary for purposes of any payments under this Agreement which are
subject to Section 409A of the Code until the Participant has incurred a Separation from Service. In the
Company’s sole and absolute discretion, interest may be paid due to such delay. Further, any interest will
be calculated in the manner determined by the Company in its sole and absolute discretion in a manner
that qualifies any interest as reasonable earnings under Section 409A of the Code. Dividend equivalents
will not be paid with respect to any dividends that would have been paid during the delay if the Stock had
been issued. To the extent required for purposes of Section 409A of the Code, each installment that
vests under this Agreement shall be construed as a separate identified payment for purposes of Section
409A of the Code.
4. 	Non-Transferability of RSUs. The RSUs may not be assigned, transferred, pledged or hypothecated
in any manner (otherwise than by will or the laws of descent or distribution) nor may the Participant enter into
any transaction for the purpose of, or which has the effect of, reducing the market risk of holding the RSUs by
using puts, calls or similar financial techniques. The RSUs subject to this Agreement may be settled during
the lifetime of the Participant only with the Participant or the Participant’s guardian or legal representative.
Upon any attempt to transfer, assign, pledge, hypothecate, or otherwise dispose of the RSUs or any related
rights to the RSUs that is contrary to the provisions of this Agreement or the Plan, or upon the levy of any
attachment or similar process upon the RSUs or such rights, the RSUs and such rights shall immediately
become null and void. The terms of this Agreement, shall be binding upon the Successors of the Participant.
5. 	Stock Subject to the RSUs; Compliance with Law. The Company will not be required to issue or
deliver any shares of Stock or any certificate or certificates for shares of Stock with respect to the
Participant’s RSUs until such shares have been listed (or authorized for listing upon official notice of
issuance) upon each stock exchange on which outstanding shares of the same class are then listed and until
the Company has taken such steps as may, in the opinion of counsel for the Company, be required by law
and applicable regulations, including the rules and regulations of the Securities and Exchange Commission,
and state securities laws and regulations, in connection with the issuance of such shares, and the listing of
such shares on each such exchange.
6. 	Rights as Stockholder. The Participant or his/her Successors shall have no rights as stockholder
with respect to any RSUs or underlying shares of Stock covered by this Agreement until the Participant or
his/her Successors shall have become the beneficial owner of such shares, and, except as provided in
Section 7 and Section 8 of this Agreement, no adjustment shall be made for dividends or distributions or
other rights in respect of such shares for which the record date is prior to the date on which the Participant or
his/her Successors shall have become the beneficial owner thereof.
7. 	Dividend Equivalents. From and after the Date of Grant and until the earlier of (a) the time when
the RSUs become Vested and are settled in accordance with Section 2 and Section 3 of this Agreement
or (b) the time when the Participant’s right to receive shares of Stock in settlement of the RSUs is
forfeited in accordance with Section 2 of this Agreement, on the date that the Company pays a cash
dividend (if any) to holders of Stock generally, the Participant shall be entitled to a number of additional
RSUs determined by dividing (i) the product of (x) the dollar amount of the cash dividend paid per share
of Stock on such date and (y) the total number of RSUs (including dividend equivalents paid thereon)
previously credited to the Participant as of such date, by (ii) the Fair Market Value of the Stock on such
date. Such dividend equivalents (if any) shall be subject to the same terms and conditions and shall be
paid, in the aggregate rounded down to the nearest whole number, or forfeited in the same manner and at
the same time as the RSUs to which the dividend equivalents were credited.
8. 	Adjustments Upon Changes in Capitalization; Change of Control. In the event of any change
in corporate capitalization, corporate transaction, sale or other disposition of assets or similar corporate
transaction or event involving the Company as described in Section 5.5 of the Plan, the Committee shall make
equitable adjustment as it determines necessary and appropriate in the number and type of shares subject to
this Agreement; provided, however, that no fractional share shall be issued upon subsequent settlement of
the RSUs. No adjustment shall be made if such adjustment is prohibited by Section 5.5 of the Plan
(relating to Section 409A of the Code).
9. 	Notices. Each notice relating to this Agreement shall be deemed to have been given on the date it
is received. Each notice to the Company shall be addressed to its principal Office in Eagle, Idaho,
Attention: Compensation. Each notice to the Participant or any other person or persons entitled to shares
issuable upon settlement of the RSUs shall be addressed to the Participant’s address and may be in
written

-- 38 of 81 --

7
or electronic form. Anyone to whom a notice may be given under this Agreement may designate a new
address by giving notice to the effect.
10. 	Benefits of Agreement. This Agreement shall inure to the benefit of and be binding upon each
successor of the Company. All obligations imposed upon the Participant and all rights granted to the
Company under this Agreement shall be binding upon the Participant's Successors. This Agreement shall
be the sole and exclusive source of any and all rights which the Participant or his/her Successors may have
in respect to the Plan or this Agreement.
11. 	No Right to Continued Employment. Nothing in this Agreement shall interfere with or affect the
rights of the Company or the Participant under any employment agreement or confer upon the Participant
any right to continued employment with the Company or a Subsidiary.
12. 	Resolution of Disputes. Any dispute or disagreement which should arise under or as a result of or
in any way related to the interpretation, construction or application of this Agreement will be determined by the
Committee. Any determination made hereunder shall be final, binding and conclusive for all purposes. This
Agreement and the legal relations between the parties hereto shall be governed by and construed in
accordance with the laws of the state of Delaware.
13. 	Section 409A of the Code. To the extent applicable, this Agreement is intended to comply with
Section 409A of the Code and any regulations or notices provided thereunder. This Agreement and the
Plan shall be interpreted in a manner consistent with this intent. The Company reserves the unilateral right
to amend this Agreement on written notice to the Participant in order to comply with Section 409A of the Code.
The Company makes no representation that any or all of the payments described in this Agreement will
be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section
409A of the Code from applying to any such payment. None of the Company or any Subsidiary, or any of
its or their contractors, agents and employees, nor the Board or any member of the Board, shall be liable
for any consequences of any failure to follow the requirements of Section 409A of the Code or any
guidance or regulations thereunder.
14. 	Clawback Policy and Stock Ownership Guidelines. Shares of Stock issued upon settlement of the
RSUs shall be subject to any stock ownership guidelines of the Company applicable to the Participant. In
addition to the clawback described in Section 18(c) of this Agreement, this Agreement and the RSUs are
subject to the Company’s clawback policy applicable to the Participant as may be in effect from time to time,
including, as applicable, being subject to recoupment or clawback by the Company on the terms and
conditions as provided for under Section 10D of the Act and any applicable rules or regulations promulgated
by the Securities and Exchange Commission or any national securities exchange or national securities
association on which the Stock may be traded.
15. 	Amendment. Any amendment to the Plan shall be deemed to be an amendment to this
Agreement to the extent that the amendment is applicable hereto.
16. 	Severability. If any provision of this Agreement or the application of any provision hereof to any
person or circumstances is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement
and the application of such provision to any other person or circumstances shall not be affected, and the
provisions so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent (and only to
the extent) necessary to make it enforceable, valid and legal.
17. 	Electronic Delivery. The Company may, in its sole discretion, deliver any documents related to
the RSUs and the Participant’s participation in the Plan, or future awards that may be granted under the
Plan, by electronic means or request the Participant’s consent to participate in the Plan by electronic
means. The Participant hereby consents to receive such documents by electronic delivery and, if
requested, agrees to participate in the Plan through an on-line or electronic system established and
maintained by the Company or another third party designated by the Company.
18. 	Restrictive Covenants.
(a) 	Confidentiality. It is a condition to the Participant’s receipt of the RSUs that the Participant
execute and agree to the terms of the Company or a Subsidiary’s current and applicable Confidentiality
Agreement (the “Confidentiality Agreement”). By electronically accepting this Agreement, the Participant
acknowledges that the Participant has either already entered into such Confidentiality Agreement with the
Company or a Subsidiary as of the date of acceptance or will enter into such agreement within 30

-- 39 of 81 --

8
days of the Participant’s receipt of this grant of RSUs. If such execution is required and the Participant
does not sign and return the Confidentiality Agreement as prompted by the Workday HR system within 30
days of the Participant’s receipt of this grant of RSUs, this grant of RSUs and any rights to the RSUs will
terminate and become null and void. The Participant further acknowledges that as consideration for the
Participant’s agreement to the terms of the Confidentiality Agreement, the Company is providing the
Participant with the opportunity to participate in this grant of RSUs under the Plan and receive the RSUs
evidenced by this Agreement. The Participant understands that this acknowledgment shall be deemed a
part of the Confidentiality Agreement and is to be interpreted in a manner consistent with its terms.
(b) 	Non-Competition and Non-Solicitation. By electronically accepting this Agreement, the
Participant acknowledges that the Participant has received or will receive specialized training, trade
secrets and confidential information from the Company and, in consideration thereof, agrees to the non-
competition and non-solicitation provisions set forth in Exhibit A to this Agreement (the “Non-Competition
and Non-Solicitation Obligations”). The Participant further acknowledges that as consideration for the
Participant’s agreement to the terms of the Non-Competition and Non-Solicitation Obligations, the
Company is providing the Participant with the opportunity to participate in this grant of RSUs under the
Plan and receive the RSUs evidenced by this Agreement. Notwithstanding the foregoing, if the Participant
is a resident of the state of California, the Participant will not be bound by the Non-Competition and Non-
Solicitation Obligations.
(c) 	Violation of Restrictive Covenants. Notwithstanding anything herein to the contrary, if the
Participant breaches the Confidentiality Agreement or, if applicable, any of the Non-Competition and Non-
Solicitation Obligations, (i) the Participant shall forfeit all RSUs and related dividend equivalents
evidenced by this Agreement, effective on the date on which the Participant first breached such
agreement or obligation(s) and (ii) if such breach occurs within 1 year following (A) the last Vesting Date
or (B) to the extent Section 3(b) applies, the applicable settlement date, all shares of Stock issued or
transferred to the Participant pursuant to this Agreement shall be returned by the Participant to the
Company within 30 days after the Company has provided notice to the Participant of such breach and, if
such shares of Stock have been sold by the Participant, an amount equal to the proceeds from such sale
(determined without regard to any taxes paid) shall become due and payable by the Participant to the
Company within 30 days after the Company has provided notice to the Participant of such breach.
Notwithstanding the foregoing, the Committee, in its sole discretion, may waive the Participant obligations
described in clause (i) and (ii) at any time if deemed to be in the best interests of the Company. The
Participant acknowledges and agrees that it would be inequitable for the Participant to benefit from the
RSUs should the Participant breach the Confidentiality Agreement or, if applicable, any of the Non-
Competition and Non-Solicitation Obligations.
(d) 	Remedies; Government Investigations; DTSA. The Participant acknowledges and agrees that
the rights and remedies set forth in this Section 18 are in addition to and are not intended to limit any
other rights or remedies the Company may have available to it, both during and at any time after the
termination of the Participant’s employment with the Company, including, without limitation, any rights or
remedies the Company may have under the Confidentiality Agreement or other similar agreements.
Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement prevents the
Participant from providing, without prior notice to the Company, information to governmental authorities
regarding possible legal violations or otherwise testifying or participating in any investigation or
proceeding by any governmental authorities regarding possible legal violations, and, for purpose of
clarity, the Participant is not prohibited from providing information voluntarily to the Securities and
Exchange Commission pursuant to Section 21F of the Act. Furthermore, the U.S. Defend Trade Secrets
Act of 2016 (“DTSA”) provides that an individual shall not be held criminally or civilly liable under any
federal or state trade secret law for the disclosure of a trade secret that (i) is made (A) in confidence to a
federal, state, or local government official, either directly or indirectly, or to an attorney; and (B) solely for
the purpose of reporting or investigating a suspected violation of law or (ii) is made in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, the DTSA
provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected
violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
information in the court proceeding, if the individual (x) files any document containing the trade secret
under seal and (y) does not disclose the trade secret, except pursuant to court order.

-- 40 of 81 --

9
Exhibit A
Non-Competition and Non-Solicitation Provisions
1. Definitions. Unless otherwise defined, capitalized terms used in this Exhibit A shall have the
meanings given to them in the Agreement or the Plan, as applicable. As used in this Exhibit A:
(a) “Company” shall include all Subsidiaries of the Company.
(b) “Competing Organization” is defined as any organization that researches, develops,
manufactures, markets, distributes and/or sells one or more Competing Products/Services.
(c) “Competing Products/Services” means any products, services or activities (including, without
limitation, products, services or activities in the planning or development stage during the
Non-Compete Period) that compete, directly or indirectly, in whole or in part, with one or
more of the material products, services or activities (including, without limitation, products,
services or activities in the planning or development stage during the Non-Compete Period)
produced, provided, or engaged in by the Company or its affiliates at the time of the
Participant’s termination of employment with the Company and with which the Participant
worked or about which the Participant obtained any trade secret or other Confidential and
Proprietary Information at any time during the five (5) years immediately preceding the
Participant’s termination of employment with the Company. “Material products, services or
activities” means the development, manufacture or production of packaged potato, sweet
potato, appetizer and vegetable products for the retail, foodservice or institutional channels. If
the products manufactured, sold or marketed by the Company are expanded at any time
during the Participant's employment, such additional products will be deemed to be “material
products, services or activities” for all purposes under this Agreement.
(d) “Confidential and Proprietary Information” is defined as information and data of any kind, in
any form, not generally available to the public, concerning any matters affecting or relating to
the Company, including but not limited to: names, addresses, and any other characteristics
identifying information or aspects of existing or potential Company customers, employees,
vendors or suppliers; the business or operations of the Company and/or the financials,
products, drawings, plans, processes; or other data of the Company not generally known or
available outside of the Company. This definition also includes derivations of Confidential and
Proprietary Information, including any information derived, summarized or extracted from any
of the foregoing whether observed in writing, electronically, mechanically, and/or orally during
the Participant’s employment with the Company.
(e) “Employee” (including its plural) means any person employed by the Company.
(f) “Non-Compete Period” means the period from the date of the Agreement through the twelve-
month period following the Participant’s termination of employment with the Company for any
reason.
(g) “Prohibited Capacity” is defined as (i) any same or similar capacity to that the Participant held
at any time during the last three years of employment with the Company prior to the date of
the Participant’s termination of employment from the Company; (ii) any executive or
managerial capacity; (iii) any marketing or sales capacity; or (iv) any capacity in which the
Participant’s knowledge of Confidential and Proprietary Information would render the
Participant’s assistance to a Competing Organization a competitive advantage.
(h) “Restricted Geographic Area” is defined as all countries, territories, parishes, municipalities
and states in which the Company is doing business or is selling its products at the time of the
Participant’s termination of employment with the Company, including, but not limited to,

-- 41 of 81 --

10
every parish and municipality in the state of Louisiana.1 The Participant acknowledges that
this geographic scope is reasonable given the Participant’s position with the Company, the
international scope of the Company’s business, and the fact that the Participant could
compete with the Company from anywhere the Company does business.
(i) “Trade Secret” means information possessed by or developed for the Company, including,
without limitation, any compilation of data, program, device, method, system, technique or
process, where: (i) the information derives independent economic value, actual or potential,
from not being generally known to, and not being readily ascertainable by proper means by,
other persons who can obtain economic value from its disclosure or use, (ii) the information
is the subject of efforts to maintain its secrecy that are reasonable under the circumstances,
or (iii) information that constitutes a “trade secret” under the Idaho Trade Secrets Act, IDAHO
STAT. § 48-801(5) and/or under the DTSA.
2. Non-Competition. During the Non-Compete Period, the Participant agrees that he or she will not,
within the Restricted Geographic Area, be employed by, work for, consult with, provide services to, or
lend assistance to any Competing Organization in a Prohibited Capacity.
3. Non-Solicitation. The Participant recognizes and agrees that the Company has a legitimate
business interest in restricting potential competitors from hiring Employees who possess or otherwise
may have or had access to the Company’s or any of its affiliates’ Confidential and Proprietary
Information or Trade Secrets. Therefore, the Participant agrees that during the Participant’s
employment with the Company and through the twelve-month period following the termination of the
Participant’s employment with the Company, the Participant shall not directly or indirectly through any
other person or entity recruit, induce, or attempt to induce any Employee to terminate his or her
employment with the Company or otherwise interfere in any way with the employment relationship
between the Company and its Employees. This restriction includes, but is not limited to: (a)
identifying Employees as potential candidates for employment by name, background or qualifications;
(b) recruiting or soliciting Employees; and/or (c) participating in any pre-employment interviews with
Employees.
4. California Residents. Notwithstanding anything in the Agreement or in this Exhibit A, if the
Participant is a resident of the state of California, the non-competition and non-solicitation obligations
described in this Exhibit A shall not apply.
1 These Louisiana parishes currently include Acadia, Allen, Ascension, Assumption, Avoyelles,
Beauregard, Bienville, Bossier, Caddo, Calcasieu, Caldwell, Cameron, Catahoula, Claiborne, Concordia,
De Soto, East Baton Rouge, East Carroll, East Feliciana, Evangeline, Franklin, Grant, Iberia, Iberville,
Jackson, Jefferson, Jefferson Davis, La Salle, Lafayette, Lafourche, Lincoln, Livingston, Madison,
Morehouse, Natchitoches, Orleans, Ouachita, Plaquemines, Pointe Coupee, Rapides, Red River,
Richland, Sabine, St. Bernard, St. Charles, St. Helena, St. James, St. John The Baptist, St. Landry, St.
Martin, St. Mary, St. Tammany, Tangipahoa, Tensas, Terrebonne, Union, Vermilion, Vernon, Washington,
Webster, West Baton Rouge, West Carroll, West Feliciana and Winn.

-- 42 of 81 --

Exhibit 10.2
Form of Lamb Weston Holdings, Inc.
Performance Share Agreement (post-July 20, 2022)
NOTICE OF GRANT
PERFORMANCE SHARES
LAMB WESTON HOLDINGS, INC. 2016 STOCK PLAN
(AS AMENDED AND RESTATED AS OF JULY 20, 2017)
Lamb Weston Holdings, Inc., a Delaware corporation (the “Company”), has awarded to the Participant, as
identified below, the number of Performance Shares (the “Performance Shares”) set forth below. The
Performance Shares are subject to all of the terms and conditions as set forth in this Notice of Grant (the
“Notice”) as well as in the Company’s 2016 Stock Plan (as amended and restated as of July 20, 2017) (the
“Plan”) and the Performance Share Agreement (the “Agreement”), both of which are attached hereto and
incorporated in their entirety. Each Performance Share represents the right to receive one share of Stock
on the Payment Date (as defined in the Agreement), subject to achievement of the Performance Targets
(as defined in the Agreement) and the other terms and conditions of this award. The number of
Performance Shares that may be earned, if any, may range from 25% of the Target Number of
Performance Shares, if the minimum Performance Targets and other conditions are met, to 200% of the
Target Number of Performance Shares (the “Maximum Number of Performance Shares”), if the
maximum Performance Targets and other conditions are met. Capitalized terms not explicitly defined in this
Notice but defined in the Plan or the Agreement will have the same definitions as in the Plan or the
Agreement. In the event of any conflict between the terms of the Award and the Plan, the terms of the Plan will
control.
Participant: 	/$ParticipantName$/
Employee ID: 	/$ParticipantID$/
Target Number of Performance
Shares:
/$TargetAwardsGranted$/
Maximum Number of Performance
Shares:
/$MaxAwardsGranted$/
Date of Grant: 	[______], 2022
Vesting Date: 	May 25, 2025, subject to the terms and
conditions set forth in Section 2 of the
Agreement and Exhibit A to the Agreement.
Dividend Equivalents: 	Yes, dividend equivalents will be
accumulated on earned Performance Shares,
but no amounts are paid, until the Payment
Date of the Performance Shares, in
accordance with Section 7 of the Agreement.
By the Company’s signature below and by the Participant’s clicking the “Accept” button online, the Company
and the Participant agree that the Performance Shares are governed by this Notice and by the provisions of
the Plan and the Agreement, both of which are attached to and made a part of this document. The Participant
acknowledges receipt of copies of the Plan and the Agreement, represents that the Participant has read and is
familiar with their provisions, and hereby accepts the Performance Shares subject to all of their terms and
conditions.
The Company has caused this Notice and the Agreement to be effective as of the Date of Grant.
LAMB WESTON HOLDINGS, INC.
By:
Date: __________________________
PARTICIPANT
/$ParticipantName$/
Date: /$CurrentDate$/

-- 43 of 81 --

2
PERFORMANCE SHARE AGREEMENT
LAMB WESTON HOLDINGS, INC. 2016 STOCK PLAN
(AS AMENDED AND RESTATED AS OF JULY 20, 2017)
Lamb Weston Holdings, Inc., a Delaware corporation (the “Company”), has awarded the Participant, as
named in the Notice of Grant (the “Notice”), to which this Performance Share Agreement (this “Agreement”)
is attached, a Performance Share Award (the “Performance Shares”) that is subject to the Company’s 2016
Stock Plan (as amended and restated as of July 20, 2017) (the “Plan”), the Notice, and this Agreement, for
the number of Performance Shares indicated in the Notice. In the event of any conflict between the terms in
this Agreement and the Plan, the terms of the Plan will control.
1. 	Definitions. Capitalized terms used herein without definition have the meanings set forth in the
Plan. The following terms shall have the respective meanings set forth below:
(a) 	“Change of Control” shall mean the occurrence of any of the following events:
(i) Individuals who, as of the effective date of the Plan, constitute the Board (the “Incumbent
Board”) cease for any reason to constitute at least a majority of the
Board; provided, however, that any person becoming a member of the Board subsequent
to the effective date of the Plan whose election, or nomination for the election by the
Company’s stockholders, was approved by a vote of at least a majority of the Board
members then comprising the Incumbent Board shall be, for purposes of this clause (i),
considered as though such person were a member of the Incumbent Board as of the
effective date of the Plan;
(ii) Consummation of a reorganization, merger or consolidation, in each case, with respect to
which persons who were the stockholders of the Company immediately prior to such
reorganization, merger or consolidation do not, immediately thereafter, own more than
50% of the Voting Power of the reorganized, merged or consolidated entity;
(iii) Any person becomes the beneficial owner, directly or indirectly, of securities of the
Company (not including in the securities beneficially owned by such person, any securities
acquired directly from the Company or its affiliates) representing 30% or more of the
Voting Power of the Company’s then outstanding securities;
(iv) A liquidation or dissolution of the Company; or
(v) The sale of all or substantially all of the assets of the Company.
(b) 	“Continuous Employment” shall mean the absence of any interruption or termination of employment
with the Company and its Subsidiaries and the performance of substantial services. Continuous Employment
shall not be considered interrupted or terminated in the case of sick leave, short-term disability (as defined in
the Company’s sole discretion), military leave or any other leave of absence approved by the Company
unless and until there is a Separation from Service (as defined in Section 1(f) below).
(c) 	“Divestiture” shall mean a permanent disposition to a person other than the Company of a plant or
other facility or property at which the Participant performs a majority of the Participant’s services, whether
such disposition is effected by means of a sale of assets, a sale of Subsidiary stock or otherwise.
(d) 	“Early Retirement” shall mean Separation from Service with the Company and its Subsidiaries
when the Participant (i) is at least age 55, and (ii) has at least ten years of credited service with the
Company and its Subsidiaries.
(e) 	“Normal Retirement” shall mean a Separation from Service with the Company and its Subsidiaries
on or after attaining age 65.
(f) 	“Performance Period” shall mean the three-year period commencing on May 30, 2022 and ending
on May 25, 2025, which is comprised of the following three annual sub-periods (or “Sub-Periods”): May 30,
2022 through May 28, 2023, May 29, 2023 through May 26, 2024, and May 27, 2024 through May 25,
2025.
(g) 	“Performance Targets” shall mean the applicable performance goals set forth on Exhibit A.
(h) 	“Separation from Service,” “termination of employment” and similar terms shall mean the date

-- 44 of 81 --

3
that the Participant incurs a “separation from service” within the meaning of Section 409A of the Code.
As used in connection with the definition of “Separation from Service,” the term “Company” includes
Lamb Weston Holdings, Inc. and any other entity that, with Lamb Weston Holdings, Inc., constitutes a
controlled group of corporations (as defined in Section 414(b) of the Code), or a group of trades or
businesses (whether or not incorporated) under common control (as defined in Section 414(c) of the
Code), substituting 25% for the 80% ownership level for purposes of both Sections 414(b) and Section
414(c) of the Code.
(i) 	“Specified Employee” is as defined under Section 409A of the Code and Treasury Regulation
Section 1.409A-1(i).
(j) 	“Successors” shall mean the beneficiaries, executors, administrators, heirs, successors and assigns
of a person.
2. 	Vesting of Performance Shares.
(a) 	Normal Vesting. Subject to the terms and conditions of the Notice, the Plan, this Agreement and
Exhibit A to this Agreement, the Performance Shares covered by this Agreement shall become
nonforfeitable (“Vest” or similar terms) to the extent that:
(i) Except as provided in Section 2(b) or Section 2(c) below, the Participant remains
Continuously Employed by the Company or a Subsidiary through the Vesting Date; and
(ii) The applicable Performance Targets set forth on Exhibit A for the Performance Period are
achieved, which level of achievement must be certified by the Committee in writing within
90 days after the end of the Performance Period (the “Committee Determination Date”).
For the avoidance of doubt, references in this Agreement to determinations and/or
payments to be made after or following “the end of the Performance Period” shall be
applied only to the Performance Period collectively comprised of all three Sub-Periods
(and not to any Sub-Period individually).
Any Performance Shares that do not satisfy both Section 2(a)(i) and Section 2(a)(ii) will be forfeited.
(b) 	Termination of Employment. If, prior to the Vesting Date, the Participant’s employment with the
Company and its Subsidiaries shall terminate:
(i) by reason of (A) Normal Retirement occurring on or after the date that is 12 months after
the Date of Grant or (B) death, the Performance Shares shall remain subject to
performance through the end of the Performance Period and shall become Vested
(based upon actual achievement of the applicable Performance Targets set forth in
Exhibit A) in accordance with the terms and conditions of this Section 2 as if the
Participant had remained Continuously Employed from the Date of Grant until the Vesting
Date (or, if earlier, the occurrence of a Change of Control to the extent a Replacement
Award is not provided).
(ii) by reason of Early Retirement or involuntary termination due to disability, position elimination,
reduction in force (each as defined in the Company's sole discretion), or Divestiture, in each
case, occurring on or after the date that is 12 months after the Date of Grant, the
Performance Shares shall remain subject to performance through the end of the
Performance Period and shall become Vested (based upon actual achievement of the
applicable Performance Targets set forth in Exhibit A) in accordance with the terms and
conditions of this Section 2 on a pro-rata basis in an amount equal to the product of (A) the
number of Performance Shares in which the Participant would have Vested in accordance
with the terms and conditions of this Section 2 if the Participant had remained Continuously
Employed from the Date of Grant until the Vesting Date (or, if earlier, the occurrence of a
Change of Control to the extent a Replacement Award is not provided), multiplied by (B) a
fraction, the numerator of which is the total number of calendar days during which the
Participant was employed by the Company or a Subsidiary during the period beginning on
May 30, 2022 and ending on the Separation from Service and the denominator of which is
the total number of calendar days beginning on May 30, 2022 and ending on May 25, 2025,
rounded to the nearest whole number of Performance Shares.
(iii) for Cause or any reason other than as described in Sections 2(b)(i) or 2(b)(ii) prior to the
Vesting Date, then all Performance Shares, whether Vested or unvested prior to the Vesting

-- 45 of 81 --

4
Date, shall be immediately forfeited without further consideration to the Participant.
For the avoidance of doubt, any Vested Performance Shares pursuant to Sections 2(b)(i) or 2(b)(ii) will be
settled pursuant to Section 3(a) hereof.
(c) 	Accelerated Vesting in Connection with a Change of Control.
(i) If a Change of Control occurs prior to the end of the Performance Period, and the
Participant has been in Continuous Employment between the Date of Grant and the date
of such Change of Control, then the Participant shall Vest in a number of Performance
Shares equal to the greater of (A) the number of Performance Shares in which the
Participant would Vest based on actual performance through the most recent date prior
to the Change of Control for which achievement of Performance Targets can reasonably
be determined, as certified by the Committee as constituted immediately prior to the
Change of Control and (B) the target number of Performance Shares subject to this
Agreement, rounded to the nearest whole number of Performance Shares, except to the
extent that (I) such Performance Shares have previously been forfeited, or (II) a
Replacement Award is provided to the Participant to replace, continue or adjust the
outstanding Performance Shares (the “Replaced Award”).
(ii) If a Change of Control occurs after the end of the Performance Period but before the
Committee Determination Date, then all Performance Shares earned based on
performance (to be measured on or prior to the date of the Change of Control) will
become 100% Vested, except to the extent that (A) such Performance Shares have
previously been forfeited, or (B) a Replacement Award is provided to the Participant to
replace, continue or adjust the outstanding Performance Shares.
(iii) Notwithstanding any other provision of this Agreement, if, (x) within a period of two years
following a Change of Control, the Participant’s employment with the Company, a
Subsidiary or any of its or their successors after the Change of Control (as applicable,
the “Successor Company”) is terminated by the Participant for Good Reason or by the
Successor Company other than for Cause prior to the Vesting Date or (y) at any time
following a Change of Control, the Participant’s employment terminates due to Early
Retirement or Normal Retirement prior to the Vesting Date, then to the extent that the
Replacement Award has not previously been Vested or forfeited, the Replacement Award
will become 100% Vested (and become entitled to settlement as specified in Section
3(b)(i)).
(iv) For purposes of this Agreement, a “Replacement Award” means an award (A) of the
same type as the Replaced Award (i.e., restricted stock or restricted stock units) but with
any remaining performance conditions of the Replaced Award deemed satisfied at the
greater of (I) the actual level of performance as of the Change of Control, if reasonably
measurable, and (II) the target level of performance, in each case without proration, and
subject to continued service through the Vesting Date, (B) that has a value at least equal
to the value of the Replaced Award, including at the deemed level of performance as
determined in clause (A) above, as applicable, (C) that relates to publicly traded equity
securities of the Successor Company in the Change of Control (or another entity that is
affiliated with the Successor Company following the Change of Control), (D) the tax
consequences of which for such Participant under the Code, if the Participant is subject
to U.S. federal income tax under the Code, are not less favorable to the Participant than
the tax consequences of the Replaced Award, and (E) the other terms and conditions of
which are not less favorable to the Participant than the terms and conditions of the
Replaced Award (including the provisions that would apply in the event of a subsequent
change of control). A Replacement Award may be granted only to the extent it does not
result in the Replaced Award or Replacement Award failing to comply with or ceasing to
be exempt from Section 409A of the Code. Without limiting the generality of the
foregoing, the Replacement Award may take the form of a continuation of the Replaced
Award if the requirements of the preceding two sentences are satisfied. The
determination of whether the conditions of this Section 2(c)(iv) are satisfied will be made
in good faith by the Committee, as constituted immediately before the Change of Control,
in its sole discretion.

-- 46 of 81 --

5
(v) For purposes of this Agreement, “Cause” means: (A) the willful and continued failure by
the Participant to substantially perform the Participant’s duties with the Successor
Company (other than any such failure resulting from termination by the Participant for
Good Reason) after a demand for substantial performance is delivered to the Participant
that specifically identifies the manner in which the Successor Company believes that the
Participant has not substantially performed the Participant’s duties, and the Participant
has failed to resume substantial performance of the Participant’s duties on a continuous
basis within five days of receiving such demand; (B) the willful engaging by the
Participant in conduct which is demonstrably and materially injurious to the Successor
Company, monetarily or otherwise; or (C) the Participant’s conviction of, or plea of nolo
contendere to, (I) a felony or (II) a misdemeanor which impairs the Participant’s ability
substantially to perform the Participant’s duties with the Successor Company. For the
purposes of this definition, no act, or failure to act, on the Participant’s part shall be
deemed “willful” unless done, or omitted to be done, by the Participant not in good faith
and without reasonable belief that the Participant’s action or omission was in the best
interest of the Successor Company.
(vi) For purposes of this Agreement, “Good Reason” means: (A) any material failure of the
Successor Company to comply with and satisfy any of the terms of any employment or
change in control (or similar) agreement between the Successor Company and the
Participant pursuant to which the Participant provides services to the Successor
Company; (B) any significant involuntary reduction of the authority, duties or
responsibilities held by the Participant immediately prior to the Change of Control (and,
for the avoidance of doubt, involuntary removal of the Participant from an officer position
that the Participant holds immediately prior to the Change of Control will not, by itself,
constitute a significant involuntary reduction of the authority, duties or responsibilities
held by the Participant immediately prior to the Change of Control); (C) any material
involuntary reduction in the aggregate target cash remuneration opportunity of the
Participant as in effect immediately prior to the Change of Control; or (D) requiring the
Participant to become based at any office or location more than 50 miles from the office
or location at which the Participant was based immediately prior to such Change of
Control, except for travel reasonably required in the performance of the Participant’s
responsibilities; provided, however, that no termination shall be deemed to be for Good
Reason unless (I) the Participant provides the Successor Company with written notice
setting forth the specific facts or circumstances constituting Good Reason within ninety
days after the initial existence of the occurrence of such facts or circumstances, (II) the
Successor Company fails to cure such facts or circumstances within thirty days of its
receipt of such written notice, and (III) the Participant actually terminates employment
within thirty days following the end of the Successor Company’s thirty-day cure period, if
such event or circumstance has not been cured.
(vii) If a Replacement Award is provided, notwithstanding anything in this Agreement to the
contrary, any outstanding Performance Shares which at the time of the Change of
Control are not subject to a "substantial risk of forfeiture" (within the meaning of Section
409A of the Code) will be deemed to be Vested at the time of such Change of Control
(and such Vested Performance Shares shall be settled in accordance with Section 3(b)
(ii) below).
(d) 	Forfeiture of Performance Shares. Subject to Section 2(b)(iii), any Performance Shares that
have not Vested pursuant to Section 2(a), Section 2(b), or Section 2(c) will be forfeited automatically and
without further notice (including if the Participant ceases to be in Continuous Employment prior to the
Vesting Date for any reason other than as described in Section 2(b) or Section 2(c)).
3. 	Settlement of Performance Shares.
(a) 	Normal. Subject to Section 3(b), the Company will issue to the Participant one share of Stock for
each earned Performance Share as soon as practicable following the later of (x) the Committee
Determination Date and (y) the Vesting Date, but in no event later than 60 days following the later such time
(the “Payment Date”).
(b) 	Other Settlement Events. Notwithstanding Section 3(a), to the extent the Performance Shares
are Vested Performance Shares on the dates set forth below and to the extent the Vested Performance

-- 47 of 81 --

6
Shares have not previously been Vested, forfeited or settled, the Company will settle such Vested
Performance Shares as follows:
(i) Separation from Service. If there are such Vested Performance Shares upon the
Participant's Separation from Service following a Change of Control pursuant to Section
2(c)(iii) hereof, within thirty days of the Participant's Separation from Service, one share
of Stock will be issued for each such Vested Performance Share; provided, that such
Change of Control qualifies as a permissible date of distribution under Section 409A(a)
(2)(A) of the Code and the regulations thereunder. If such Change of Control does not
qualify, the Participant is entitled to receive the corresponding payment on the date that
would have otherwise applied pursuant to Section 3 as though such Change of Control
had not occurred.
(ii) Change of Control. If there are such Vested Performance Shares upon a Change of
Control, one share of Stock will be issued for each such Vested Performance Share as of
the date of the Change of Control; provided, however, that if such Change of Control
would not qualify as a permissible date of distribution under Section 409A(a)(2)(A) of the
Code, and the regulations thereunder, and where Section 409A of the Code applies to
such distribution, the Participant is entitled to receive the corresponding payment on the
date that would have otherwise applied pursuant to Section 3 as though such Change of
Control had not occurred.
(c) 	Payment of Taxes Upon Settlement. As a condition of the issuance of shares of Stock upon
settlement of Performance Shares hereunder, the Participant agrees to remit to the Company at the time of
settlement any taxes or other amounts required to be withheld by the Company under Federal, State or
local law as a result of the settlement of the Performance Shares. As a condition of the issuance of shares
of Stock upon settlement of Performance Shares hereunder, the Participant agrees that the Company
will deduct from the total shares to be issued as a result of the Vesting of the Performance Shares a
sufficient number of shares to satisfy the required statutory withholding amount, which may exceed the
minimum statutory tax withholding amount only if it would not cause adverse accounting or tax
consequences for the Company or a Subsidiary.
(d) 	Specified Employee. Notwithstanding anything (including any provision of the Agreement or the
Plan) to the contrary, if a Participant is a Specified Employee and if the Performance Shares are subject
to Section 409A of the Code, payment to the Participant on account of a Separation from Service shall, to
the extent required to comply with Treasury Regulation Section 1.409A-3(i)(2), be made to the Participant
on the earlier of (i) the Participant’s death or (ii) the first business day (or within 30 days after such first
business day) that is more than six months after the date of Separation from Service. Notwithstanding
anything contained herein to the contrary, the Participant shall not be considered to have terminated
employment with the Company or any Subsidiary for purposes of any payments under this Agreement
which are subject to Section 409A of the Code until the Participant has incurred a Separation from
Service. In the Company’s sole and absolute discretion, interest may be paid due to such delay. Further,
any interest will be calculated in the manner determined by the Company in its sole and absolute
discretion in a manner that qualifies any interest as reasonable earnings under Section 409A of the
Code. Dividend equivalents will not be paid with respect to any dividends that would have been paid
during the delay if the Stock had been issued. To the extent required for purposes of Section 409A of the
Code, each installment that vests under this Agreement shall be construed as a separate identified
payment for purposes of Section 409A of the Code.
4. 	Non-Transferability of Performance Shares. The Performance Shares may not be assigned,
transferred, pledged or hypothecated in any manner (otherwise than by will or the laws of descent or
distribution) nor may the Participant enter into any transaction for the purpose of, or which has the effect of,
reducing the market risk of holding the Performance Shares by using puts, calls or similar financial
techniques. The Performance Shares subject to this Agreement may be settled during the lifetime of the
Participant only with the Participant or the Participant’s guardian or legal representative. Upon any attempt to
transfer, assign, pledge, hypothecate, or otherwise dispose of the Performance Shares or any related rights to
the Performance Shares that is contrary to the provisions of this Agreement or the Plan, or upon the levy of
any attachment or similar process upon the Performance Shares or such rights, the Performance Shares and
such rights shall immediately become null and void. The terms of this Agreement shall be binding upon the
Successors of the Participant.

-- 48 of 81 --

7
5. 	Stock Subject to the Performance Shares; Compliance with Law. The Company will not be
required to issue or deliver any shares of Stock or any certificate or certificates for shares of Stock with
respect to the Participant’s Performance Shares until such shares have been listed (or authorized for listing
upon official notice of issuance) upon each stock exchange on which outstanding shares of the same class
are then listed and until the Company has taken such steps as may, in the opinion of counsel for the
Company, be required by law and applicable regulations, including the rules and regulations of the Securities
and Exchange Commission, and state securities laws and regulations, in connection with the issuance of
such shares, and the listing of such shares on each such exchange.
6. 	Rights as Stockholder. The Participant or his/her Successors shall have no rights as stockholder
with respect to any Performance Shares or underlying shares covered by this Agreement until the Participant
or his/her Successors shall have become the beneficial owner of such shares on the Payment Date.
7. 	Dividend Equivalents. Upon the payment of earned Performance Shares as of the Payment
Date, the Participant shall receive additional shares of Stock equal in value to the accrued dividend
equivalents. The amount of dividend equivalents for each Performance Share earned shall equal the
dividends paid on one share of Stock for each dividend whose record date occurs during the period
between the Date of Grant and the Payment Date.
8. 	Adjustments Upon Changes in Capitalization; Change of Control. In the event of any change
in corporate capitalization, corporate transaction, sale or other disposition of assets or similar corporate
transaction or event involving the Company as described in Section 5.5 of the Plan, the Committee shall make
equitable adjustment as it determines necessary and appropriate in the number and type of shares subject to
this Agreement; provided, however, that no fractional share shall be issued upon subsequent settlement of
the Performance Shares. No adjustment shall be made if such adjustment is prohibited by Section 5.5 of
the Plan (relating to Section 409A of the Code).
9. 	Notices. Each notice relating to this Agreement shall be deemed to have been given on the date it
is received. Each notice to the Company shall be addressed to its principal Office in Eagle, Idaho,
Attention: Compensation. Each notice to the Participant or any other person or persons entitled to shares
issuable upon settlement of the Performance Shares shall be addressed to the Participant’s address and
may be in written or electronic form. Anyone to whom a notice may be given under this Agreement may
designate a new address by giving notice to the effect.
10. 	Benefits of Agreement. This Agreement shall inure to the benefit of and be binding upon each
successor of the Company. All obligations imposed upon the Participant and all rights granted to the
Company under this Agreement shall be binding upon the Participant's Successors. This Agreement shall
be the sole and exclusive source of any and all rights which the Participant or his/her Successors may have
in respect to the Plan or this Agreement.
11. 	No Right to Continued Employment. Nothing in this Agreement shall interfere with or affect the
rights of the Company or the Participant under any employment agreement or confer upon the Participant
any right to continued employment with the Company or a Subsidiary.
12. 	Resolution of Disputes. Any dispute or disagreement which should arise under or as a result of or
in any way related to the interpretation, construction or application of this Agreement will be determined by the
Committee. Any determination made hereunder shall be final, binding and conclusive for all purposes. This
Agreement and the legal relations between the parties hereto shall be governed by and construed in
accordance with the laws of the state of Delaware.
13. 	Section 409A of the Code. To the extent applicable, this Agreement is intended to comply with
Section 409A of the Code and any regulations or notices provided thereunder. This Agreement and the
Plan shall be interpreted in a manner consistent with this intent. The Company reserves the unilateral right
to amend this Agreement on written notice to the Participant in order to comply with Section 409A of the Code.
The Company makes no representation that any or all of the payments described in this Agreement will
be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section
409A of the Code from applying to any such payment. None of the Company or any Subsidiary, or any of
its or their contractors, agents and employees, nor the Board or any member of the Board, shall be liable
for any consequences of any failure to follow the requirements of Section 409A of the Code or any
guidance or regulations thereunder.

-- 49 of 81 --

8
14. 	Clawback Policy and Stock Ownership Guidelines. Shares of Stock issued upon settlement of
the Performance Shares shall be subject to any stock ownership guidelines of the Company applicable to
the Participant. In addition to the clawback described in Section 18(c) of this Agreement, this Agreement
and the Performance Shares are subject to the Company’s clawback policy as may be in effect from time
to time, including, as applicable, being subject to recoupment or clawback by the Company on the terms
and conditions as provided for under Section 10D of the Act and any applicable rules or regulations
promulgated by the Securities and Exchange Commission or any national securities exchange or national
securities association on which the Stock may be traded.
15. 	Amendment. Any amendment to the Plan shall be deemed to be an amendment to this
Agreement to the extent that the amendment is applicable hereto.
16. 	Severability. If any provision of this Agreement or the application of any provision hereof to any
person or circumstances is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement
and the application of such provision to any other person or circumstances shall not be affected, and the
provisions so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent (and only to
the extent) necessary to make it enforceable, valid and legal.
17. 	Electronic Delivery. The Company may, in its sole discretion, deliver any documents related to
the Performance Shares and the Participant’s participation in the Plan, or future awards that may be
granted under the Plan, by electronic means or request the Participant’s consent to participate in the Plan
by electronic means. The Participant hereby consents to receive such documents by electronic delivery
and, if requested, agrees to participate in the Plan through an on-line or electronic system established
and maintained by the Company or another third party designated by the Company.
18. 	Restrictive Covenants.
(a) 	Confidentiality. It is a condition to the Participant’s receipt of the Performance Shares that the
Participant execute and agree to the terms of the Company or a Subsidiary’s current and applicable
Confidentiality Agreement (the “Confidentiality Agreement”). By electronically accepting this Agreement,
the Participant acknowledges that the Participant has either already entered into such Confidentiality
Agreement with the Company or a Subsidiary as of the date of acceptance or will enter into such
agreement within 30 days of the Participant’s receipt of this grant of Performance Shares. If such
execution is required and the Participant does not sign and return the Confidentiality Agreement as
prompted by the Workday HR system within 30 days of the Participant’s receipt of this grant of
Performance Shares, this grant of Performance Shares and any rights to the Performance Shares will
terminate and become null and void. The Participant further acknowledges that as consideration for the
Participant’s agreement to the terms of the Confidentiality Agreement, the Company is providing the
Participant with the opportunity to participate in this grant of Performance Shares under the Plan and
receive the Performance Shares evidenced by this Agreement. The Participant understands that this
acknowledgment shall be deemed a part of the Confidentiality Agreement and is to be interpreted in a
manner consistent with its terms.
(b) 	Non-Competition and Non-Solicitation. By electronically accepting this Agreement, the
Participant acknowledges that the Participant has received or will receive specialized training, trade
secrets and confidential information from the Company and, in consideration thereof, agrees to the non-
competition and non-solicitation provisions set forth in Exhibit B to this Agreement (the “Non-Competition
and Non-Solicitation Obligations”). The Participant further acknowledges that as consideration for the
Participant’s agreement to the terms of the Non-Competition and Non-Solicitation Obligations, the
Company is providing the Participant with the opportunity to participate in this grant of Performance
Shares under the Plan and receive the Performance Shares evidenced by this Agreement.
Notwithstanding the foregoing, if the Participant is a resident of the state of California, the Participant will
not be bound by the Non-Competition and Non-Solicitation Obligations.
(c) 	Violation of Restrictive Covenants. Notwithstanding anything herein to the contrary, if the
Participant breaches the Confidentiality Agreement or, if applicable, any of the Non-Competition and Non-
Solicitation Obligations, (i) the Participant shall forfeit all Performance Shares and related dividend
equivalents evidenced by this Agreement, effective on the date on which the Participant first breached
such agreement or obligation(s) and (ii) if such breach occurs within 1 year following (A) the Vesting Date
or (B) to the extent Section 3(b) applies, the applicable settlement date, all shares of Stock issued or
transferred to the Participant pursuant to this Agreement shall be returned by the Participant to the
Company within 30 days after the Company has provided notice to the Participant of such breach and, if

-- 50 of 81 --

9
such shares of Stock have been sold by the Participant, an amount equal to the proceeds from such sale
(determined without regard to any taxes paid) shall become due and payable by the Participant to the
Company within 30 days after the Company has provided notice to the Participant of such breach.
Notwithstanding the foregoing, the Committee, in its sole discretion, may waive the Participant obligations
described in clause (i) and (ii) at any time if deemed to be in the best interests of the Company. The
Participant acknowledges and agrees that it would be inequitable for the Participant to benefit from the
Performance Shares should the Participant breach the Confidentiality Agreement or, if applicable, any of
the Non-Competition and Non-Solicitation Obligations.
(d) 	Remedies; Government Investigations; DTSA. The Participant acknowledges and agrees that
the rights and remedies set forth in this Section 18 are in addition to and are not intended to limit any
other rights or remedies the Company may have available to it, both during and at any time after the
termination of the Participant’s employment with the Company, including, without limitation, any rights or
remedies the Company may have under the Confidentiality Agreement or other similar agreements.
Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement prevents the
Participant from providing, without prior notice to the Company, information to governmental authorities
regarding possible legal violations or otherwise testifying or participating in any investigation or
proceeding by any governmental authorities regarding possible legal violations, and, for purpose of
clarity, the Participant is not prohibited from providing information voluntarily to the Securities and
Exchange Commission pursuant to Section 21F of the Act. Furthermore, the U.S. Defend Trade Secrets
Act of 2016 (“DTSA”) provides that an individual shall not be held criminally or civilly liable under any
federal or state trade secret law for the disclosure of a trade secret that (i) is made (A) in confidence to a
federal, state, or local government official, either directly or indirectly, or to an attorney; and (B) solely for
the purpose of reporting or investigating a suspected violation of law or (ii) is made in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, the DTSA
provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected
violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
information in the court proceeding, if the individual (x) files any document containing the trade secret
under seal and (y) does not disclose the trade secret, except pursuant to court order.

-- 51 of 81 --

10
Exhibit B
Non-Competition and Non-Solicitation Provisions
1. Definitions. Unless otherwise defined, capitalized terms used in this Exhibit B shall have the
meanings given to them in the Agreement or the Plan, as applicable. As used in this Exhibit B:
(a) “Company” shall include all Subsidiaries of the Company.
(b) “Competing Organization” is defined as any organization that researches, develops,
manufactures, markets, distributes and/or sells one or more Competing Products/Services.
(c) “Competing Products/Services” means any products, services or activities (including, without
limitation, products, services or activities in the planning or development stage during the
Non-Compete Period) that compete, directly or indirectly, in whole or in part, with one or
more of the material products, services or activities (including, without limitation, products,
services or activities in the planning or development stage during the Non-Compete Period)
produced, provided, or engaged in by the Company or its affiliates at the time of the
Participant’s termination of employment with the Company and with which the Participant
worked or about which the Participant obtained any trade secret or other Confidential and
Proprietary Information at any time during the five (5) years immediately preceding the
Participant’s termination of employment with the Company. “Material products, services or
activities” means the development, manufacture or production of packaged potato, sweet
potato, appetizer and vegetable products for the retail, foodservice or institutional channels. If
the products manufactured, sold or marketed by the Company are expanded at any time
during the Participant's employment, such additional products will be deemed to be “material
products, services or activities” for all purposes under this Agreement.
(d) “Confidential and Proprietary Information” is defined as information and data of any kind, in
any form, not generally available to the public, concerning any matters affecting or relating to
the Company, including but not limited to: names, addresses, and any other characteristics
identifying information or aspects of existing or potential Company customers, employees,
vendors or suppliers; the business or operations of the Company and/or the financials,
products, drawings, plans, processes; or other data of the Company not generally known or
available outside of the Company. This definition also includes derivations of Confidential and
Proprietary Information, including any information derived, summarized or extracted from any
of the foregoing whether observed in writing, electronically, mechanically, and/or orally during
the Participant’s employment with the Company.
(e) “Employee” (including its plural) means any person employed by the Company.
(f) “Non-Compete Period” means the period from the date of the Agreement through the twelve-
month period following the Participant’s termination of employment with the Company for any
reason.
(g) “Prohibited Capacity” is defined as (i) any same or similar capacity to that the Participant held
at any time during the last three years of employment with the Company prior to the date of
the Participant’s termination of employment from the Company; (ii) any executive or
managerial capacity; (iii) any marketing or sales capacity; or (iv) any capacity in which the
Participant’s knowledge of Confidential and Proprietary Information would render the
Participant’s assistance to a Competing Organization a competitive advantage.
(h) “Restricted Geographic Area” is defined as all countries, territories, parishes, municipalities
and states in which the Company is doing business or is selling its products at the time of the
Participant’s termination of employment with the Company, including, but not limited to,

-- 52 of 81 --

11
every parish and municipality in the state of Louisiana.1 The Participant acknowledges that
this geographic scope is reasonable given the Participant’s position with the Company, the
international scope of the Company’s business, and the fact that the Participant could
compete with the Company from anywhere the Company does business.
(i) “Trade Secret” means information possessed by or developed for the Company, including,
without limitation, any compilation of data, program, device, method, system, technique or
process, where: (i) the information derives independent economic value, actual or potential,
from not being generally known to, and not being readily ascertainable by proper means by,
other persons who can obtain economic value from its disclosure or use, (ii) the information
is the subject of efforts to maintain its secrecy that are reasonable under the circumstances,
or (iii) information that constitutes a “trade secret” under the Idaho Trade Secrets Act, IDAHO
STAT. § 48-801(5) and/or under the DTSA.
2. Non-Competition. During the Non-Compete Period, the Participant agrees that he or she will not,
within the Restricted Geographic Area, be employed by, work for, consult with, provide services to, or
lend assistance to any Competing Organization in a Prohibited Capacity.
3. Non-Solicitation. The Participant recognizes and agrees that the Company has a legitimate
business interest in restricting potential competitors from hiring Employees who possess or otherwise
may have or had access to the Company’s or any of its affiliates’ Confidential and Proprietary
Information or Trade Secrets. Therefore, the Participant agrees that during the Participant’s
employment with the Company and through the twelve-month period following the termination of the
Participant’s employment with the Company, the Participant shall not directly or indirectly through any
other person or entity recruit, induce, or attempt to induce any Employee to terminate his or her
employment with the Company or otherwise interfere in any way with the employment relationship
between the Company and its Employees. This restriction includes, but is not limited to: (a)
identifying Employees as potential candidates for employment by name, background or qualifications;
(b) recruiting or soliciting Employees; and/or (c) participating in any pre-employment interviews with
Employees.
4. California Residents. Notwithstanding anything in the Agreement or in this Exhibit A, if the
Participant is a resident of the state of California, the non-competition and non-solicitation obligations
described in this Exhibit A shall not apply.
1 These Louisiana parishes currently include Acadia, Allen, Ascension, Assumption, Avoyelles,
Beauregard, Bienville, Bossier, Caddo, Calcasieu, Caldwell, Cameron, Catahoula, Claiborne, Concordia,
De Soto, East Baton Rouge, East Carroll, East Feliciana, Evangeline, Franklin, Grant, Iberia, Iberville,
Jackson, Jefferson, Jefferson Davis, La Salle, Lafayette, Lafourche, Lincoln, Livingston, Madison,
Morehouse, Natchitoches, Orleans, Ouachita, Plaquemines, Pointe Coupee, Rapides, Red River,
Richland, Sabine, St. Bernard, St. Charles, St. Helena, St. James, St. John The Baptist, St. Landry, St.
Martin, St. Mary, St. Tammany, Tangipahoa, Tensas, Terrebonne, Union, Vermilion, Vernon, Washington,
Webster, West Baton Rouge, West Carroll, West Feliciana and Winn.

-- 53 of 81 --

Exhibit 10.3
Form of Lamb Weston Holdings, Inc.
Nonqualified Stock Option Agreement for Employees (post-July 20, 2022)
NOTICE OF GRANT
NONQUALIFIED STOCK OPTION
LAMB WESTON HOLDINGS, INC. 2016 STOCK PLAN
(AS AMENDED AND RESTATED AS OF JULY 20, 2017)
Lamb Weston Holdings, Inc., a Delaware corporation (the “Company”), has awarded to the
Optionee, as identified below, an option (the “Option”) to purchase the number of shares of the Company’s
common stock (the “Common Stock”) set forth below. The Option is subject to all of the terms and
conditions as set forth in this Notice of Grant (the “Notice”) as well as in the Company’s 2016 Stock
Plan (as amended and restated as of July 20, 2017) (the “Plan”) and the Nonqualified Stock Option
Agreement (the “Agreement”), both of which are attached hereto and incorporated in their entirety.
Capitalized terms not explicitly defined in this Notice but defined in the Plan or the Agreement will have
the same definitions as in the Plan or the Agreement. In the event of any conflict between the terms of
the Award and the Plan, the terms of the Plan will control.
Optionee: 	/$ParticipantName$/
Employee ID: 	/$OptioneeID$/
Number of Shares of Common Stock: 	/$AwardsGranted$/
Exercise Price Per Share: 	$_____
Date of Grant: 	__________
Type of Option: 	Nonqualified
Expiration Date: 	[INSERT 7th anniversary of Date of Grant]
Vesting Dates:
33%, 33% and 34%, respectively, of the shares of Common
Stock subject to the Option will vest and become exercisable
on each of the first three anniversaries of the Date of Grant
(each, a “Vesting Date”), with any fractional shares being
rounded down to the nearest whole share and vesting with
the next vesting installment (if applicable) and subject to the
terms and conditions set forth in the Agreement
By the Company’s signature below and by the Optionee’s clicking the “Accept” button online, the Company
and the Optionee agree that the Option is governed by this Notice and by the provisions of the Plan and the
Agreement, both of which are attached to and made a part of this document. The Optionee acknowledges
receipt of copies of the Plan and the Agreement, represents that the Optionee has read and is familiar with
their provisions, and hereby accepts the Option subject to all of its terms and conditions. For the avoidance
of doubt, the Option is intended to constitute a nonqualified stock option and shall not be treated as an
“incentive stock option.”
The Company has caused this Notice and the Agreement to be effective as of the Date of Grant.
LAMB WESTON HOLDINGS, INC.
By:
Date:

-- 54 of 81 --

2
NONQUALIFIED OPTION AGREEMENT
LAMB WESTON HOLDINGS, INC. 2016 STOCK PLAN
(AS AMENDED AND RESTATED AS OF JULY 20, 2017)
Lamb Weston Holdings, Inc., a Delaware corporation (the “Company”), has awarded the
Optionee, as named in the Notice of Grant (the “Notice”), to which this Nonqualified Option Agreement
(this “Agreement”) is attached, an Option that is subject to the Company’s 2016 Stock Plan (as amended
and restated as of July 20, 2017) (the “Plan”), the Notice, and this Agreement, to purchase the number of
shares of Common Stock indicated in the Notice. In the event of any conflict between the terms in this
Agreement and the Plan, the terms of the Plan will control.
1. 	Definitions. Capitalized terms used herein without definition have the meanings set forth in the
Plan. The following terms shall have the respective meanings set forth below:
a. “Change of Control” shall mean the occurrence of any of the following events:
i. Individuals who, as of the effective date of the Plan, constitute the Board (the
“Incumbent Board”) cease for any reason to constitute at least a majority of the
Board; provided, however, that any person becoming a member of the Board
subsequent to the effective date of the Plan whose election, or nomination for the
election by the Company’s stockholders, was approved by a vote of at least a
majority of the Board members then comprising the Incumbent Board shall be,
for purposes of this clause (i), considered as though such person were a
member of the Incumbent Board as of the effective date of the Plan;
ii. Consummation of a reorganization, merger or consolidation, in each case, with
respect to which persons who were the stockholders of the Company
immediately prior to such reorganization, merger or consolidation do not,
immediately thereafter, own more than 50% of the Voting Power of the
reorganized, merged or consolidated entity;
iii. Any person becomes the beneficial owner, directly or indirectly, of securities of
the Company (not including in the securities beneficially owned by such person,
any securities acquired directly from the Company or its affiliates) representing
30% or more of the Voting Power of the Company’s then outstanding securities;
iv. A liquidation or dissolution of the Company; or
v. The sale of all or substantially all of the assets of the Company.
b. “Continuous Employment” shall mean the absence of any interruption or termination of employment
with the Company and its Subsidiaries. Continuous Employment shall not be considered interrupted in the
case of sick leave, short-term disability (as defined in the Company’s sole discretion), military leave or any
other leave of absence approved by the Company.
c. “Divestiture” shall mean a permanent disposition to a person other than the Company of a plant or
other facility or property at which the Optionee performs a majority of the Optionee’s services, whether
such disposition is effected by means of a sale of assets, a sale of Subsidiary stock or otherwise.
d. “Early Retirement” shall mean terminating employment with the Company and its Subsidiaries when
the Optionee (i) is at least age 55, and (ii) has at least ten years of credited service with the Company and its
Subsidiaries.
e. “Exercise Price” shall mean the per share purchase price payable on exercise of the Option.
f. “Normal Retirement” shall mean terminating employment with the Company and its Subsidiaries on
or after attaining age 65.

-- 55 of 81 --

3
2. 	Exercise of Option.
a. 	Normal Vesting. A portion of this Option shall become vested and exercisable, on each
Vesting Date as set forth in the Notice, if the Optionee remains in Continuous Employment until such
Vesting Date.
b. 	Accelerated Vesting Upon Termination of Employment. If, prior to the last Vesting
Date set forth in the Notice, the Optionee’s employment with the Company and its Subsidiaries shall
terminate:
i. by reason of Normal Retirement on or after the date that is 12 months following
the Date of Grant, then this Option shall, to the extent it has not previously been
forfeited, become 100% vested and exercisable; or
ii. by reason of the Optionee’s death or disability, by the Optionee for Good
Reason, by the Company other than for Cause, or by reason of Early
Retirement, then an additional portion of this Option shall vest and become
exercisable (the “Additional Portion”), with the number of shares of Common
Stock subject to the Additional Portion determined by (A) multiplying the total
number of shares of Common Stock that are subject to the Option by a fraction,
the numerator of which is the total number of calendar days during which the
Optionee was employed by the Company or a Subsidiary during the period
beginning on the Date of Grant and ending on the date of such termination, and
the denominator of which is the total number of calendar days beginning with the
Date of Grant and ending on the last Vesting Date set forth in the Notice,
rounded to the nearest whole number of shares, and (B) subtracting the number
of shares subject to the portion of the Option that is vested pursuant to Section
2(a) (the Additional Portion, together with the portion of the Option that is vested
pursuant to Section 2(a), the “Pro Rata Vested Option”), and the Optionee will
forfeit all rights to any portions of the Option other than those included in the Pro
Rata Vested Option; provided, however, that such Additional Portion shall not
vest in the event of an Early Retirement that occurs less than 12 months
following the Date of Grant.
For the avoidance of doubt, if the Optionee’s employment with the Company and its Subsidiaries shall
terminate for any reason other than as described in Sections 2(b)(i) and 2(b)(ii) above, then any portion
of this Option that remains unvested at the time of such termination shall be immediately forfeited without
further consideration to the Optionee.
c. 	Accelerated Vesting in Connection with a Change of Control.
i. Upon a Change of Control occurring prior to the last Vesting Date set forth in the
Notice, if the Optionee has been in Continuous Employment between the Date of
Grant and the date of such Change of Control, to the extent that this Option has
not previously been forfeited, this Option will fully vest and become fully
exercisable, except to the extent that a Replacement Award is provided to the
Optionee to replace, continue or adjust the outstanding Option (the “Replaced
Award”). If the Optionee is provided with a Replacement Award in connection
with the Change of Control, then if, upon or after receiving the Replacement
Award, the Optionee’s employment with the Company and its Subsidiaries (or
any of its or their successors after the Change of Control) (as applicable, the
“Successor Company”) is terminated by the Optionee for Good Reason or by the
Successor Company other than for Cause, in each case within a period of two
years after the Change of Control and prior to the last Vesting Date set forth in
the Notice, to the extent that the Replacement Award has not previously been
forfeited, (A) the Replacement Award will become fully vested and immediately
exercisable in full, and (B) the Replacement Award will remain exercisable for a
period of 90 days following such termination or until the expiration of the stated
term of such Replacement Award, whichever period is shorter.

-- 56 of 81 --

4
ii. For purposes of this Agreement, a “Replacement Award” means an award (A) of
the same type (i.e., stock option) as the Replaced Award, (B) that has a value at
least equal to the value of the Replaced Award, (C) that relates to publicly traded
equity securities of the Successor Company in the Change of Control (or another
entity that is affiliated with the Successor Company following the Change of
Control), (D) the tax consequences of which for such Optionee under the Code, if
the Optionee is subject to U.S. federal income tax under the Code, are not less
favorable to the Optionee than the tax consequences of the Replaced Award,
and (E) the other terms and conditions of which are not less favorable to the
Optionee than the terms and conditions of the Replaced Award (including the
provisions that would apply in the event of a subsequent change of control). A
Replacement Award may be granted only to the extent it does not result in the
Replaced Award or Replacement Award failing to comply with or ceasing to be
exempt from Section 409A of the Code. Without limiting the generality of the
foregoing, the Replacement Award may take the form of a continuation of the
Replaced Award if the requirements of the preceding two sentences are
satisfied. The determination of whether the conditions of this Section 2(c)(ii) are
satisfied will be made in good faith by the Committee, as constituted immediately
before the Change of Control, in its sole discretion.
iii. For purposes of this Agreement, “Cause” means: (A) the willful and continued
failure by the Optionee to substantially perform the Optionee’s duties with the
Successor Company (other than any such failure resulting from termination by
the Optionee for Good Reason) after a demand for substantial performance is
delivered to the Optionee that specifically identifies the manner in which the
Successor Company believes that the Optionee has not substantially performed
the Optionee’s duties, and the Optionee has failed to resume substantial
performance of the Optionee’s duties on a continuous basis within five days of
receiving such demand; (B) the willful engaging by the Optionee in conduct
which is demonstrably and materially injurious to the Successor Company,
monetarily or otherwise; or (C) the Optionee’s conviction of, or plea of nolo
contendere to, (I) a felony or (II) a misdemeanor which impairs the Optionee’s
ability substantially to perform the Optionee’s duties with the Successor
Company. For the purposes of this definition, no act, or failure to act, on the
Optionee’s part shall be deemed “willful” unless done, or omitted to be done, by
the Optionee not in good faith and without reasonable belief that the Optionee’s
action or omission was in the best interest of the Successor Company.
iv. For purposes of this Agreement, “Good Reason” means: (A) any material failure
of the Successor Company to comply with and satisfy any of the terms of any
employment or change in control (or similar) agreement between the Successor
Company and the Optionee pursuant to which the Optionee provides services to
the Successor Company; (B) any significant involuntary reduction of the
authority, duties or responsibilities held by the Optionee immediately prior to the
Change of Control (and, for the avoidance of doubt, involuntary removal of the
Optionee from an officer position that the Optionee holds immediately prior to the
Change of Control will not, by itself, constitute a significant involuntary reduction
of the authority, duties or responsibilities held by the Optionee immediately prior
to the Change of Control); (C) any material involuntary reduction in the
aggregate target cash remuneration opportunity of the Optionee as in effect
immediately prior to the Change of Control; or (D) requiring the Optionee to
become based at any office or location more than 50 miles from the office or
location at which the Optionee was based immediately prior to such Change of
Control, except for travel reasonably required in the performance of the
Optionee’s responsibilities; provided, however, that no termination shall be
deemed to be for Good Reason unless (x) the Optionee

-- 57 of 81 --

5
provides the Successor Company with written notice setting forth the specific
facts or circumstances constituting Good Reason within 90 days after the initial
existence of the occurrence of such facts or circumstances, (y) the Successor
Company has failed to cure such facts or circumstances within thirty days of its
receipt of such written notice, and (z) the Optionee actually terminates
employment within 30 days following the end of the Successor Company’s 30-
day cure period, if such event or circumstance has not been cured.
d. 	Right to Exercise. Each vested portion of this Option shall be exercisable beginning on
the applicable Vesting Date or vesting event and ending at the conclusion of the applicable Option
Expiration Date (as hereinafter defined), all in accordance with the terms of this Agreement and the Plan.
To the extent this Option is exercisable, it may be exercised in whole or in part. Subject to Section 2(i)
below, this Option shall terminate on the earliest of the following dates (such earliest date, the “Option
Expiration Date”):
i. 	the date on which the Optionee’s Continuous Employment terminates for Cause;
ii. 	subject to the exercise period specified as applicable in Section 2(c) above, 12 months
after the date on which the Optionee’s Continuous Employment is terminated by the
Company other than for Cause, by the Optionee for Good Reason, or due to the
Optionee’s death or involuntary termination due to disability. The Option may be
exercised as to the portion of the Option that is vested (and not previously exercised) at
the time such termination of employment occurs;
iii. 	three years after the date of the Optionee’s Early Retirement; provided, however, that the
Company, at the sole and absolute discretion of the Committee, may shorten or eliminate
such period. The Option may be exercised as to the portion of the Option that is vested
(and not previously exercised) at the time such Early Retirement occurs;
iv. 	three years after the date of the Optionee’s Normal Retirement;
v. 	90 days after the date of any other type of termination not described above; and
vi. 	the Expiration Date.
e. 	Method of Exercise. This Option shall be exercisable by delivering to the Company a
notice (in accordance with Section 7) which shall state the election to exercise the Option, identify the
portion of the Option being exercised and be accompanied by such additional information and documents
as the Company in its discretion may prescribe. Such notice shall be accompanied by the payment of the
full Exercise Price of the shares then to be purchased, except as provided below. The Exercise Price of
any shares of Common Stock with respect to which the Option is being exercised shall be paid by one or
any combination of the following:
i. 	cash,
ii. 	check,
iii. 	wire transfer,
iv. 	certified or cashier’s check,
v. 	subject to the provisions of any applicable insider trading policy, by delivering previously
owned shares of Common Stock held by the Optionee for at least six months valued at Fair Market Value
in accordance with Section 6.4 of the Plan,
vi. 	subject to the provisions of any applicable insider trading policy, by electing to have the
Company retain shares of Common Stock that would otherwise be issued upon exercise of the Option
valued at Fair Market Value in accordance with Section 6.4 of the Plan, or
vii. 	subject to the provisions of any applicable insider trading policy and applicable law, by
irrevocably authorizing a third party to sell shares of Common Stock (or a sufficient portion thereof)
acquired upon exercise of the Option and remitting to the Company a sufficient portion of the sale
proceeds to pay both the entire Exercise Price and amounts owed under Section 2(g) of this Agreement.

-- 58 of 81 --

6
f. 	Restrictions on Exercise. As a condition to exercise of this Option, the Company may
require the person exercising this Option to make any representation and warranty to the Company as
may be required by any applicable law or regulation.
g. 	Payment of Taxes Upon Exercise. As a condition of the issuance of shares of
Common Stock upon exercise hereunder, the Optionee agrees to remit to the Company at the time of
exercise of this Option any taxes required to be withheld by the Company under Federal, state or local
law (the “Withholding Taxes”) as a result of the exercise. The Withholding Taxes may be paid by one or
any combination of the following:
i. 	cash,
ii. 	check,
iii. 	wire transfer,
iv. 	certified or cashier’s check,
v. 	subject to the provisions of any applicable insider trading policy, by delivering previously
owned shares of Common Stock held by the Optionee for at least six months valued at Fair Market Value
in accordance with Section 12.4 of the Plan,
vi. 	subject to the provisions of any applicable insider trading policy, by electing to have the
Company retain shares of Common Stock that would otherwise be issued upon exercise of the Option
valued at Fair Market Value in accordance with Section 12.4 of the Plan, or
vii. 	subject to the provisions of any applicable insider trading policy and subject to applicable
law, by irrevocably authorizing a third party to sell shares of Common Stock (or a sufficient portion
thereof) acquired upon exercise of the Option and remitting to the Company a sufficient portion of the
sale proceeds to pay both the entire Exercise Price and amounts owed under this Section 2(g).
In addition, the Optionee may deliver previously acquired shares of Common Stock held by the Optionee
for at least six months in order to satisfy additional tax withholding above the minimum statutory tax
withholding amount permissible; provided, however, that the Optionee shall not be entitled to deliver such
additional shares if it would cause adverse accounting consequences for the Company.
h. 	Cancellation of Option. Except as set forth in Section 2(a), Section 2(b), or Section
2(c), upon the Optionee’s termination of employment, any unvested portion of the Option shall immediately
terminate and any vested portion of the Option not exercised during the exercise period set forth in Section
2(d) shall automatically terminate at the end of such exercise period.
i. 	Automatic Exercise. Notwithstanding anything in this Agreement to the contrary, but
subject to applicable law, if and only if, at 4:15 p.m. ET on the applicable Option Expiration Date, (i) the
product of (A) the closing sale price of one share of Common Stock on the principal stock exchange on which
the Common Stock is then listed (or, if there are no sales of Common Stock on the Option Expiration Date,
on the next preceding trading day during which a sale of Common Stock occurred), multiplied by (B) the
number of shares of Common Stock subject to the exercisable portion of the Option, exceeds the product of
(X) the Exercise Price, multiplied by (Y) the number of shares of Common Stock subject to the exercisable
portion of the Option, by at least $500; (ii) to the extent the Option is exercisable and the Optionee has not
yet exercised the Option; and (iii) to the extent the Option has not otherwise expired, terminated, or been
cancelled or forfeited, then the Company will deem such remaining exercisable portion of the Option to have
been exercised by the Optionee on the Option Expiration Date (and prior to the Option’s termination) at such
time (“Automatic Exercise”). Further to such Automatic Exercise, payment of the aggregate Exercise Price
for such Automatic Exercise and any applicable withholding taxes in connection with such Automatic
Exercise will be deemed to have been made by the Company withholding a number of shares of Common
Stock otherwise issuable in connection with such Automatic Exercise that are equal in value to the amount
necessary to satisfy such aggregate Exercise Price payment and applicable Withholding Taxes. To clarify,
upon Automatic Exercise, the Company will deliver to the Optionee the number of whole shares of Common
Stock resulting from such Automatic Exercise less a number of shares of Common Stock equal in value to (x)
the aggregate Exercise Price plus (y) any applicable Withholding Taxes; provided, however, that any
fractional share otherwise deliverable to the Optionee will be cancelled for no consideration.

-- 59 of 81 --

7
3. 	Non-Transferability of Option. This Option may not be assigned, transferred, pledged or
hypothecated in any manner (otherwise than by will or the laws of descent or distribution) nor may the
Optionee enter into any transaction for the purpose of, or which has the effect of, reducing the market risk of
holding the Option by using puts, calls or similar financial techniques. This Option may be exercised during
the lifetime of the Optionee only by the Optionee or the Optionee’s guardian or legal representative. Upon
any attempt to assign, transfer, pledge, hypothecate, or otherwise dispose of the Option or any related rights
to the Option that is contrary to the provisions of this Agreement or the Plan, or upon the levy of any
attachment or similar process upon the Option or such rights, the Option and such rights shall immediately
become null and void. The terms of this Option shall be binding upon the beneficiaries, executors,
administrators, heirs, successors and assigns (“Successors”) of the Optionee.
4. 	Stock Subject to the Option. The Company will not be required to issue or deliver any shares of
Common Stock or certificate or certificates for shares of Common Stock to be issued upon exercise of any
vested portion of the Option hereunder until such shares have been listed (or authorized for listing upon
official notice of issuance) upon each stock exchange on which outstanding shares of the same class are
then listed and until the Company has taken such steps as may, in the opinion of counsel for the Company,
be required by law and applicable regulations, including the rules and regulations of the Securities and
Exchange Commission, and state securities laws and regulations, in connection with the issuance or sale of
such shares, and the listing of such shares on each such exchange.
5. 	Rights as Stockholder. The Optionee or his/her Successors shall have no rights as a
stockholder with respect to any shares covered by this Option until the Optionee or his/her Successors
shall have become the beneficial owner of such shares, and, except as provided in Section 6 of this
Agreement, no adjustment shall be made for dividends or distributions or other rights in respect of such
shares for which the record date is prior to the date on which the Optionee or his/her Successors shall
have become the beneficial owner thereof.
6. 	Adjustments Upon Changes in Capitalization; Change of Control. In the event of any change in
corporate capitalization, corporate transaction, sale or other disposition of assets or similar corporate
transaction or event involving the Company as described in Section 5.5 of the Plan, the Committee shall
make such equitable adjustments as it determines necessary and appropriate, including in the number and
type of shares subject to this Option and adjustment in the Exercise Price; provided, however, that no
fractional share shall be issued upon subsequent exercise of the Option and the aggregate price paid shall
be appropriately reduced on account of any fractional share not issued. No adjustment shall be made if such
adjustment is prohibited by Section 5.5 of the Plan (relating to Section 409A of the Code).
7. 	Notices. Each notice relating to this Agreement shall be deemed to have been given on the date it
is received. Each notice to the Company shall be addressed to its principal office in Eagle, Idaho, Attention:
Compensation. Each notice to the Optionee or any other person or persons entitled to exercise the Option
shall be addressed to the Optionee’s address and may be in written or electronic form. Anyone to whom a
notice may be given under this Agreement may designate a new address by notice to the effect.
8. 	Benefits of Agreement. This Agreement shall inure to the benefit of and be binding upon each
successor of the Company. All obligations imposed upon the Optionee and all rights granted to the Company
under this Agreement shall be binding upon the Optionee’s Successors. This Agreement shall be the sole
and exclusive source of any and all rights which the Optionee or his/her Successors may have in respect to
the Plan or this Agreement.
9. 	No Right to Continued Employment. Nothing in this Agreement shall interfere with or affect the
rights of the Company or the Optionee under any employment agreement or confer upon the Optionee any
right to continued employment with the Company or a Subsidiary.
10. 	Compliance with Section 409A of the Code. It is intended that this Agreement comply with or be
exempt from the provisions of Section 409A of the Code. This Agreement shall be administered in a manner
consistent with this intent. Reference to Section 409A of the Code is to Section 409A of the Internal Revenue
Code of 1986, as amended, and will also include any regulations or other formal guidance promulgated with
respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.
11. 	Resolution of Disputes. Any dispute or disagreement which should arise under or as a result of or
in any way related to the interpretation, construction or application of this Agreement will be determined

-- 60 of 81 --

8
by the Committee. Any determination made hereunder shall be final, binding and conclusive for all purposes.
This Agreement and the legal relations between the parties hereto shall be governed by and construed in
accordance with the laws of the state of Delaware.
12. 	Clawback Policy and Stock Ownership Guidelines. Shares of Common Stock issued upon the
exercise of the Option (or any portion thereof) shall be subject to any stock ownership guidelines of the
Company applicable to the Optionee. In addition to the clawback described in Section 16(c) of this
Agreement, this Agreement and the Option are subject to the Company’s clawback policy applicable to the
Optionee as may be in effect from time to time, including, as applicable, being subject to recoupment or
clawback by the Company on the terms and conditions as provided for under Section 10D of the Act and any
applicable rules or regulations promulgated by the Securities and Exchange Commission or any national
securities exchange or national securities association on which the Common Stock may be traded.
13. 	Amendment. Any amendment to the Plan shall be deemed to be an amendment to this Agreement
to the extent that the amendment is applicable hereto.
14. 	Severability. If any provision of this Agreement or the application of any provision hereof to any
person or circumstances is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement
and the application of such provision to any other person or circumstances shall not be affected, and the
provisions so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent (and only to
the extent) necessary to make it enforceable, valid and legal.
15. 	Electronic Delivery. The Company may, in its sole discretion, deliver any documents related to the
Option and the Optionee’s participation in the Plan, or future awards that may be granted under the Plan, by
electronic means or request the Optionee’s consent to participate in the Plan by electronic means. The
Optionee hereby consents to receive such documents by electronic delivery and, if requested, agrees to
participate in the Plan through an on-line or electronic system established and maintained by the Company or
another third party designated by the Company.
16. 	Restrictive Covenants.
(a) 	Confidentiality. It is a condition to the Optionee’s receipt of the Option that the Optionee
execute and agree to the terms of the Company or a Subsidiary’s current and applicable Confidentiality
Agreement (the “Confidentiality Agreement”). By electronically accepting this Agreement, the Optionee
acknowledges that the Optionee has either already entered into such Confidentiality Agreement with the
Company or a Subsidiary as of the date of acceptance or will enter into such agreement within 30 days of
the Optionee’s receipt of this Option grant. If such execution is required and the Optionee does not sign
and return the Confidentiality Agreement as prompted by the Workday HR system within 30 days of the
Optionee’s receipt of this Option grant, this Option grant and any rights to the Option will terminate and
become null and void. The Optionee further acknowledges that as consideration for the Optionee’s
agreement to the terms of the Confidentiality Agreement, the Company is providing the Optionee with the
opportunity to participate in this Option grant under the Plan and receive the Option evidenced by this
Agreement. The Optionee understands that this acknowledgment shall be deemed a part of the
Confidentiality Agreement and is to be interpreted in a manner consistent with its terms.
(b) 	Non-Competition and Non-Solicitation. By electronically accepting this Agreement, the
Optionee acknowledges that the Optionee has received or will receive specialized training, trade secrets
and confidential information from the Company and, in consideration thereof, agrees to the non-
competition and non-solicitation provisions set forth in Exhibit A to this Agreement (the “Non-Competition
and Non-Solicitation Obligations”). The Optionee further acknowledges that as consideration for the
Optionee’s agreement to the terms of the Non-Competition and Non-Solicitation Obligations, the
Company is providing the Optionee with the opportunity to participate in this Option grant under the Plan
and receive the Option evidenced by this Agreement. Notwithstanding the foregoing, if the Optionee is a
resident of the state of California, the Optionee will not be bound by the Non-Competition and Non-
Solicitation Obligations.
(c) 	Violation of Restrictive Covenants. Notwithstanding anything herein to the contrary, if the
Optionee breaches the Confidentiality Agreement or, if applicable, any of the Non-Competition and Non-
Solicitation Obligations, (i) the Optionee shall forfeit the entire Option evidenced by this Agreement,
effective on the date on which the Optionee first breached such agreement or obligation(s) and (ii) if such
breach occurs within one year following any date on which the Option or a portion thereof is exercised,

-- 61 of 81 --

9
all shares of Common Stock issued or transferred to the Optionee pursuant to this Agreement shall be
returned by the Optionee to the Company within 30 days after the Company has provided notice to the
Optionee of such breach and, if such shares of Common Stock have been sold by the Optionee, an
amount equal to the proceeds from such sale (determined without regard to any taxes paid) shall become
due and payable by the Optionee to the Company within 30 days after the Company has provided notice
to the Optionee of such breach. Notwithstanding the foregoing, the Committee, in its sole discretion, may
waive the Optionee’s obligations described in clause (i) and (ii) at any time if deemed to be in the best
interests of the Company. The Optionee acknowledges and agrees that it would be inequitable for the
Optionee to benefit from the Option should the Optionee breach the Confidentiality Agreement or, if
applicable, any of the Non-Competition and Non-Solicitation Obligations.
(d) 	Remedies; Government Investigations; DTSA. The Optionee acknowledges and agrees that
the rights and remedies set forth in this Section 16 are in addition to and are not intended to limit any
other rights or remedies the Company may have available to it, both during and at any time after the
termination of the Optionee’s employment with the Company, including, without limitation, any rights or
remedies the Company may have under the Confidentiality Agreement or other similar agreements.
Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement prevents the
Optionee from providing, without prior notice to the Company, information to governmental authorities
regarding possible legal violations or otherwise testifying or participating in any investigation or
proceeding by any governmental authorities regarding possible legal violations, and, for purpose of
clarity, the Optionee is not prohibited from providing information voluntarily to the Securities and
Exchange Commission pursuant to Section 21F of the Act. Furthermore, the U.S. Defend Trade Secrets
Act of 2016 (“DTSA”) provides that an individual shall not be held criminally or civilly liable under any
federal or state trade secret law for the disclosure of a trade secret that (i) is made (A) in confidence to a
federal, state, or local government official, either directly or indirectly, or to an attorney; and (B) solely for
the purpose of reporting or investigating a suspected violation of law or (ii) is made in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, the DTSA
provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected
violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
information in the court proceeding, if the individual (x) files any document containing the trade secret
under seal and (y) does not disclose the trade secret, except pursuant to court order.

-- 62 of 81 --

10
Exhibit A
Non-Competition and Non-Solicitation Provisions
1. Definitions. Unless otherwise defined, capitalized terms used in this Exhibit A shall have the meanings
given to them in the Agreement or the Plan, as applicable. As used in this Exhibit A:
(a) “Company” shall include all Subsidiaries of the Company.
(b) “Competing Organization” is defined as any organization that researches, develops,
manufactures, markets, distributes and/or sells one or more Competing Products/Services.
(c) “Competing Products/Services” means any products, services or activities (including, without
limitation, products, services or activities in the planning or development stage during the Non-
Compete Period) that compete, directly or indirectly, in whole or in part, with one or more of the
material products, services or activities (including, without limitation, products, services or
activities in the planning or development stage during the Non-Compete Period) produced,
provided, or engaged in by the Company or its affiliates at the time of the Optionee’s
termination of employment with the Company and with which the Optionee worked or about
which the Optionee obtained any trade secret or other Confidential and Proprietary Information
at any time during the five years immediately preceding the Optionee’s termination of
employment with the Company. “Material products, services or activities” means the
development, manufacture or production of packaged potato, sweet potato, appetizer and
vegetable products for the retail, foodservice or institutional channels. If the products
manufactured, sold or marketed by the Company are expanded at any time during the
Optionee's employment, such additional products will be deemed to be “material products,
services or activities” for all purposes under this Agreement.
(d) “Confidential and Proprietary Information” is defined as information and data of any kind, in any
form, not generally available to the public, concerning any matters affecting or relating to the
Company, including but not limited to: names, addresses, and any other characteristics
identifying information or aspects of existing or potential Company customers, employees,
vendors or suppliers; the business or operations of the Company and/or the financials,
products, drawings, plans, processes; or other data of the Company not generally known or
available outside of the Company. This definition also includes derivations of Confidential and
Proprietary Information, including any information derived, summarized or extracted from any of
the foregoing whether observed in writing, electronically, mechanically, and/or orally during the
Optionee’s employment with the Company.
(e) “Employee” (including its plural) means any person employed by the Company.
(f) “Non-Compete Period” means the period from the date of the Agreement through the twelve-
month period following the Optionee’s termination of employment with the Company for any
reason.
(g) “Prohibited Capacity” is defined as (i) any same or similar capacity to that the Optionee held at
any time during the last three years of employment with the Company prior to the date of the
Optionee’s termination of employment from the Company; (ii) any executive or managerial
capacity; (iii) any marketing or sales capacity; or (iv) any capacity in which the Optionee’s
knowledge of Confidential and Proprietary Information would render the Optionee’s assistance
to a Competing Organization a competitive advantage.
(h) “Restricted Geographic Area” is defined as all countries, territories, parishes, municipalities and
states in which the Company is doing business or is selling its products at the time of the
Optionee’s termination of employment with the Company, including, but not limited to, every

-- 63 of 81 --

11
parish and municipality in the state of Louisiana.1 The Optionee acknowledges that this
geographic scope is reasonable given the Optionee’s position with the Company, the
international scope of the Company’s business, and the fact that the Optionee could compete
with the Company from anywhere the Company does business.
(i) “Trade Secret” means information possessed by or developed for the Company, including,
without limitation, any compilation of data, program, device, method, system, technique or
process, where: (i) the information derives independent economic value, actual or potential,
from not being generally known to, and not being readily ascertainable by proper means by,
other persons who can obtain economic value from its disclosure or use, (ii) the information is
the subject of efforts to maintain its secrecy that are reasonable under the circumstances, or (iii)
information that constitutes a “trade secret” under the Idaho Trade Secrets Act, IDAHO STAT. §
48-801(5) and/or under the DTSA.
2. Non-Competition. During the Non-Compete Period, the Optionee agrees that he or she will not, within
the Restricted Geographic Area, be employed by, work for, consult with, provide services to, or lend
assistance to any Competing Organization in a Prohibited Capacity.
3. Non-Solicitation. The Optionee recognizes and agrees that the Company has a legitimate business
interest in restricting potential competitors from hiring Employees who possess or otherwise may have
or had access to the Company’s or any of its affiliates’ Confidential and Proprietary Information or Trade
Secrets. Therefore, the Optionee agrees that during the Optionee’s employment with the Company and
through the twelve-month period following the termination of the Optionee’s employment with the
Company, the Optionee shall not directly or indirectly through any other person or entity recruit, induce,
or attempt to induce any Employee to terminate his or her employment with the Company or otherwise
interfere in any way with the employment relationship between the Company and its Employees. This
restriction includes, but is not limited to: (a) identifying Employees as potential candidates for
employment by name, background or qualifications; (b) recruiting or soliciting Employees; and/or (c)
participating in any pre-employment interviews with Employees.
4. California Residents. Notwithstanding anything in the Agreement or in this Exhibit A, if the Optionee is
a resident of the state of California, the non-competition and non-solicitation obligations described in
this Exhibit A shall not apply.
1 These Louisiana parishes currently include Acadia, Allen, Ascension, Assumption, Avoyelles, Beauregard,
Bienville, Bossier, Caddo, Calcasieu, Caldwell, Cameron, Catahoula, Claiborne, Concordia, De Soto, East
Baton Rouge, East Carroll, East Feliciana, Evangeline, Franklin, Grant, Iberia, Iberville, Jackson, Jefferson,
Jefferson Davis, La Salle, Lafayette, Lafourche, Lincoln, Livingston, Madison, Morehouse, Natchitoches,
Orleans, Ouachita, Plaquemines, Pointe Coupee, Rapides, Red River, Richland, Sabine, St. Bernard, St.
Charles, St. Helena, St. James, St. John The Baptist, St. Landry, St. Martin, St. Mary, St. Tammany,
Tangipahoa, Tensas, Terrebonne, Union, Vermilion, Vernon, Washington, Webster, West Baton Rouge,
West Carroll, West Feliciana and Winn.

-- 64 of 81 --

Exhibit 10.4
1
Form of Lamb Weston Holdings, Inc. Leveraged Performance Share Agreement
NOTICE OF GRANT
PERFORMANCE SHARES
LAMB WESTON HOLDINGS, INC. 2016 STOCK PLAN
(AS AMENDED AND RESTATED AS OF JULY 20, 2017)
Lamb Weston Holdings, Inc., a Delaware corporation (the “Company”), has awarded to the Participant, as
identified below, the number of Performance Shares (the “Performance Shares”) set forth below. The
Performance Shares are subject to all of the terms and conditions as set forth in this Notice of Grant (the
“Notice”) as well as in the Company’s 2016 Stock Plan (as amended and restated as of July 20, 2017) (the
“Plan”) and the Performance Share Agreement (the “Agreement”), both of which are attached hereto and
incorporated in their entirety. Each Performance Share represents the right to receive one share of Stock
on the Payment Date (as defined in the Agreement), subject to achievement of the Performance Targets
(as defined in the Agreement) and the other terms and conditions of this award. The number of
Performance Shares that may be earned, if any, may range from 50% of the Target Number of
Performance Shares, if the minimum Performance Targets and other conditions are met, to 300% of the
Target Number of Performance Shares (the “Maximum Number of Performance Shares”), if the
maximum Performance Targets and other conditions are met. Capitalized terms not explicitly defined in this
Notice but defined in the Plan or the Agreement will have the same definitions as in the Plan or the
Agreement. In the event of any conflict between the terms of the Award and the Plan, the terms of the Plan will
control.
Participant: 	/$ParticipantName$/
Employee ID: 	/$ParticipantID$/
Target Number of Performance
Shares:
/$TargetAwardsGranted$/
Maximum Number of Performance
Shares:
/$MaxAwardsGranted$/
Date of Grant: 	[______], 2022
Vesting Date: 	May 25, 2025, subject to the terms and
conditions set forth in Section 2 of the
Agreement and Exhibit A to the Agreement.
Dividend Equivalents: 	Yes, dividend equivalents will be
accumulated on earned Performance Shares,
but no amounts are paid, until the Payment
Date of the Performance Shares, in
accordance with Section 7 of the Agreement.
By the Company’s signature below and by the Participant’s clicking the “Accept” button online, the Company
and the Participant agree that the Performance Shares are governed by this Notice and by the provisions of
the Plan and the Agreement, both of which are attached to and made a part of this document. The Participant
acknowledges receipt of copies of the Plan and the Agreement, represents that the Participant has read and is
familiar with their provisions, and hereby accepts the Performance Shares subject to all of their terms and
conditions.
The Company has caused this Notice and the Agreement to be effective as of the Date of Grant.
LAMB WESTON HOLDINGS, INC.
By:
Date: __________________________
PARTICIPANT
/$ParticipantName$/
Date: /$CurrentDate$/

-- 65 of 81 --

2
PERFORMANCE SHARE AGREEMENT
LAMB WESTON HOLDINGS, INC. 2016 STOCK PLAN
(AS AMENDED AND RESTATED AS OF JULY 20, 2017)
Lamb Weston Holdings, Inc., a Delaware corporation (the “Company”), has awarded the Participant, as
named in the Notice of Grant (the “Notice”), to which this Performance Share Agreement (this “Agreement”)
is attached, a Performance Share Award (the “Performance Shares”) that is subject to the Company’s 2016
Stock Plan (as amended and restated as of July 20, 2017) (the “Plan”), the Notice, and this Agreement, for
the number of Performance Shares indicated in the Notice. In the event of any conflict between the terms in
this Agreement and the Plan, the terms of the Plan will control.
1. 	Definitions. Capitalized terms used herein without definition have the meanings set forth in the
Plan. The following terms shall have the respective meanings set forth below:
(a) 	“Change of Control” shall mean the occurrence of any of the following events:
(i) Individuals who, as of the effective date of the Plan, constitute the Board (the “Incumbent
Board”) cease for any reason to constitute at least a majority of the
Board; provided, however, that any person becoming a member of the Board subsequent
to the effective date of the Plan whose election, or nomination for the election by the
Company’s stockholders, was approved by a vote of at least a majority of the Board
members then comprising the Incumbent Board shall be, for purposes of this clause (i),
considered as though such person were a member of the Incumbent Board as of the
effective date of the Plan;
(ii) Consummation of a reorganization, merger or consolidation, in each case, with respect to
which persons who were the stockholders of the Company immediately prior to such
reorganization, merger or consolidation do not, immediately thereafter, own more than
50% of the Voting Power of the reorganized, merged or consolidated entity;
(iii) Any person becomes the beneficial owner, directly or indirectly, of securities of the
Company (not including in the securities beneficially owned by such person, any securities
acquired directly from the Company or its affiliates) representing 30% or more of the
Voting Power of the Company’s then outstanding securities;
(iv) A liquidation or dissolution of the Company; or
(v) The sale of all or substantially all of the assets of the Company.
(b) 	“Continuous Employment” shall mean the absence of any interruption or termination of employment
with the Company and its Subsidiaries and the performance of substantial services. Continuous Employment
shall not be considered interrupted or terminated in the case of sick leave, short-term disability (as defined in
the Company’s sole discretion), military leave or any other leave of absence approved by the Company
unless and until there is a Separation from Service (as defined in Section 1(f) below).
(c) 	“Early Retirement” shall mean Separation from Service with the Company and its Subsidiaries
when the Participant (i) is at least age 55, and (ii) has at least ten years of credited service with the
Company and its Subsidiaries.
(d) 	“Normal Retirement” shall mean a Separation from Service with the Company and its Subsidiaries
on or after attaining age 65.
(e) 	“Performance Period” shall mean the three-year period commencing on May 30, 2022 and ending
on May 25, 2025.
(f) 	“Performance Targets” shall mean the applicable performance goals set forth on Exhibit A.
(g) 	“Separation from Service,” “termination of employment” and similar terms shall mean the date
that the Participant incurs a “separation from service” within the meaning of Section 409A of the Code.
As used in connection with the definition of “Separation from Service,” the term “Company” includes
Lamb Weston Holdings, Inc. and any other entity that, with Lamb Weston Holdings, Inc., constitutes a
controlled group of corporations (as defined in Section 414(b) of the Code), or a group of trades or
businesses

-- 66 of 81 --

3
(whether or not incorporated) under common control (as defined in Section 414(c) of the Code),
substituting 25% for the 80% ownership level for purposes of both Sections 414(b) and Section 414(c) of
the Code.
(h) 	“Specified Employee” is as defined under Section 409A of the Code and Treasury Regulation
Section 1.409A-1(i).
(i) 	“Successors” shall mean the beneficiaries, executors, administrators, heirs, successors and assigns
of a person.
2. 	Vesting of Performance Shares.
(a) 	Normal Vesting. Subject to the terms and conditions of the Notice, the Plan, this Agreement and
Exhibit A to this Agreement, the Performance Shares covered by this Agreement shall become
nonforfeitable (“Vest” or similar terms) to the extent that:
(i) Except as provided in Section 2(b) or Section 2(c) below, the Participant remains
Continuously Employed by the Company or a Subsidiary through the Vesting Date; and
(ii) The applicable Performance Targets set forth on Exhibit A for the Performance Period are
achieved, which level of achievement must be certified by the Committee in writing within
90 days after the end of the Performance Period (the “Committee Determination Date”).
Any Performance Shares that do not satisfy both Section 2(a)(i) and Section 2(a)(ii) will be forfeited.
(b) 	Termination of Employment. If, prior to the Vesting Date, the Participant’s employment with the
Company and its Subsidiaries shall terminate:
(i) by reason of Normal Retirement on or after the date that is 12 months following the Date
of Grant, the Performance Shares shall remain subject to performance through the end
of the Performance Period and shall become fully Vested (based upon actual
achievement of the applicable Performance Targets set forth in Exhibit A).
(ii) by reason of Early Retirement, by the Participant for Good Reason, by the Company
other than for Cause, or due to the Participant’s death or disability, the Performance
Shares shall remain subject to performance through the end of the Performance Period
and shall become Vested (based upon actual achievement of the applicable
Performance Targets set forth in Exhibit A) in accordance with the terms and conditions
of this Section 2 on a pro-rata basis in an amount equal to the product of (A) the number
of Performance Shares in which the Participant would have Vested in accordance with the
terms and conditions of this Section 2 if the Participant had remained Continuously
Employed from the Date of Grant until the Vesting Date (or, if earlier, the occurrence of a
Change of Control to the extent a Replacement Award is not provided), multiplied by (B) a
fraction, the numerator of which is the total number of calendar days during which the
Participant was employed by the Company or a Subsidiary during the period beginning on
May 30, 2022 and ending on the Separation from Service and the denominator of which is
the total number of calendar days beginning on May 30, 2022 and ending on May 25, 2025,
rounded to the nearest whole number of Performance Shares; provided, however, that such
Performance Shares shall not vest in the event of an Early Retirement that occurs less than
12 months following the Date of Grant.
(iii) for Cause or any reason other than as described in Sections 2(b)(i) or 2(b)(ii) prior to the
Vesting Date, then all Performance Shares, whether Vested or unvested prior to the Vesting
Date, shall be immediately forfeited without further consideration to the Participant.
For the avoidance of doubt, any Vested Performance Shares pursuant to Sections 2(b)(i) or 2(b)(ii) will be
settled pursuant to Section 3(a) hereof.
(c) 	Accelerated Vesting in Connection with a Change of Control.
(i) If a Change of Control occurs prior to the end of the Performance Period, and the
Participant has been in Continuous Employment between the Date of Grant and the date
of such Change of Control, then the Participant shall Vest in a number of Performance
Shares equal to the greater of (A) the number of Performance Shares in which the

-- 67 of 81 --

4
Participant would Vest based on actual performance through the most recent date prior
to the Change of Control for which achievement of Performance Targets can reasonably
be determined, as certified by the Committee as constituted immediately prior to the
Change of Control and (B) the target number of Performance Shares subject to this
Agreement, rounded to the nearest whole number of Performance Shares, except to the
extent that (I) such Performance Shares have previously been forfeited, or (II) a
Replacement Award is provided to the Participant to replace, continue or adjust the
outstanding Performance Shares (the “Replaced Award”).
(ii) If a Change of Control occurs after the end of the Performance Period but before the
Committee Determination Date, then all Performance Shares earned based on
performance (to be measured on or prior to the date of the Change of Control) will
become 100% Vested, except to the extent that (A) such Performance Shares have
previously been forfeited, or (B) a Replacement Award is provided to the Participant to
replace, continue or adjust the outstanding Performance Shares.
(iii) If, within a period of two years following a Change of Control, the Participant’s
employment with the Company, a Subsidiary or any of its or their successors after the
Change of Control (as applicable, the “Successor Company”) is terminated by the
Participant for Good Reason or by the Successor Company other than for Cause prior to
the Vesting Date, to the extent that the Replacement Award has not previously been
Vested or forfeited, the Replacement Award will become 100% Vested (and become
entitled to settlement as specified in Section 3(b)(i)).
(iv) For purposes of this Agreement, a “Replacement Award” means an award (A) of the
same type as the Replaced Award (i.e., restricted stock or restricted stock units) but with
any remaining performance conditions of the Replaced Award deemed satisfied at the
greater of (I) the actual level of performance as of the Change of Control, and (II) the
target level of performance, in each case without proration, and subject to continued
service through the Vesting Date, (B) that has a value at least equal to the value of the
Replaced Award, including at the deemed level of performance as determined in clause
(A) above, as applicable, (C) that relates to publicly traded equity securities of the
Successor Company in the Change of Control (or another entity that is affiliated with the
Successor Company following the Change of Control), (D) the tax consequences of
which for such Participant under the Code, if the Participant is subject to U.S. federal
income tax under the Code, are not less favorable to the Participant than the tax
consequences of the Replaced Award, and (E) the other terms and conditions of which
are not less favorable to the Participant than the terms and conditions of the Replaced
Award (including the provisions that would apply in the event of a subsequent change of
control). A Replacement Award may be granted only to the extent it does not result in
the Replaced Award or Replacement Award failing to comply with or ceasing to be
exempt from Section 409A of the Code. Without limiting the generality of the foregoing,
the Replacement Award may take the form of a continuation of the Replaced Award if the
requirements of the preceding two sentences are satisfied. The determination of whether
the conditions of this Section 2(c)(iv) are satisfied will be made in good faith by the
Committee, as constituted immediately before the Change of Control, in its sole
discretion.
(v) For purposes of this Agreement, “Cause” means: (A) the willful and continued failure by
the Participant to substantially perform the Participant’s duties with the Successor
Company (other than any such failure resulting from termination by the Participant for
Good Reason) after a demand for substantial performance is delivered to the Participant
that specifically identifies the manner in which the Successor Company believes that the
Participant has not substantially performed the Participant’s duties, and the Participant
has failed to resume substantial performance of the Participant’s duties on a continuous
basis within five days of receiving such demand; (B) the willful engaging by the
Participant in conduct which is demonstrably and materially injurious to the Successor
Company, monetarily or otherwise; or (C) the Participant’s conviction of, or plea of nolo
contendere to, (I) a felony or (II) a misdemeanor which impairs the Participant’s ability
substantially to perform the Participant’s duties with the Successor Company. For the

-- 68 of 81 --

5
purposes of this definition, no act, or failure to act, on the Participant’s part shall be
deemed “willful” unless done, or omitted to be done, by the Participant not in good faith
and without reasonable belief that the Participant’s action or omission was in the best
interest of the Successor Company.
(vi) For purposes of this Agreement, “Good Reason” means: (A) any material failure of the
Successor Company to comply with and satisfy any of the terms of any employment or
change in control (or similar) agreement between the Successor Company and the
Participant pursuant to which the Participant provides services to the Successor
Company; (B) any significant involuntary reduction of the authority, duties or
responsibilities held by the Participant immediately prior to the Change of Control (and,
for the avoidance of doubt, involuntary removal of the Participant from an officer position
that the Participant holds immediately prior to the Change of Control will not, by itself,
constitute a significant involuntary reduction of the authority, duties or responsibilities
held by the Participant immediately prior to the Change of Control); (C) any material
involuntary reduction in the aggregate target cash remuneration opportunity of the
Participant as in effect immediately prior to the Change of Control; or (D) requiring the
Participant to become based at any office or location more than 50 miles from the office
or location at which the Participant was based immediately prior to such Change of
Control, except for travel reasonably required in the performance of the Participant’s
responsibilities; provided, however, that no termination shall be deemed to be for Good
Reason unless (I) the Participant provides the Successor Company with written notice
setting forth the specific facts or circumstances constituting Good Reason within ninety
days after the initial existence of the occurrence of such facts or circumstances, (II) the
Successor Company fails to cure such facts or circumstances within thirty days of its
receipt of such written notice, and (III) the Participant actually terminates employment
within thirty days following the end of the Successor Company’s thirty-day cure period, if
such event or circumstance has not been cured.
(vii) If a Replacement Award is provided, notwithstanding anything in this Agreement to the
contrary, any outstanding Performance Shares which at the time of the Change of
Control are not subject to a "substantial risk of forfeiture" (within the meaning of Section
409A of the Code) will be deemed to be Vested at the time of such Change of Control
(and such Vested Performance Shares shall be settled in accordance with Section 3(b)
(ii) below).
(d) 	Forfeiture of Performance Shares. Subject to Section 2(b)(iii), any Performance Shares that
have not Vested pursuant to Section 2(a), Section 2(b), or Section 2(c) will be forfeited automatically and
without further notice (including if the Participant ceases to be in Continuous Employment prior to the
Vesting Date for any reason other than as described in Section 2(b) or Section 2(c)).
3. 	Settlement of Performance Shares.
(a) 	Normal. Subject to Section 3(b), the Company will issue to the Participant one share of Stock for
each Vested Performance Share as soon as practicable following the later of (x) the Committee
Determination Date and (y) the Vesting Date, but in no event later than 30 days following the later such time
(the “Payment Date”).
(b) 	Other Settlement Events. Notwithstanding Section 3(a), to the extent the Performance Shares
are Vested Performance Shares on the dates set forth below and to the extent the Vested Performance
Shares have not previously been Vested, forfeited or settled, the Company will settle such Vested
Performance Shares as follows:
(i) Separation from Service. If there are such Vested Performance Shares upon the
Participant's Separation from Service (including after taking into account any
Performance Shares that become Vested Performance Shares following certain
terminations described in Section 2(b)(ii) or (2(c)), within 60 days of the Participant's
Separation from Service, one share of Stock will be issued for each such Vested
Performance Share
(ii) Change of Control. If there are such Vested Performance Shares upon a Change of
Control, one share of Stock will be issued for each such Vested Performance Share as

-- 69 of 81 --

6
of the date of the Change of Control; provided, however, that if such Change of Control
would not qualify as a permissible date of distribution under Section 409A(a)(2)(A) of the
Code, and the regulations thereunder, and where Section 409A of the Code applies to
such distribution, the Participant is entitled to receive the corresponding payment on the
date that would have otherwise applied pursuant to Section 3 as though such Change of
Control had not occurred.
(c) 	Payment of Taxes Upon Settlement. As a condition of the issuance of shares of Stock upon
settlement of Performance Shares hereunder, the Participant agrees to remit to the Company at the time of
settlement any taxes or other amounts required to be withheld by the Company under Federal, State or
local law as a result of the settlement of the Performance Shares. As a condition of the issuance of shares
of Stock upon settlement of Performance Shares hereunder, the Participant agrees that the Company
will deduct from the total shares to be issued as a result of the Vesting of the Performance Shares a
sufficient number of shares to satisfy the required statutory withholding amount, which may exceed the
minimum statutory tax withholding amount only if it would not cause adverse accounting or tax
consequences for the Company or a Subsidiary.
(d) 	Specified Employee. Notwithstanding anything (including any provision of the Agreement or the
Plan) to the contrary, if a Participant is a Specified Employee and if the Performance Shares are subject
to Section 409A of the Code, payment to the Participant on account of a Separation from Service shall, to
the extent required to comply with Treasury Regulation Section 1.409A-3(i)(2), be made to the Participant
on the earlier of (i) the Participant’s death or (ii) the first business day (or within 30 days after such first
business day) that is more than six months after the date of Separation from Service. Notwithstanding
anything contained herein to the contrary, the Participant shall not be considered to have terminated
employment with the Company or any Subsidiary for purposes of any payments under this Agreement
which are subject to Section 409A of the Code until the Participant has incurred a Separation from
Service. In the Company’s sole and absolute discretion, interest may be paid due to such delay. Further,
any interest will be calculated in the manner determined by the Company in its sole and absolute
discretion in a manner that qualifies any interest as reasonable earnings under Section 409A of the
Code. Dividend equivalents will not be paid with respect to any dividends that would have been paid
during the delay if the Stock had been issued. To the extent required for purposes of Section 409A of the
Code, each installment that vests under this Agreement shall be construed as a separate identified
payment for purposes of Section 409A of the Code.
4. 	Non-Transferability of Performance Shares. The Performance Shares may not be assigned,
transferred, pledged or hypothecated in any manner (otherwise than by will or the laws of descent or
distribution) nor may the Participant enter into any transaction for the purpose of, or which has the effect of,
reducing the market risk of holding the Performance Shares by using puts, calls or similar financial
techniques. The Performance Shares subject to this Agreement may be settled during the lifetime of the
Participant only with the Participant or the Participant’s guardian or legal representative. Upon any attempt to
transfer, assign, pledge, hypothecate, or otherwise dispose of the Performance Shares or any related rights to
the Performance Shares that is contrary to the provisions of this Agreement or the Plan, or upon the levy of
any attachment or similar process upon the Performance Shares or such rights, the Performance Shares and
such rights shall immediately become null and void. The terms of this Agreement shall be binding upon the
Successors of the Participant.
5. 	Stock Subject to the Performance Shares; Compliance with Law. The Company will not be
required to issue or deliver any shares of Stock or any certificate or certificates for shares of Stock with
respect to the Participant’s Performance Shares until such shares have been listed (or authorized for listing
upon official notice of issuance) upon each stock exchange on which outstanding shares of the same class
are then listed and until the Company has taken such steps as may, in the opinion of counsel for the
Company, be required by law and applicable regulations, including the rules and regulations of the Securities
and Exchange Commission, and state securities laws and regulations, in connection with the issuance of
such shares, and the listing of such shares on each such exchange.
6. 	Rights as Stockholder. The Participant or his/her Successors shall have no rights as stockholder
with respect to any Performance Shares or underlying shares covered by this Agreement until the Participant
or his/her Successors shall have become the beneficial owner of such shares on the Payment Date.
7. 	Dividend Equivalents. Upon the payment of earned Performance Shares as of the Payment
Date, the Participant shall receive additional shares of Stock equal in value to the accrued dividend

-- 70 of 81 --

7
equivalents. The amount of dividend equivalents for each Performance Share earned shall equal the
dividends paid on one share of Stock for each dividend whose record date occurs during the period
between the Date of Grant and the Payment Date.
8. 	Adjustments Upon Changes in Capitalization; Change of Control. In the event of any change
in corporate capitalization, corporate transaction, sale or other disposition of assets or similar corporate
transaction or event involving the Company as described in Section 5.5 of the Plan, the Committee shall make
equitable adjustment as it determines necessary and appropriate in the number and type of shares subject to
this Agreement; provided, however, that no fractional share shall be issued upon subsequent settlement of
the Performance Shares. No adjustment shall be made if such adjustment is prohibited by Section 5.5 of
the Plan (relating to Section 409A of the Code).
9. 	Notices. Each notice relating to this Agreement shall be deemed to have been given on the date it
is received. Each notice to the Company shall be addressed to its principal Office in Eagle, Idaho,
Attention: Compensation. Each notice to the Participant or any other person or persons entitled to shares
issuable upon settlement of the Performance Shares shall be addressed to the Participant’s address and
may be in written or electronic form. Anyone to whom a notice may be given under this Agreement may
designate a new address by giving notice to the effect.
10. 	Benefits of Agreement. This Agreement shall inure to the benefit of and be binding upon each
successor of the Company. All obligations imposed upon the Participant and all rights granted to the
Company under this Agreement shall be binding upon the Participant's Successors. This Agreement shall
be the sole and exclusive source of any and all rights which the Participant or his/her Successors may have
in respect to the Plan or this Agreement.
11. 	No Right to Continued Employment. Nothing in this Agreement shall interfere with or affect the
rights of the Company or the Participant under any employment agreement or confer upon the Participant
any right to continued employment with the Company or a Subsidiary.
12. 	Resolution of Disputes. Any dispute or disagreement which should arise under or as a result of or
in any way related to the interpretation, construction or application of this Agreement will be determined by the
Committee. Any determination made hereunder shall be final, binding and conclusive for all purposes. This
Agreement and the legal relations between the parties hereto shall be governed by and construed in
accordance with the laws of the state of Delaware.
13. 	Section 409A of the Code. To the extent applicable, this Agreement is intended to comply with
Section 409A of the Code and any regulations or notices provided thereunder. This Agreement and the
Plan shall be interpreted in a manner consistent with this intent. The Company reserves the unilateral right
to amend this Agreement on written notice to the Participant in order to comply with Section 409A of the Code.
The Company makes no representation that any or all of the payments described in this Agreement will
be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section
409A of the Code from applying to any such payment. None of the Company or any Subsidiary, or any of
its or their contractors, agents and employees, nor the Board or any member of the Board, shall be liable
for any consequences of any failure to follow the requirements of Section 409A of the Code or any
guidance or regulations thereunder.
14. 	Clawback Policy and Stock Ownership Guidelines. Shares of Stock issued upon settlement of
the Performance Shares shall be subject to any stock ownership guidelines of the Company applicable to
the Participant. In addition to the clawback described in Section 18(c) of this Agreement, this Agreement
and the Performance Shares are subject to the Company’s clawback policy as may be in effect from time
to time, including, as applicable, being subject to recoupment or clawback by the Company on the terms
and conditions as provided for under Section 10D of the Act and any applicable rules or regulations
promulgated by the Securities and Exchange Commission or any national securities exchange or national
securities association on which the Stock may be traded.
15. 	Amendment. Any amendment to the Plan shall be deemed to be an amendment to this
Agreement to the extent that the amendment is applicable hereto.
16. 	Severability. If any provision of this Agreement or the application of any provision hereof to any
person or circumstances is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement
and the application of such provision to any other person or circumstances shall not be affected, and the
provisions so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent (and only to
the extent) necessary to make it enforceable, valid and legal.

-- 71 of 81 --

8
17. 	Electronic Delivery. The Company may, in its sole discretion, deliver any documents related to
the Performance Shares and the Participant’s participation in the Plan, or future awards that may be
granted under the Plan, by electronic means or request the Participant’s consent to participate in the Plan
by electronic means. The Participant hereby consents to receive such documents by electronic delivery
and, if requested, agrees to participate in the Plan through an on-line or electronic system established
and maintained by the Company or another third party designated by the Company.
18. 	Restrictive Covenants.
(a) 	Confidentiality. It is a condition to the Participant’s receipt of the Performance Shares that the
Participant execute and agree to the terms of the Company or a Subsidiary’s current and applicable
Confidentiality Agreement (the “Confidentiality Agreement”). By electronically accepting this Agreement,
the Participant acknowledges that the Participant has either already entered into such Confidentiality
Agreement with the Company or a Subsidiary as of the date of acceptance or will enter into such
agreement within 30 days of the Participant’s receipt of this grant of Performance Shares. If such
execution is required and the Participant does not sign and return the Confidentiality Agreement as
prompted by the Workday HR system within 30 days of the Participant’s receipt of this grant of
Performance Shares, this grant of Performance Shares and any rights to the Performance Shares will
terminate and become null and void. The Participant further acknowledges that as consideration for the
Participant’s agreement to the terms of the Confidentiality Agreement, the Company is providing the
Participant with the opportunity to participate in this grant of Performance Shares under the Plan and
receive the Performance Shares evidenced by this Agreement. The Participant understands that this
acknowledgment shall be deemed a part of the Confidentiality Agreement and is to be interpreted in a
manner consistent with its terms.
(b) 	Non-Competition and Non-Solicitation. By electronically accepting this Agreement, the
Participant acknowledges that the Participant has received or will receive specialized training, trade
secrets and confidential information from the Company and, in consideration thereof, agrees to the non-
competition and non-solicitation provisions set forth in Exhibit B to this Agreement (the “Non-Competition
and Non-Solicitation Obligations”). The Participant further acknowledges that as consideration for the
Participant’s agreement to the terms of the Non-Competition and Non-Solicitation Obligations, the
Company is providing the Participant with the opportunity to participate in this grant of Performance
Shares under the Plan and receive the Performance Shares evidenced by this Agreement.
Notwithstanding the foregoing, if the Participant is a resident of the state of California, the Participant will
not be bound by the Non-Competition and Non-Solicitation Obligations.
(c) 	Violation of Restrictive Covenants. Notwithstanding anything herein to the contrary, if the
Participant breaches the Confidentiality Agreement or, if applicable, any of the Non-Competition and Non-
Solicitation Obligations, (i) the Participant shall forfeit all Performance Shares and related dividend
equivalents evidenced by this Agreement, effective on the date on which the Participant first breached
such agreement or obligation(s) and (ii) if such breach occurs within 1 year following (A) the Vesting Date
or (B) to the extent Section 3(b) applies, the applicable settlement date, all shares of Stock issued or
transferred to the Participant pursuant to this Agreement shall be returned by the Participant to the
Company within 30 days after the Company has provided notice to the Participant of such breach and, if
such shares of Stock have been sold by the Participant, an amount equal to the proceeds from such sale
(determined without regard to any taxes paid) shall become due and payable by the Participant to the
Company within 30 days after the Company has provided notice to the Participant of such breach.
Notwithstanding the foregoing, the Committee, in its sole discretion, may waive the Participant obligations
described in clause (i) and (ii) at any time if deemed to be in the best interests of the Company. The
Participant acknowledges and agrees that it would be inequitable for the Participant to benefit from the
Performance Shares should the Participant breach the Confidentiality Agreement or, if applicable, any of
the Non-Competition and Non-Solicitation Obligations.
(d) 	Remedies; Government Investigations; DTSA. The Participant acknowledges and agrees that
the rights and remedies set forth in this Section 18 are in addition to and are not intended to limit any
other rights or remedies the Company may have available to it, both during and at any time after the
termination of the Participant’s employment with the Company, including, without limitation, any rights or
remedies the Company may have under the Confidentiality Agreement or other similar agreements.
Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement prevents the
Participant from providing, without prior notice to the Company, information to governmental authorities

-- 72 of 81 --

9
regarding possible legal violations or otherwise testifying or participating in any investigation or
proceeding by any governmental authorities regarding possible legal violations, and, for purpose of
clarity, the Participant is not prohibited from providing information voluntarily to the Securities and
Exchange Commission pursuant to Section 21F of the Act. Furthermore, the U.S. Defend Trade Secrets
Act of 2016 (“DTSA”) provides that an individual shall not be held criminally or civilly liable under any
federal or state trade secret law for the disclosure of a trade secret that (i) is made (A) in confidence to a
federal, state, or local government official, either directly or indirectly, or to an attorney; and (B) solely for
the purpose of reporting or investigating a suspected violation of law or (ii) is made in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, the DTSA
provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected
violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
information in the court proceeding, if the individual (x) files any document containing the trade secret
under seal and (y) does not disclose the trade secret, except pursuant to court order.

-- 73 of 81 --

Exhibit B
Non-Competition and Non-Solicitation Provisions
1. Definitions. Unless otherwise defined, capitalized terms used in this Exhibit B shall have the
meanings given to them in the Agreement or the Plan, as applicable. As used in this Exhibit B:
(a) “Company” shall include all Subsidiaries of the Company.
(b) “Competing Organization” is defined as any organization that researches, develops,
manufactures, markets, distributes and/or sells one or more Competing Products/Services.
(c) “Competing Products/Services” means any products, services or activities (including, without
limitation, products, services or activities in the planning or development stage during the
Non-Compete Period) that compete, directly or indirectly, in whole or in part, with one or
more of the material products, services or activities (including, without limitation, products,
services or activities in the planning or development stage during the Non-Compete Period)
produced, provided, or engaged in by the Company or its affiliates at the time of the
Participant’s termination of employment with the Company and with which the Participant
worked or about which the Participant obtained any trade secret or other Confidential and
Proprietary Information at any time during the five (5) years immediately preceding the
Participant’s termination of employment with the Company. “Material products, services or
activities” means the development, manufacture or production of packaged potato, sweet
potato, appetizer and vegetable products for the retail, foodservice or institutional channels. If
the products manufactured, sold or marketed by the Company are expanded at any time
during the Participant's employment, such additional products will be deemed to be “material
products, services or activities” for all purposes under this Agreement.
(d) “Confidential and Proprietary Information” is defined as information and data of any kind, in
any form, not generally available to the public, concerning any matters affecting or relating to
the Company, including but not limited to: names, addresses, and any other characteristics
identifying information or aspects of existing or potential Company customers, employees,
vendors or suppliers; the business or operations of the Company and/or the financials,
products, drawings, plans, processes; or other data of the Company not generally known or
available outside of the Company. This definition also includes derivations of Confidential and
Proprietary Information, including any information derived, summarized or extracted from any
of the foregoing whether observed in writing, electronically, mechanically, and/or orally during
the Participant’s employment with the Company.
(e) “Employee” (including its plural) means any person employed by the Company.
(f) “Non-Compete Period” means the period from the date of the Agreement through the twelve-
month period following the Participant’s termination of employment with the Company for any
reason.
(g) “Prohibited Capacity” is defined as (i) any same or similar capacity to that the Participant held
at any time during the last three years of employment with the Company prior to the date of
the Participant’s termination of employment from the Company; (ii) any executive or
managerial capacity; (iii) any marketing or sales capacity; or (iv) any capacity in which the
Participant’s knowledge of Confidential and Proprietary Information would render the
Participant’s assistance to a Competing Organization a competitive advantage.
(h) “Restricted Geographic Area” is defined as all countries, territories, parishes, municipalities
and states in which the Company is doing business or is selling its products at the time of the
Participant’s termination of employment with the Company, including, but not limited to,

-- 74 of 81 --

every parish and municipality in the state of Louisiana.1 The Participant acknowledges that
this geographic scope is reasonable given the Participant’s position with the Company, the
international scope of the Company’s business, and the fact that the Participant could
compete with the Company from anywhere the Company does business.
(i) “Trade Secret” means information possessed by or developed for the Company, including,
without limitation, any compilation of data, program, device, method, system, technique or
process, where: (i) the information derives independent economic value, actual or potential,
from not being generally known to, and not being readily ascertainable by proper means by,
other persons who can obtain economic value from its disclosure or use, (ii) the information
is the subject of efforts to maintain its secrecy that are reasonable under the circumstances,
or (iii) information that constitutes a “trade secret” under the Idaho Trade Secrets Act, IDAHO
STAT. § 48-801(5) and/or under the DTSA.
2. Non-Competition. During the Non-Compete Period, the Participant agrees that he or she will not,
within the Restricted Geographic Area, be employed by, work for, consult with, provide services to, or
lend assistance to any Competing Organization in a Prohibited Capacity.
3. Non-Solicitation. The Participant recognizes and agrees that the Company has a legitimate
business interest in restricting potential competitors from hiring Employees who possess or otherwise
may have or had access to the Company’s or any of its affiliates’ Confidential and Proprietary
Information or Trade Secrets. Therefore, the Participant agrees that during the Participant’s
employment with the Company and through the twelve-month period following the termination of the
Participant’s employment with the Company, the Participant shall not directly or indirectly through any
other person or entity recruit, induce, or attempt to induce any Employee to terminate his or her
employment with the Company or otherwise interfere in any way with the employment relationship
between the Company and its Employees. This restriction includes, but is not limited to: (a)
identifying Employees as potential candidates for employment by name, background or qualifications;
(b) recruiting or soliciting Employees; and/or (c) participating in any pre-employment interviews with
Employees.
4. California Residents. Notwithstanding anything in the Agreement or in this Exhibit A, if the
Participant is a resident of the state of California, the non-competition and non-solicitation obligations
described in this Exhibit A shall not apply.
1 These Louisiana parishes currently include Acadia, Allen, Ascension, Assumption, Avoyelles,
Beauregard, Bienville, Bossier, Caddo, Calcasieu, Caldwell, Cameron, Catahoula, Claiborne, Concordia,
De Soto, East Baton Rouge, East Carroll, East Feliciana, Evangeline, Franklin, Grant, Iberia, Iberville,
Jackson, Jefferson, Jefferson Davis, La Salle, Lafayette, Lafourche, Lincoln, Livingston, Madison,
Morehouse, Natchitoches, Orleans, Ouachita, Plaquemines, Pointe Coupee, Rapides, Red River,
Richland, Sabine, St. Bernard, St. Charles, St. Helena, St. James, St. John The Baptist, St. Landry, St.
Martin, St. Mary, St. Tammany, Tangipahoa, Tensas, Terrebonne, Union, Vermilion, Vernon, Washington,
Webster, West Baton Rouge, West Carroll, West Feliciana and Winn.

-- 75 of 81 --

Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
I, THOMAS P. WERNER, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q for the quarter ended August 28, 2022 of Lamb
Weston Holdings, Inc.;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations, and cash flows of the
registrant as of, and for, the periods presented in this report;
4. 	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented
in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant's internal control over financial reporting
that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal
quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting; and
5. 	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal
control over financial reporting which are reasonably likely to adversely affect the registrant's
ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a
significant role in the registrant's internal control over financial reporting.
Date: October 5, 2022
/s/ THOMAS P. WERNER
THOMAS P. WERNER
Chief Executive Officer
(Principal Executive Officer)

-- 76 of 81 --



-- 77 of 81 --

Exhibit 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
I, BERNADETTE M. MADARIETA, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q for the quarter ended August 28, 2022 of Lamb
Weston Holdings, Inc.;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations, and cash flows of the
registrant as of, and for, the periods presented in this report;
4. 	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented
in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant's internal control over financial reporting
that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal
quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting; and
5. 	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal
control over financial reporting which are reasonably likely to adversely affect the registrant's
ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a
significant role in the registrant's internal control over financial reporting.
Date: October 5, 2022
/s/ BERNADETTE M. MADARIETA
BERNADETTE M. MADARIETA
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
J

-- 78 of 81 --



-- 79 of 81 --

Exhibit 32.1
CERTIFICATION
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, THOMAS P. WERNER, Chief Executive Officer of Lamb Weston Holdings, Inc., certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that Lamb Weston
Holdings, Inc.'s Quarterly Report on Form 10-Q for the quarter ended August 28, 2022 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and that the information contained in such
Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Lamb Weston
Holdings, Inc. as of and for the periods presented.
October 5, 2022
/s/ THOMAS P. WERNER
THOMAS P. WERNER
Chief Executive Officer
(Principal Executive Officer)
A signed original of this written statement required by Section 906 has been provided to Lamb Weston Holdings,
Inc. and will be retained by Lamb Weston Holdings, Inc. and furnished to the Securities and Exchange Commission or its
staff upon request.

-- 80 of 81 --

Exhibit 32.2
CERTIFICATION
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, BERNADETTE M. MADARIETA, Senior Vice President and Chief Financial Officer of Lamb Weston Holdings,
Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to
my knowledge that Lamb Weston Holdings, Inc.'s Quarterly Report on Form 10-Q for the quarter ended August 28, 2022
fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and that the
information contained in such Quarterly Report fairly presents, in all material respects, the financial condition and results
of operations of Lamb Weston Holdings, Inc. as of and for the periods presented.
October 5, 2022
/s/ BERNADETTE M. MADARIETA
BERNADETTE M. MADARIETA
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
A signed original of this written statement required by Section 906 has been provided to Lamb Weston Holdings,
Inc. and will be retained by Lamb Weston Holdings, Inc. and furnished to the Securities and Exchange Commission or its
staff upon request.

-- 81 of 81 --